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Plasmodium falciparum infection can be distinguished from that of other plasmodia 
which infect humans by one specific facet of it's biology, that of sequestration of mature 
developmental forms in capillary beds. A variant antigen, Plasmodium falciparum 
erythrocyte membrane protein 1 (PfEMP-1) is involved in this process and members of 
this trypsin soluble 210-230 kDa protein family are responsible for cytoadherence of 
mature infected erythrocytes. Their sequestration in vital organs including the brain, 
lungs, kidney and placenta may result in local pathology and in severe malaria 
syndromes such as cerebral malaria. PfEMP-1 genes are also subject to clonal antigenic 
variation and the development of anti-PfEMP-1 antibody may be a highly significant 
component of immunity against both mild and severe malaria.
A model system has been developed to investigate the molecular basis of infected 
erythrocyte adhesion to host endothelial receptors. P. falciparum clone 3D7A was 
selected for adhesion to Chinese Hamster Ovary (CHO) cells resulting in an adhesive 
phenotype, which is sensitive to trypsin treatment of infected erythrocytes. The nature of 
the cytoadesion receptor on the CHO cell surface has been analysed and does not appear 
to correspond to any of the protein or glycoprotein cytoadherence receptors so far 
described. It has been demonstrated that unselected 3D7A transcribes at least 27 
different var genes. On selection for adhesion to CHO cells this transcription is 
narrowed down to the transcription of a single gene named var-CHO. This gene has 
been cloned, sequenced and annotated. Var-CHO consists of 3 DEL domains, DBL-a, 
DBL-P and DBL-8, two CIDR domains, CIDR-cc and CIDR-(3, and a C2 domain. A 
provisional genomic map position of this member of the PfEMP-1 has been identified as 
chromosome 13 by a combination of pulse field gel and P. falciparum genome project 
data.
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1.1 The biology of malaria: the parasite life cycle
The elucidation of the life cycle of the malaria parasite ranks as one of the greatest 
advancements of medical science. Starting with Laveran's description of the 
exflagellation of microgametes in a blood sample taken from a French soldier serving in 
Algeria (Laveran 1880), and climaxing with the work of Grassi and Ross and the 
definitive description of the Anopheles mosquito as the vector infecting humans in 1898- 
99. The identification of liver forms as the intermediate stage between sporozoite 
infection and the erythrocytic invasion cycle by Shortt & Garnham (1948) ended an era 
of biological research which defined key features of the parasite and which subsequently 
had major influences on the epidemiology of the disease. Our current understanding of 
the life cycle is as follows.
Human infection by Plasmodium falciparum is initiated by the inoculation of 
sporozoites from the salivary glands of a female Anopheles mosquito into subcutaneous 
capillaries. After invading the parenchymal cells of the liver each sporozoite starts to 
replicate via a process known as hepatic schizogony (Figure 1.1, Phase 3). The nucleus 
divides repeatedly generating up to 30,000 merozoites in each hepatic schizont. Hepatic 
schizogony terminates as exoerythrocytic merozoites are released by schizont rupture. 
This is followed by merozoite invasion of erythrocytes in the blood stream. Invasion is 
achieved by the attachment of the merozoite apical complex to the erythrocyte
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membrane, formation of a vacuole and engulfment of the merozoite by the erythrocyte. 
Inside the erythrocyte the merozoite becomes vacuolated and ring shaped, becoming a 
so-called ring form. Growth of the ring form results in the parasite occupying a large 
portion of the cell and this growing stage is thus called a trophozoite. This stage 
undergoes nuclear division, which continues until the parasite reaches maturity with the 
formation of 8-16 erythrocytic merozoites by a process known as erythrocytic 
schizogony (Figure 1.1, Phase 4,). The erythrocyte ruptures and the merozoites are 
released into circulation. Many are destroyed by the host immune system, but others 
survive and re-invade other erythrocytes, perpetuating another cycle of erythrocytic 
schizogony. In each cycle a small proportion of the intracellular merozoites do not 
become schizonts but develop into gametocytes which are taken up into the mosquito 
during a blood meal, where zygote formation takes place. The zygote becomes an 
ookinete which invades the gut wall to form oocysts (Figure 1.1, Phase 1). The oocysts 
eventually burst to release sporozoites, some of which re-invade the salivary glands 
(Figure 1.1, Phase 2). The mosquito injects saliva, containing sporozoites, while 








































































































































































1.2 Plasmodium falciparum: parasite genomics
The parasite life cycle is fairly well understood, however deeper understanding of the 
parasite biology has been hampered by a lack of genomic data. P. falciparum harbours 
three gnomes, two small organellar genomes, a 5.9kb mitochondrial genome, and a 35kb 
circular genome (Wilson et al, 1996). The third genome, the nuclear genome, is 
approximately 30 Mb in size and is structured into 14 chromosomes, which vary in size 
from 0.6 to 3.5Mb in length. To address the lack of genomic data the nuclear genome 
has become the focus of a large scale sequencing effort by the malaria genome 
sequencing consortium. The consortium to date has been successful in sequencing 2 
chromosomes, numbers 2 and 3 (Gardener et al., 1998; Bowman et al, 1999). The P. 
falciparum genome has an -80% AT base content with one predicted gene per 4.7 kb of 
chromosome sequence. -50% of the genes maintain an intro-exon gene structure 
characteristic of genes found in higher eukaryotes, indicating that gene splicing is an 
integral part of Plasmodium gene transcription. In addition 40 % of predicted proteins 
show homology matches to eukaryotic proteins (Bowman et al, 1999).
The sequencing project has also identified many Plasmodium specific genes. 
Chromosomes 2 and 3 both have located at each chromosomal end, genes encoding for 
antigens involved in antigenic variation and cytoadhesion in P. falciparum malaria 
(Smith et al, 1995; Baruch et al, 1995; Su et al, 1995). Theses genes, named var genes, 
are members of a multi-gene family and encode the erythrocyte surface protein PfEMP- 
1. Research on the genes and the proteins they encode is the subject of this thesis. The 
sequencing effort has unearthed two previously known gene families. Members of the
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rif-1 gene family are transcribed at the late trophozoite stage and are found in clusters at 
chromosomal ends. These genes contain a 1kb open reading frame and a two exon gene 
structure, rif-1 genes contain a transmembrane sequence and recent experimental results 
have shown that the products of these genes are expressed at the erythrocytes surface 
and may be antigenically variant (Kyes et al, 1999; Fernandez et al, 2000). The third 
gene family described, stevor is also thought to be an antigenically variant erythrocyte 
surface protein family (Cheng et al, 1998). The function of these gene families is 
unknown and requires further characterisation.
The genome sequence data are providing an invaluable resource for scientists working in 
malaria research. The discovery of novel P. falciparum specific genes and genes with 
homologues in other organisms will not only accelerate basic malaria research but 
should also facilitate the development of new drugs and vaccines.
Introduction
1.3 Malaria pathogenesis
P. falciparum remains an organism of intense research not due to interest in the parasite 
biology per se but because malaria remains one of the most important infectious diseases 
in terms of morbidity and mortality. The symptoms of malaria vary, depending upon the 
species of infecting parasite, the transmission dynamics of infection and the immune 
status of the patient (Warrell, 1999). Malaria disease cannot be defined by a single 
diagnostic feature, however episodic chills, fever and sweating, interspersed by periods 
of wellbeing are characteristic symptoms. Classic P. falciparum malaria can be defined 
by the periodicity of febrile stages experienced by the patient, which is determined by 
the duration of the intra-erythrocytic cycle. Attacks of fever lasting 8-12 hours are 
usually precipitated by schizont rupture during blood stage parasitaemia. The symptoms 
of subsequent infections, after several weeks, become less marked with further 
infections resulting in milder symptoms in spite of persistent parasitaemia.
Blood parasitaemia bears little relationship to disease severity although hyper- 
parasitaemia is extremely dangerous. Immune individuals in endemic areas may be 
constantly parasitised, but often remain asymptomatic (Marsh, 1992). For many living in 
endemic areas, partial or complete immunity to malaria disease will eventually be 
acquired with age and symptoms will not develop in subsequent infections. However, a 
small proportion of patients, normally young African children, develop a severe life 
threatening illness when infected with P. falciparum malaria. Factors influencing 
disease severity are poorly understood but may include sporozoite dose, immune status, 
parasite virulence, socio-economic variables and host genetics (Weatherall, 1996).
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Symptoms of severe malaria can be variable and can differ between different age 
groups, transmission intensities and geographical locations. Different manifestations of 
malaria morbidity arise from the interaction of a number of pathogenic processes 
including red cell destruction and toxin-mediated activation of cytokine cascades 
(Warrell et al, 1999). However, it is believed by many that infected cell sequestration in 
the vascular beds of major organs plays some role in the pathogenesis of severe disease.
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1.3.1 Cerebral malaria
Cerebral malaria is the best known although not the only clinical manifestation of severe 
malaria. It is defined as coma due to malaria (Warrell et al, 1987,1992,). It is also 
confirmed by the histological appearance of infected erythrocytes sequestered in the 
micro-vasculature of some malaria post-mortem brain tissue samples (Macpherson, 
1985). As has been described, during asymptomatic infection with P. falciparum only 
the uninucleate ring forms are found in the peripheral circulation of severe patients. 
Mature parasites, withdraw or sequester deep in the vascular beds of a variety of organs 
including the brain. This binding is mediated by receptors expressed at the surface of 
endothelial cells and ligands expressed at the surface of the parasite. Several endothelial 
receptors medating the adhesive phenotype have been identified (Section 1.7). The 
evidence suggests that a hyper-variable protein family PfEMP-1 expressed at the surface 
of the red cell is the parasite derived receptor mediating most of the cytoadhesion in P. 
falciparum malaria. (Newbold et al., 1997 a) (Section 1.6).
There seems to be a great deal of variation in receptor usage by the parasite (Newbold et 
al., 1997 b). Heterogeneity in binding phenotype has raised the possibility that 
differences in either degree or site of cytoadherence may give rise to different 
pathological consequences. Expression of some receptors can be up-regulated in the 
presence of cytokines released during malaria infection (Udeinya & Akogyram, 1993). 
There are also differences in the parasite's ability to stimulate and control human 
cytokine responses (Allan et al, 1993), not to mention host genetics, which undoubtedly 
plays a role in the development of cerebral disease (Weatherall, 1996). This has led to
8
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the suggestion that cerebral malaria may be a consequence of particularly virulent 
parasites infecting a genetically susceptible host (Berendt et al., 1989). To test this, 
attempts have been made to try and explain cerebral malaria by investigation of host cell 
ligand expression and the propensity of parasites associated with disease to bind to 
specific ligands.
Histological studies of brain endothelium have shown that the endothelial receptor CD36 
is poorly expressed in brain tissue relative to other organs, and that it is in fact different 
in nature to CD36 expressed in other tissues (Barnwell et al, 1989; Chulay & 
Ockenhouse 1990; Turner et al, 1994). However Endothelial Adhesion Molecule 
l(ICAM-l) in brain tissue is expressed at significantly higher levels in patients suffering 
from cerebral disease than in non-cerebral controls (Turner et al, 1994).
There have been a number of studies attempting to correlate the binding to specific 
adhesion receptors with disease (Marsh et al, 1988; Ho et al, 1991; Ockenhouse, 1991 
b; Chaiyaroj et al, 1996; Goldring et al, 1992; Ringwald et al, 1993; Rogerson et al, 
1999 a; Newbold et al, 1997 b). There has been a great deal of variation in the affinity 
and specificity of binding of different parasite isolates to different receptors. The only 
consistent finding is that most parasites bind to CD36 and that CD36 binding is 
associated with non-cerebral disease (Ho et al, 1991; Okenhouse et al, 1991 b; and 
Newbold et al, 1997 b).
Only in one study has there been any correlation between cerebral malaria and receptor 
binding. Newbold et al (1997 b) found that ICAM-1 binding correlated with cerebral
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malaria, although the correlation was not statistically significant. Drawing correlations 
between this type of receptor binding and symptoms of disease is fraught with 
complexity. The clinical definition of disease can only take into account symptoms at 
presentation. Some individuals presenting early with uncomplicated malaria may have 
gone on to develop cerebral involvement in the absence of treatment. In such correlative 
studies these patients would be grouped in the uncomplicated malaria group. For 
logistical and ethical reasons these studies are forced to draw their samples from 
peripheral blood and not damaged tissue. One study conducted on placental 
sequestration has shown that the binding specificities of parasites in the peripheral 
circulation differ from that of the sequestered population (Fried et al, 1996). Other 
problems with such studies are that they rely on static assays that do not reflect the shear 
stress conditions under which parasites would have to bind in the blood stream. Also 
parasite binding to individual receptors does not necessarily reflect the natural situation 
where it is plausible that receptors work in co-operation to mediate cytoadherence (See 
section 1.7).
Host genes may also affect the progression of cerebral disease, having a direct effect on 
sequestration. Observations have been made suggesting an association between 
polymorphisms in the ICAM-1 gene and cerebral malaria. A polymorphism in the 
ICAM-1 gene has been found in individuals from East and West Africa, which is not 
present in Europeans (ICAM-Kilifi). In a large case control study it was found that 
homozygotes for this allele had a significantly higher risk of developing cerebral malaria 
than other genotypes (Fernandes-Reyes, et al, 1997).
10
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Elevated cytokine production may also play a role in the sequestration process. High 
plasma levels of TNF-oc have been associated with cerebral malaria (Kwiatkowski et al, 
1990). This cytokine has been proposed to affect disease via its local effect on 
endothelial receptor expression (Berendt et al, 1989). There is evidence that TNF-cc 
production is up-regulated in both P. vivax and P. falcipamm but the ensuing pathology 
differs between the two (reviewed by Kwiatkowski 1995). TNF-a and other cytokines 
may increase the levels of sequestration locally by activating endothelial cells, causing 
the up-regulation of host derived cytoadherence receptors (Rothlein et al, 1988; Pober 
et al, 1988). This up-regulation by cytokines has been demonstrated in vitro for the 
parasite cytoadherence receptor 1C AM-1 (Berendt et al, 1989, 1992)
11
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1.3.2 The resetting phenotype in infected red blood cells
Another adhesive phenotype, which some authors have associated with severe disease is 
that of resetting, the ability of infected erythrocytes to adhere to uninfected erythrocytes. 
The rosetting phenotype was first described in P. fragile which sequesters in its natural 
host the toque monkey (David et al, 1988). This phenomenon has also been observed in 
P. falciparum, which also sequesters (Carlson et al, 1992). These initial experiments 
revealed that rosettes could be disrupted by immune serum in a specific manner, 
suggesting that the molecules involved were antigenic (David et al., 1988, Carlson et al, 
1992). However this study shed no light on whether this phenomenon occurred in vivo or 
was clinically relevant.
Association of rosetting with severe disease was first investigated in The Gambia where 
it was found that all patients suffering from cerebral malaria possessed parasites that 
formed rosettes, a phenotype exhibited by only 18% of the uncomplicated malaria cases 
(Carlson et al, 1990). The ability of immune serum to inhibit or reverse rosettes was 
also analysed. Antisera from cerebral cases failed to reverse rosetting while almost 40% 
of sera from uncomplicated malaria cases did reverse rosetting. Data from ex vivo 
studies show that rosetting enhances micro-vascular obstruction by compounding the 
effects of cytoadhesion. Parasites capable of cytoadherence and rosetting showed a 3.6 
fold increase in flow resistance compared to a 2.7 fold increase in parasites which only 
cytoadhere (Kaul et al, 1991). Heparin and antibody can disrupt these clusters, the latter
12
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observation supporting the contention that antibody which inhibits resetting in vitro may 
also play a role in preventing or reversing sequestration in vivo. Although there is a 
strong link between this phenotype and the pathogenesis of severe disease the ultimate 
significance of this phenotype remains unclear. Hypotheses to explain its selective value 
to the parasite have included the idea that phagocytosis is prevented through additional 
protection from host antibody, and that resetting is a mechanism to promote red cell 
invasion. The latter property has been tested and it was found that there was no 




1.4 Placental malaria and P. falciparum cytoadhesion
The brain is only one of several organs within which the mature infected erythrocyte 
sequesters. In pregnant women, especially those experiencing their first pregnancy 
(primigravidae), the placenta represents another site (Fried et al, 1996). This has clinical 
consequences, as these women become more susceptible to frequent and severe forms of 
malaria infection (Gilles et al, 1969; Brabin et al, 1983). Pregnant women suffer two- 
to ten-fold higher mortality due to severe malaria than non-pregnant women (Brabin, 
1983, 1991). Abortion, still birth, premature delivery and low birth weight of the infant 
are also common. The most frequent presentation of maternal malaria is anaemia 
(Brabin, 1983), and the most common effect this has on the foetus is a significant 
reduction in birth weight (Bruce-Chawatt, 1952; Gilles, 1969; McGregor, 1983, 
Watkinson & Rushton, 1983; Cot et al, 1992; Matteelli et al, 1996; Steketee et al, 
1996).
Malaria can cause low birth weight via different aetiologies including intra-uterine 
growth retardation (IUGR), premature delivery or both. However, a consensus has 
emerged that IUGR is the predominant mechanism (McGregor 1984; Steketee, 1996) 
and that it is associated with placental infection. Malaria-induced low birth weight is 
thus associated with a significantly increased risk of mortality and morbidity in the first 
year of life.(Bloland, 1996). Parasitised erythrocytes have consistently been described in 
the intervillous spaces in placentae delivered at term. The predominant stage found is 
the trophozoite, although schizonts have also been reported (Rogerson & Beeson 1999). 
Malaria pigment is however present in several sites during the early stages of infection, 
concentrating in the macrophages, intervillous spaces, trophoblasts, Hoffbauer cells and
14
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in fibrin deposits in the villous stroma. Pigment disappears after active infection is 
resolved (Bulmer et al, 1993). This clearance occurs within months and thus any 
pigment present in term placentae probably derives from infections acquired during the 
second half of pregnancy. The appearance of parasite pigment is not the only 
histological change observed in placental infection. Monocytes sequester in the 
intervillous spaces, cytotrophoblastic cells become more common and there is a 
thickening of the trophoblastic basement membrane (Galbraith et al, 1980; Walter et 
al, 1981; Yamada etal, 1989)
1.4.1 Ligand receptor interactions associated with placental 
malaria infection
Histological examination of placenta may show signs of acute infection (the presence of 
infected erythrocytes in the intervillous spaces), past infection (malarial pigment in 
leukocytes) or both. Placental parasitaemias exceed 50% in contrast to peripheral 
parasitaemias, which are typically between 0.5 and 2.0% (Bulmer et al, 1993). Bulmer 
et al (1993) and McGregor, (1984) postulated that the accumulation of parasites in the 
placenta results from sequestration, shielding the parasites from immune destruction. 
This observation has been linked with the ability of the infected erythrocyte to adhere in 
vitro. Mature infected erythrocytes exhibit a number of adhesive specificities in vitro. It 
has been shown that the glycosaminoglycan chondroitin sulphate A (CSA) is an infected 
erythrocyte adhesive receptor (Rogerson et al, 1995). CSA binding is not a property of 




The identification of CSA as P. falciparum cytoadhesion receptor prompted a more 
systematic search for its biological significance. Fried et al (1996) investigated the 
placenta as a possible site for in vivo cytoadherence via CSA, as CSA is expressed on 
the syncytiotrophoblast of the placenta. Parasites sequestered in the placenta adhered to 
trophoblastic villi, extracellular villi and syncytial bridges in a CSA dependent manner. 
CSA inhibits and reverses binding of infected erythrocytes to placenta. Pre-treatment of 
tissue samples with chondroitinase ABC, an enzyme which hydrolyses CSA, also 
inhibited adhesion. Parasites taken from the peripheral circulation failed to adhere in 
substantial numbers to CSA but bound to another cytoadhesion receptor, CD36. 
Parasites isolated from the placenta were unable to bind to CD36 or ICAM-1 but bound 
in significant numbers to CSA. Fried et al (1996) suggest that P. falciparum infection 
consists of a mixed population (in terms of the adhesive phenotype they express) and 
that parasites expressing the ligand for adhesion to CSA are selectively sequestered in 
the placentae of pregnant women. The authors also suggest that this phenomenon is 
more common in primigravid women due to the development of anti-adhesive antibodies 
with successive pregnancies. Multigravid women possess antibodies which are able to 
block adhesion to CSA and these antibodies are absent from men, children and 
primigravid women (Fried et al., 1998; Ricke et al., 2000). The presence of these 
antibodies also correlate with reduced placental infection. This antibody response is 
strain-independent (Fried et al, 1998).
The issue of placental sequestration has been complicated by the recent identification of 
hyaluronic acid (HA) as a cytoadhesion receptor for the infected erythrocyte, which is
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also expressed in placental tissue. In a recent study it has been shown that 80% of 
parasites isolated from the placenta adhere to hyaluronic acid in vitro, compared to 36% 
of parasites isolated from the peripheral circulation of pregnant women and 33% of 
parasites isolated from the peripheral circulation of children (Beeson et al, 2000). 
Laboratory isolates selected for binding to CSA also adhere via HA. However, this 
cross-binding is not consistently found in field isolates. The authors thus suggest that 
the binding epitope for these two adhesive phenotypes may be expressed on the same 
protein, but this is yet to be proven. It is difficult to say whether these binding receptors 
work synergistically in placental sequestration or whether they merely provide the 
parasite with a number of options for binding to the placenta. More research into this 
area will provide answers to these questions.
1.4.2 Host factors which may also influence placental 
infection
Host factors may exacerbate the pathological effect of parasites sequestering in the 
placenta. Placental intervillous spaces may be infiltrated to varying degrees by 
leukocytes, predominantly mononuclear cells which often contain pigment (Galbraith et 
al., 1980; Bulmer etal., 1993). There is a higher proportion of leukocytes in intervillous 
blood than peripheral blood. In over half of the moderately to heavily parasitised 
placentae, mononuclear cells represented greater than 5% of intervillous cells. The 
degree of infiltration can be intense, resulting in chronic intervillousitis (Ordi et al., 
1998). This condition occurs in approximately 10% of placentae isolated and most
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frequently in primigravidae. Intervillousitis also appears to be strongly associated with 
low birth weight (Ordi et al, 1998).
Many cells within the placenta including Hoffbauer cells, cells of the 
syncytiotrophoblast, uterine epithelial cells, amniotic membranes, foetal endothelium, 
and intervillous maternal leukocytes can produce a wide variety of cytokines and 
chemokines (Robertson et al., 1994). Although the Thl-Th2 dichotomy has not been 
firmly established in human pregnancies, the pro-inflammatory Thl and the anti- 
inflammatory Th2 response may help explain the immune response to malaria in the 
placenta. Robertson et al., (1994) suggest that successful pregnancy and foetal growth 
are associated with a predominant Th2 response in the placenta, whereas a predominant 
Thl response may lead to foetal loss. Recently a study was conducted on the cytokine 
responses in the placenta in relation to malaria infection, which suggested that infection 
induces a shift towards the production of a Thl response, resulting in adverse pregnancy 
outcome (Fried et al., 1998).
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1.5 Immunity to malaria and antibody responses 
against PfEMP-1
Understanding of the pathogenesis of malaria has provided an insight into the 
mechanisms of pathology. This understanding combined with an understanding of the 
immune response against the parasite may permit the development of public health 
interventions such as vaccines. In endemic areas a degree of immunity only appears to 
develop after multiple infections over several years. This immunity appears to develop 
in two phases. An anti-disease immunity, signified by a reduction in clinical symptoms, 
followed by an anti-parasite immunity, signified by a reduction in parasitaemia. Children 
from the age of six months to five years are at risk from severe malaria and even in 
adults this immunity is rarely complete (Marsh et al, 1992). The persistence of the 
parasite in immune individuals is thought to result from immune evasion mechanisms 
such as antigenic variation (Roberts et al., 1992), the ability to down-regulate host 
immune responses (Urban et al., 1999) and possibly to antagonise cytotoxic T- 
lymphocyte responses (Gilbert etal, 1998).
1.5.1 The species specificity of immune responses to 
malaria
Evidence of the species specificity of immunity to malaria comes from analysis of 
neurospyhillitic patients treated with malaria as a therapeutic measure. These treatments 
used several different Plasmodium species, with individual patients often receiving
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multiple inoculations during the course of treatment. This work demonstrated that some 
degree of immunity was observed in individuals infected with homologous species of 
Plasmodium, an immunity which was not protective against inoculations with 
heterologous species (Covell & Nicol, 1951; Jeffrey, 1966). These conclusions have 
recently been challenged by epidemiological data suggesting that in areas where 
Plasmodium falciparum and Plasmodium vivax coexist there is a dynamic relationship 
between them. The authors observed an apparent suppression of P. vivax infection by P. 
falciparum and suggest that the nature of this suppression could be based on a level of 
immunological cross-protection (Maitland et al., 1996).
1.5.2 Strain Specific immunity to P. falciparum
Analysis of malaria treatment of neurosyphillitic patients also revealed that there are 
significant differences in clinical symptoms between patients infected with heterologous 
strains of the same species as compared to those infected with homologous strains. Any 
acquired immunity is essentially strain-specific (Covell & Nicol 1951; Jeffrey, 1966). 
These results were confirmed in the primate model P. knowlesi (Brown & Brown, 1965, 
Brown et al, 1970), studies which also led to the identification of variant-specific 
immune responses (section 1.6).




1.5.3.1 liver stage immunity
Immunity against P falciparum is essentially stage-specific. Almost all of the 
information available on the protective immune response against the sporozoite and 
hepatic stages of infection is based on data generated from immunisation experiments 
with irradiated sporozoites (Orjih et al,. 1980). Infection with P. berghei sporozoites 
can be immunogenic and elicit a response which protects against sporozoite challenge 
(Beaudoin et al., 1977). It is essential for the induction of this immune response that the 
sporozoites are able to invade and at least partially develop in the hepatocytes 
(Herrington et al., 1991). The predominantly expressed protein at this stage of the 
parasite's life cycle is the circumsporozoite protein (CS). The gene determining this 
protein was first cloned in 1984. The gene sequence consists of a repeat region flanked 
by two repetitive conserved regions (Enea et al., 1984). The protein is thought to be 
involved in sporozoite mobility and is essential for binding to and invasion of the 
hepatocyte (Stewart, 1986; Cerami et al., 1992). Human volunteers immunised with 
irradiated sporozoites produce CD8+ cytotoxic T-cells with specific activity against CS 
protein (Kumar et al., 1988), a response subsequently observed in adult Kenyans 
(Sedegah et al., 1992) and Australians who had lived in malaria endemic areas (Doolan 
et al., 1991). Recently its has been demonstrated that HLABw53 restricted CTLs 
recognise a polymorphic epitope on the CS protein which antagonises the CTL response 
in-vitro (Gilbert et al., 1998). This CTL response may be important in clinical immunity 




1.5.3.2. Blood stage immunity
The next stages in the parasite life-cycle to be exposed to the host immune response are 
the asexual blood stages, which are responsible for the mortality, pathology and 
morbidity associated with malaria disease. Protective immunity to these stages is 
thought to be both antibody and cell-mediated, but again the precise mechanisms of 
protection are unclear. In some murine malarias such as P. chabaudi, control and 
elimination of the parasite can be achieved in an antibody independent manner 
(McDonald & Phillips, 1980; Langhorne et al, 1989; Taylor-Robinson, 1993). For P. 
chabaudi chabaudi AS strain the control of the primary acute parasitaemia is 
independent of antibody but the subsequent elimination of the parasite is dependent on 
antibody. For the latter parasite, CD4+ T-cells are essential for mice to survive infection 
(Langhorne et al., 1989). In this murine model the primary acute parasitaemia seems to 
be mediated by CD4+ Thl cells (the subset of CD4+ cells associated with 
antibody-independent immunity), whereas immediately following the decline in 
parasitaemia there is a switch to the CD4+ Th2 response (associated with antibody 
production) (Langhorne et al., 1989; Taylor-Robinson & Phillips, 1994 a, 1994 b). 
These animal experiments now have support from epidemiological findings, which have 
shown that the reduction of CD4+ cells brought about by HIV infection contributes to 
and increased risk of developing clinical disease (Whitworth et al., 2000)
The merozoite stage of infection is also a target for the host immune response, a 
response that has been correlated with clinical immunity (Egan et al, 1996). The most 
abundant protein on the surface of the merozoite is the merozoite surface protein -1
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(MSP-1). This protein consists of a complex of polypeptides, which are proteolytically 
cleaved from the surface of the merozoite prior to merozoite invasion. The protein is 
anchored to the surface of the merozoite via a GPI anchor and can be divided into 
seventeen variable semi-variable and conserved sequence blocks ( reviewed by Cooper 
et al., 1993). The protein is subject to several cleavage events prior to invasion, the 
penultimate cleavage leaving a 42 Kd protein product attached to the merozoite surface. 
The ultimate cleavage step can be blocked by monoclonal antibody, which also has the 
ability to block invasion in vitro (Blackman et al, 1994). In primate and mouse models, 
immunisations with recombinant protein or by passive transfer of antibody confer 
protection against homologous challenge. This supports epidemiological evidence which 
suggests that the development of antibody responses to MSP-1 correlates with protection 
from both clinical malaria and parasitaemia (Egan et al, 1996).
1.5.3.3 Immune responses to the P. falciparum-mfected 
erythrocyte surface
The merozoite, once it has successfully invaded the red cell, develops into a trophozoite. 
The red cells express no MHC-antigens and thus cannot present parasite proteins to the 
host immune system. It has been suggested that the parasite's metabolites are exported 
to the surface of the infected red cells via proteins expressed through knob structures 
present at the red cell surface (Berendt et al, 1994). Knob proteins appear at the surface 
of the infected red cell. They are a complex of proteins, which include the P. falciparum 
erythrocyte membrane protein-1 (PfEMP-1). This protein family is involved in 
cytoadherence, antigenic variation and is the target of clinical immunity to P. falciparum
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(Reeder & Brown 1996). As far back as 1938 it was show by agglutination assays that 
red cells containing mature trophozoite stage parasites could be agglutinated by immune 
serum, from which it was concluded that the surface of the infected red cell was of 
immunological importance (Eaton etal, 1938).
In 1986, Marsh & Howard published experiments to examine the presence of these 
variant-specific agglutination responses in individuals living in endemic areas and to see 
whether these responses correlated with protection from severe disease (clinical 
immunity). They conducted agglutination experiments using acute sera, obtained on the 
day of reported infection and convalescent sera, collected 21 days post infection from 
the same patient. In most cases, acute sera from children aged one to five years did not 
recognise their infecting parasite whereas the convalescent sera of each child did. 
Agglutination of heterologous parasites by the children's acute or convalescent sera was 
relatively rare. However, sera collected from adults from the same area possessed 
agglutinating antibodies capable of agglutinating a wide range of parasite isolates (pan- 
agglutinating antibodies). From these experiments they concluded that the agglutinating 
antibody response was isolate specific and with age one could develop an agglutinating 
response against a number of isolates either through exposure to the entire antigenic 
repertoire of the parasite or through exposure to conserved determinants on the red cell 
surface.
Absorption and elution experiments have shown that adult sera absorbed onto and eluted 
from the surface of the infected red cell are able to pan-agglutinate a number of different 
parasite isolates whereas the remaining non-absorbed sera lose all ability to pan-
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agglutinate (Marsh & Howard, 1986). The authors inferred from this result that the pan- 
agglutinating antibody response is to conserved determinants. Agglutination studies 
conducted in a variety of geographical locations have confirmed that, at least in children, 
the agglutination response is isolate specific (Forsyth et al, 1989; Reeder et al, 1994; 
Bull et al., 1998). Many studies indicate that many if not all adults living in malaria 
endemic areas acquire pan-agglutinating antibodies (Marsh & Howard, 1986; Forsyth et 
al, 1989; Aguire et al., 1992). However, Reeder et al. (1994) were unable to isolate 
these pan-agglutinating antibodies. The existence of pan-agglutinating antibodies and 
how they are derived remains contentious; however, the answers to these questions are 
pertinent to the development of a malaria vaccine against this stage of infection.
Although a number of studies have confirmed that increased agglutination response is 
directly proportional to the age of the serum donor (an indirect measure of clinical 
immunity) only two studies have directly correlated the agglutinating response with 
protection against clinical malaria (Marsh et al., 1989; Bull et al., 1998). Bull et al., 
conducted a large prospective study of the agglutinating antibody response and its 
relationship with clinical immunity. They showed that children who develop clinical 
malaria show a significant reduction in the ability of their pre-infection sera to 
agglutinate the infecting parasite, compared to age-matched asymptomatic controls. 
They thus concluded that the agglutinating antibody response correlates to some degree 
with protection. They also showed that there was an almost exclusive appearance during 
clinical disease of parasite variants corresponded to "gaps" in the child's developing 
repertoire of PfEMP-1 antibodies. The authors inferred from this that pre-existing
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antibodies only provide protection against the variants to which they are directed (they 
are isolate specific).
Another study looking at the agglutinating antibody response, in an area of meso- 
endemic malaria in Sudan (Giha et al, 1998), has demonstrated that the pan- 
agglutinating response in the post-transmission season is greater than the pre- 
transmission response, indicating that this response is a) against conserved determinants 
and short-lived, b) against conserved determinants and boosted by infection or c) against 
greatly diverse antigenic determinants. They also show that the acquisition of pan- 
agglutinating antibody can occur in the absence of clinical disease, an observation that 
has potential implications for the treatment of sub-clinical infections. Further to this 
Bull et al. (1999) have observed that the most frequently agglutinated isolates (that is, 
the variant specific antigen recognised by most serum) tended to be from individuals 
suffering from severe disease. This suggests that clinical immunity is acquired through 
immune responses against specific antigenic variants, which are common or at least 
commonly recognised by the host immune system.
A number of studies have shown that a natural acquired immune response against the 
trophozoite stage of malaria prevents or reverses binding of infected erythrocytes to cell 
lines (Forsyth et al., 1989) and purified receptors (Reeder et al., 1994) in vitro. Indeed a 
high level of agglutinating antibodies seems to correlate with having a high degree of 
anti-binding antibody (Forsyth et al., 1989). One study has indicated that individuals 
who presented with severe disease tended to lack antibodies, which inhibited or reversed 
rosetting. A number of individuals who presented with mild disease in the same study
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possessed anti-rosetting antibodies, the implication being that this immune response 
protects individuals against severe disease (Carlson et al, 1990). Recently evidence also 
suggests that the immune response against the infected erythrocyte's surface protects 
multigravid women from the adverse effects of malaria during pregnancy (Ricke et al, 
2000). This has been discussed in greater detail in section 1.4.
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1.6 Antigenic variation and the identification of 
PfEMP-1
It is known that some Plasmodium species maintain chronic erythrocytic infections over 
long periods of time (Brown & Brown 1965). One possible biological phenomenon that 
could explain this observation is that the parasite modifies its antigenic surface during 
infection to escape the developing immune response. Clonal antigenic variation has been 
observed in other parasitic protozoa such as Trypanosoma brucei and Giardia lamblia 
and could explain, in part, chronic malaria infection and the slow development of 
immunity.
The first evidence suggesting antigenic variation in malaria was provided by serological 
experiments employing a Schizont Infected Cell Agglutination assay (SICA) developed 
by Eaton et al. (1938) in which immune serum from monkeys immunised with 
Plasmodium knowlesi agglutinated the mature trophozoite forms of the parasite. Brown 
& Brown (1965) demonstrated that the target of this agglutinating response was a novel 
antigenically variant antigen expressed at the infected erythrocytes' surface. P. knowlesi 
schizonts were agglutinated by convalescent sera obtained from the infected monkey 
two to three weeks post inoculation. Serum immunoglobulin reacted with an antigen 
being expressed at the parasites surface. However the inoculation of parasites into a 
monkey already possessing antibodies to the specific variant being expressed resulted in 
the emergence of a parasite population expressing a novel antigenic type. The authors
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concluded from these experiments that P. knowlesi like T. brucei, was capable of clonal 
antigenic variation.
Other authors suggested that the emergence of an antigenically distinct parasite 
population might represent immune selection of a parasite population from a genetically 
mixed parasite pool. Thus these experiments were eventually repeated with cloned 
parasites and similar results obtained (Barnwell et al, 1983). It was also shown that the 
target of the agglutinating antibody response against the variant antigen seemed to be 
modulated by the spleen, which the authors correlated with virulence (Barnwell et al, 
1983). Experiments in squirrel monkeys demonstrated that antigenic variation and 
splenic regulation of the variant antigen were also properties of P. falciparum. These 
experiments were the first to link changes in variant antigen expression with changes in 
the cytoadhesion properties of P. falciparum (Hommel et al, 1983) (see section 1.7).
As similar experiments were conducted on other species of Plasmodium it became 
apparent that antigenic variation was not a phenomenon specific to just a few species of 
Plasmodium but probably an immune evasion strategy employed by all species . In P. 
fragile there is also some evidence that switching of the variant antigen occurs in 
sequential order (Handunnetti etal, 1987).
Parallel to these in vivo studies, biochemical experiments on P. knowlesi were being 
performed with the aim of defining the SIC A antigen involved in antigenic variation. It 
was shown that this protein could be detected by radio-iodination and was 
approximately 210 kDa in size. It could also be immuno-precipitated specifically by
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antibody which agglutinated the same parasite in a variant specific manner (Barnwell et 
al., 1983). Similar experiments conducted on P. falcipamm identified the P. falcipamm 
equivalent of SICA which was termed Plasmodium falcipamm erythrocyte membrane 
protein-1 (PfEMP-1) (Leech et al, 1984). Cloned parasites cultured in vitro over a 
number of months eventually gave rise to antigenically different parasite populations, 
which expressed different PfEMP-1 molecules of different size and antigenicity and 
again could only be immuno-precipitated by serum that agglutinated the parasites from 
which these proteins were derived. This was the first evidence that antigenic variation 
also occurs in vitro (Biggs et al., 1991).
In a set of experiments conducted by Roberts et al. (1992) 7 sub clones were produced 
from the ITO-4 parasite line. Twenty-one clones were produced during a two month 
cloning period. During this time the antigenicity of some of the cloned parasites had 
switched as defined by a change in agglutination and cytoadherence phenotype. From 
these data it was calculated that antigenic variation occurred at a rate of 2% per parasite 
generation. Biggs et al. (1992) demonstrated that cloning followed by selection for 
adherence of infected erythrocytes to an endothelial cell line resulted in the selection of 
specific PfEMP-l variants of similar size and antigenicity. The size of the PfEMP-1 
variant and its antigenicity were shown to be distinct from the parental unselected clone. 
These experiments showed that PfEMP-1 is antigenically variant, and is linked to 
cytoadherence. However, in the absence of data indicating the existence of a multi-gene 




In 1995, using a variety of methods, the multi-gene family encoding PfEMP-1 was 
finally identified (Su et al, 1995 Smith et al, 1995, Baruch et al, 1995). Baruch et al, 
(1995) conducted an elegant set of experiments using agglutinating serum recognising 
the Malayan Camp parasite strain to identify a clone expressing PfEMP-1 epitopes 
expressed in a A,gtl 1 cDNA expression library. Su et al (1995) fortuitously identified a 
multi-gene family with PfEMP-1 type characteristics while in search of genes 
determining chloroquine resistance on chromosome 7. Through a collaborative effort it 
was show that the sequences identified matched the criteria required for PfEMP-1 type 
proteins. Baruch et al (1995) were able to show that antisera raised against the 
sequence expressed in a heterologous expression vector, recognised the surface of the 
infected red cell. The third paper in the set representing this major discovery 
demonstrated that transcription of a specific gene family member correlated with the 
expression of a corresponding PfEMP-1 specificity (Smith et al, 1995). The gene 
family was named var and is thought to be present as approximately 50 copies per P. 
falciparum genome (Su et al, 1995). The genes vary in size between 4 and 13 kb, and 
always consist of two exons separated by an approximately 1 kb intron, which is 
adjacent to the trans-membrane region of the gene. Exon-1 encodes the part of the 
protein which lies extracellular to the red cell membrane and is divided up into 1-2 
Cysteine-Rich Interdomain Regions (CIDR) and 2-7 Duffy binding ligands (DBL) 
domains, one CIDR and four different types of DBL domain groups were originally 
identified, DBL-1 to DBL-4, based on specific conserved sequence motifs previously 
noted in the P. vixax duffy binding protein (Su et al., 1995). However, recently a second
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type of CIDR domain and another DEL homology group have been defined. The 
nomenclature has also changed, replacing the original numerical labelling of CIDR and 
DEL domains with the Greek alphabet (i.e. DBLoc, P, y, 8, and e) (Smith et al, 1998, 
2000 b). The authors also discovered a new C2 domain, which is always found 3' of the 
DBL-P domain. A schematic representation of a var gene is shown in Figure 1.4
Var genes have been localised to the subtelomeric region of each of the 14 plasmodial 
chromosomes and to the internal regions of a number of them (Rubio et al, 1996). The 
var gene sequence exhibits a great deal of diversity both within and between clones from 
different geographical locations (Kyes et al, 1997; Ward et al, 1999). This may 
contribute to antigenic diversity with regard to the immune response against this stage of 
the parasite. Analysis of parasite clones which undergo meiosis under laboratory 
conditions have revealed that this diversity is generated at a rate far greater than would 
be expected by homologous recombination (Freitas-Junior et al, 2000). The authors 
suggest that in addition to homologous crossover events, var gene diversity in P. 






































































































































































































































































































1.6.2 Var gene transcription
Var genes are known to be transcribed from both internal and subtelomeric 
chromosomal locations (Fischer et al, 1997), thus differentiating their expression from 
that of the African trypanosome vsg (variant surface glycoprotein) genes whose 
expression is largely limited to telomeric expression sites (Borst et al, 1995). It seems 
likely that in P. falciparum most, maybe all, var genes can be transcribed, regardless of 
their chromosomal location. Early developmental stage parasites (rings or early 
trophozoites) are capable of simultaneously expressing several var genes from different 
chromosomes (Fischer et al, 1997; Scherf et al, 1998; Chen et al, 1998 b). However, 
the expression of var genes in mature parasites is thought to be less heterologous and 
may even be monogenic (Scherf et al, 1998; Chen et al, 1998 b ).
Although many mechanisms of transcriptional regulation of var genes have been 
postulated (Borst et al, 1995) it is becoming clear that var gene expression could have 
some element of post transcriptional regulation. Chen et al, (1998 b) and Scherf et al, 
(1998) suggest that early developmental forms may undergo a process of 'loose 
transcription' during early ring stage, resulting in the short-lived activation of many and 
perhaps all var genes. By the trophozoite stage of infection, transcripts of a single var 
gene may in some way be selected for expression on the cell surface. These findings 
have not been supported by all workers in the field, some of whom suggest that only one 
full length var transcript is present at ring stage (Taylor et al, 2000).
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1.7 The molecular basis of cytoadherence
P. falciparum is the most pathogenic of the human malaria species. A feature which 
distinguishes P. falciparum infection from that of the other malaria species infectious to 
humans, P. ovale, P malariae and P. vivax, is the absence of mature 
trophozoites/schizont forms in the peripheral circulation. Post-mortem samples of 
specific organs such as the brain frequently show that capillaries are occluded by these 
mature parasite forms, a process known as sequestration (MacPherson et al, 1985). 
Sequestration may be due to a variety of cellular interactions as the parasite is able to 
bind in vitro to a number of cell types. These include monocytes, macrophages, platelets, 
lymphocytes, uninfected erythrocytes, infected erythrocytes and syncytiotrophoblast 
surfaces of placental villi. The relative importance of these interactions in vitro are 
unknown, but sequestration clearly has important consequences for both host and 
parasite.
1.7.1 The host receptors for P. falciparum cytoadherence 
and sequestration
Due to the relative wealth of information on receptors expressed by the host, significant 
progress has been made in our understanding of this half of the host-parasite interaction. 
In vitro models of endothelial binding first demonstrated that the most plausible 
explanation for infected cell sequestration was that the infected erythrocyte adhered to 
microvascular endothelium and that the presence of parasites in the micro-vasculature
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was not simply due to mechanical obstruction as has been suggested by some authors. 
Human umbilical vein endothelial cells (HUVEC), amniotic endothelial cells and C32 
melanoma cells all mediate cytoadherence in vitro and each were pivotal in identifying 
cytoadherence receptors. An antibody against the human cell surface antigen OKM-5 
(which was later identified as the leukocyte differentiation antigen CD36) inhibited 
adhesion of infected erythrocytes to C32 melanoma cells (Barnwell et al., 1989). A 
second adhesion receptor was identified by demonstrating that parasitised erythrocytes 
could adhere to petri dishes coated with thrombrospondin, another glycoprotein involved 
in adhesion migration, proliferation and differentiation of leukocytes (Roberts, et al., 
1985). In an elegant set of experiments Berendt et al., (1989) demonstrated that 
transfection of COS cells with cDNA from the ICAM-1 encoding sequence permitted 
these cells to support the cytoadhesion of infected erythrocytes. ICAM-1 is a member of 
the immunoglobulin superfamily which plays a major role in the adhesion and 
transmigration of leukocytes from the blood to the tissues during inflammation. COS 
cell transfection was subsequently used to provide definitive evidence that another cell 
surface molecule, CD36 mediates cytoadherence (Oquendo et al., 1989). Other 
endothelial receptors responsible for recruitment of leukocytes during inflammation also 
appear to be involved in cytoadherence. Two of these receptors, endothelial cell 
adhesion molecule-1 (ECAM-1) and vascular cell adhesion molecule -1 (VCAM-1) 
mediated cytoadhesion after cytokine induction of their expression at the surface of 
HUVEC cells (Ockenhouse et al., 199Ib). The list of cytoadherence receptors now 
includes, P-Selectin (Ho et al, 1998), PECAM-1 (Treutiger et al, 1997), hyaluronic 
acid (Beeson et al, 2000) and chondroitin sulphate-A (Rogerson et al, 1995), indicating 
that the parasite exhibits an array of host ligands which it may use to attach itself to host
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endothelium. As the list has grown ever longer some authors have suggested that only 
one or two of these receptors may be of clinical importance. This idea has been 
investigated, but the results are still inconclusive (see section 1.3).
1.7.2 Are static assays of adhesion good models of in vivo 
parasite mediated sequestration?
Most studies of cytoadherence of parasitised erythrocytes have employed static assays 
because they are technically simple and inexpensive. However, experiments conducted 
in a static environment ignore the shear forces exerted on cell-cell interactions by 
circulating blood. These forces presumably affect the ability of parasitised erythrocytes 
to localise in the venular circulation in vivo. Flow based assays are therefore likely to be 
better able to model the dynamic relationship which occurs between parasitised 
erythrocytes and the lining of the endothelium. Animal models of infection such as P. 
falciparum infection of Aotus or Saimiri monkeys has provided some insight into 
cytoadherence under flow, but extrapolation from these systems to that of the human 
disease must be interpreted with caution because there are many differences in malaria 
induced pathology in these animal models (Miller et al, 1969; Whiteley et al, 1987). 
Ex vivo experiments using rat mesoappendix have yielded some interesting results. 
Increase in resistance to flow correlates with the occurrence of parasitised erythrocyte 
sequestration, but defining the precise interplay of cytoadherence receptors in these 
systems is difficult (Raventos-Suarez et al., 1985).
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In vitro flow based assays permit assessment of both qualitative and quantitative aspects 
of the adhesive interaction. When infected erythrocytes are passed over either 
enddthelial cell lines or purified proteins the different endothelial cell expressed 
receptors operate with different efficiencies and mediate characteristically different 
types of adhesion. Experiments investigating the effect of flow on adhesion to ICAM-1, 
TSP and CD36 showed that ICAM-1 was least sensitive to increased sheer stress and 
that TSP adhesion appeared to be transient. CD36 mediated static adhesion whereas 
infected erythrocytes appeared to roll continuously when attached to ICAM-1. The 
velocity of this rolling appeared to be inversely related to the concentration of ICAM-1 
(Cooke et al, 1994). The observation that CD36 is more sensitive to flow and that 
increasing ICAM-1 density reduces the velocity of rolling is consistent with the idea that 
ICAM-1 traps infected erythrocytes and slows them down prior to their attachment to 
CD36 in a static fashion. This idea has recently been tested. It has been demonstrated 
that up-regulation of ICAM-1 on human dermal microvascular endothelial cells 
(HDMEC) (which also expresses CD36) dramatically increases adhesion via this cell 
line and that these two receptors work synergistically in vitro to support cytoadhesion 
(McCormick et al., 1997).
1.7.3 Parasite derived proteins that mediate cytoadhesion
The P. falciparum parasite derived ligands which mediate cytoadherence have not been 
easy to identify. When in vitro cytoadhesion was first described in 1981, electron 
microscopic examination of this interaction revealed that cytoadhesion appeared to be
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mediated by protein protrusions, subsequently named knobs, present at the infected 
erythrocyte surface (Udeinya et al, 1981). The knob proteins appeared to be a complex 
of proteins, but erythrocyte surface expression of these proteins is know known to be 
dependent upon the expression of the knob associated histidine-rich protein, KAHRP 
(Kilejian et al, 1979; Crabb et al, 1997). The selection of knobless clones still capable 
of cytoadherence led to the suggestion that knobs may be involved in but are not 
essential for cytoadhesion (Biggs et al, 1990; Udomsangpetch et al, 1989). 
Transfection studies, subsequently demonstrated that knobs were indeed not essential for 
static adhesion but play a functional role in adhesion under flow conditions (Crabb et al, 
1997).
1.7.3.1 The role of PfEMP-1 in cytoadhesion
Experiments attempting to identify the protein mediating antigenic variation in malaria 
were pivotal in defining the parasite-derived cytoadhesion receptor. As discussed in 
section 1.6, experiments on P. knowlesi demonstrated that expression of the variant 
antigen at the surface of the infected erythrocyte was mediated by the spleen (Barnwell 
et al, 1983). These experiments were also conducted in animal models which also 
sequester, revealing that removal of the spleen not only modulates expression of the 
variant antigen but also the ability of parasites to sequester in vivo (Handunnetti et al, 
1987; Hommel et al,. 1983). Removal of the spleen resulted in the appearance of mature 
stages of parasites in the peripheral circulation. Infection of intact animals resulted in 
both the withdrawal of mature forms from the peripheral circulation and the expression 
of the variant antigen. The implication of this was that agglutination and sequestration 
were mediated by the same molecule. This suggestion was supported by the observation
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that sera capable of agglutinating field isolates could also inhibit cytoadherence in vitro 
(Forsythefa/., 1989, Reederefa/., 1994).
The variant antigen in P. falciparum was biochemically defined and termed PfEMP-1. 
This was followed some years later by the coning of the gene family encoding these 
proteins (Section 1.6). The cloning of the var gene family permitted heterologous 
expression of the binding epitopes thought to mediate cytoadherence. Molecular studies 
demonstrated that a semi-conserved region within the CIDR-oc domain of a specific var 
gene was capable of binding to CD36, and inhibited CD36 mediated cytoadherence 
(Baruch et al, 1997). Expression of this domain in COS cells supported cytoadhesion of 
infected erythrocytes to the surface of this cell line, providing further evidence of the 
role of this domain in this process (Smith et al., 1998). Heterologous expression has 
also permitted the identification of binding epitopes of PfEMP-1 which mediate 
adhesion to CSA and ICAM-1, these epitopes residing within DBL-y and DBL-p of 
specific var genes respectively (Reeder et al., 1999, Buffet et al., 1999, Smith et al., 
2000 a).
Two separate studies have shown that the DBL-a domain from two different var genes 
mediate another adhesive phenotype, resetting (Chen et al., 1998 a, Rowe et al, 1997). 
These studies showed that parasites rosette via two different erythrocyte surface 
receptors.
Although there is much evidence to support the role of PfEMP-1 in adhesion, others 
have identified an invariant molecule, named sequestrin, which appears to mediate
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adhesion of infected erythrocytes to CD36 (Ockenhouse et al, 1991 b). Crandall & 
Sherman (1991) have also suggested that the modification of an erythrocyte protein, 
band 3, results in adhesion to CD36. Recent experimental evidence suggests that this 
adherent phenotype may be mediated via parasite modified Thrombospondin adhering to 
the CD36 receptor (Lucas & Sherman, 1998).
1.8 Aims
Our laboratory has a continuing interest in the var gene family and the proteins they 
encode. This gene family is estimated to represent 2-6% of the parasites genome, a 
substantial investment of the parasite's resources (Su et al, 1995). These genes are not 
only important in terms of parasite biology but have been implicated in the severity of 
the disease. Evidence continues to accumulate suggesting that these genes mediate the 
cytoadherence phenotypes, which precipitate sequestration in organs such as the brain 
and the placenta, resulting in pathology. Immunological studies also provide evidence to 
suggest that the immune response against these antigens is important in the development 
of clinical immunity. Thus defining both the host and parasite receptors involved in this 
process will permit investigation in to the mechanisms of sequestration, and the immune 
response against the infected erythrocyte surface. Such studies will also facilitate the 
development of anti-adhesive therapies for use in treatment of disease.
The primary aim of this study is to try and identify the parasite ligand that mediates 
cytoadhesion to Chondroitin sulphate A (CSA), a host ligand implicated in the placental 
sequestration of infected erythrocytes. Chinese Hamster Ovary cells (CHO), which have
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been developed as an adhesion model for infected erythrocyte adhesion to CSA, will be 
used to select for infected erythrocyte adhesion. The second aim of this study is the 
identification of the gene sequence of the var gene (PfEMPl) which mediates CSA 
adhesion. The parasite clone 3D7A is being sequenced by the Malaria Genome project. 
To make use of this sequence data 3D7A has been chosen as the parasite clone to be 
used in these assays. The third aim of this study is to investigate whether 3D7A parasites 







2.1.1 Chemicals and equipment
Standard laboratory chemicals and solvents were obtained from British Drug House 
(BDH) pic. and Sigma Chemical Co. Ltd., UK. and were of analytical grade. The 
sources of other materials are given in the text. Centrifugation was either carried 
out in a bench top centrifuge MSB, (Fisons) or IMV-13 microfuge (IBI). Higher 
speed centrifugations were performed in a Sorvall-RC-5B-refrigerated centrifuge.
2.1.2 Parasite, erythrocytes and sera
The P. falciparum clone 3D7A (Walliker. et al, 1987) is kept in the WHO Registry 
of Standard Strains of Malaria Parasites in the Centre for Parasite Biology, ICAPB, 
University of Edinburgh. Fresh whole blood, group O Rh +, and serum used for 
parasite culturing was obtained from Edinburgh and South East Scotland Blood 
Transfusion Service. The blood was washed and centrifuged at 1500g three times in 
incomplete RPMI medium to remove citrate. The "buffy coat" of white cells was 
removed from the red cell pellet, which was resuspended in complete medium to
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give a haematocrit of 50%. The washed red blood cells were kept at 4°C for up to 
one week (Hyde, 1993).
2.1.3 Bacterial strains
The following bacterial strains were used in the course of this study: XLl-Blue, 
genotype \supE44 hsdRl? recAl endAl gyrA46 thi relAl lac'Y [proAB+ 
lacIqlacZAM15TnlO(tef)].
2.1.4 CHO Cells
Standard Kl-CHO cells and CHO cells transfected with the enocoding sequence for 
the ICAM-1 gene and the CD36 gene were a kind gift from Dr A. Rowe (Hasler et 
al .,1993). The CHO-745 Mutant cell line was a kind gift from Dr A. Scherf (Scherf 
etal, 1998)
2.1.5 General stock solutions and media
All aqueous solutions were prepared in de-ionised glass distilled water. pH values 
of solutions were measured with a pH meter model PW 9410 (Philips).
TAE 50x stock solution 242g Tris base, 37.2g Na^DTA^O, 57.1ml glacial
acetic acid, dH20 to 1 litre. This solution was diluted 
x50 to give Ix working solution (40mM tris acetate, 
2mM EOT A).
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SDS 10% stock solution lOOg was dissolved in 900ml dH20, heated to 68°C
and the pH was adjusted to 7.2 by HC1, and made up 
to 1 litre with dH0.
PBS IQx stock solution 80g NaCl, 2g KC1, 11. 5g Na2HPO4.7 H20, 2g
KH.PCX
were dissolved in a final volume of 1 litre of dH20. 
working solution. pH~7.3 consisted of 137mM NaCl, 
2.7mM KC1, 4.3mM Na^PC^J H20 and 1.4mM 
KH2PO4 .
TE Buffer (Ix) lOmM Tris-HCl pH 8.0,lmM EDTA pH 8.0
SOC Medium 2% Bacto-tryptone,0.5% Bacto-yeast extract,lOmM 
NaCl, 2.5mM KCl,10mM Mg 2 Cl, lOmM 
Mg2SO4,20mM glucose
Luria-Bertani Medium (LB) 1% Bacto-tryptone, 0.5% Bacto-yeast extract,
1% NaCl, adjusted to pH 7.2 using NaOH
LB agar LB medium with 1.5% Bacto-agar
LB-amp 
X-Gal
LB supplemented with ampicillin to 50|ig/ml 
Fresh dry LB-amp. plates spread with 25(0,1 X-Gal 
(40mg/ml stock solution in dimethyl-formamide).
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IPTG Stock solution (0.1M) was made by dissolving 0.238g
in dH2O, filter sterilised, and stored in 1ml aliquots at 
-20°C.
DNA Loading Buffer 50mM NajEDTA. 0.25% bromophenol blue, 0.25%
xylene cyanol, 40% (w/v) sucrose in H2O. 20ml 
volumes were made up and stored as small aliquots at 
4°C.
RPMI (incomplete) Medium 10.4g of RPMI 1640, 5.94g of HEPES, dissolved in
960ml of dH2O, filtered through 0.22^iM Nalgene 
filter and stored for up to four weeks at 4°C.
Complete RPMI Medium (parasite culture)
Prepared by addition of 42ml sodium bicarbonate, 
50mg/ml gentamycin, and 40ml of heat inactivated 
human serum to 400ml of incomplete RPMI 
medium.(pH 7.2)
Complete RPMI Medium (CHO cell culture)
Prepared by addition of 42ml sodium bicarbonate, 
50mg/ml gentamycin, and 40ml of heat inactivated 





Prepared by addition of 50mg/ml gentamycin, and 
40ml of heat inactivated Foetal calf serum to 400ml of 
incomplete RPMI medium (pH 6.9)
Competent Cell Buffer 60mM calcium chloride, 15% glycerol, filter 
sterilised.
Store at -70.
20 X SSPE 3.6M NaCl, 0.2 Sodium Phosphate and 0.02M EDTA 
pH7.7
20 X SSC 3M NaCl 0.3M Na citratrate
Denaturing Solution 1.5M NaCl and 0.5M NaOH
Neutralising Solution 1.5M NaCl, 0.5M Tris-HCL pH 7.2 and 0.001M
EDTA
Denhardt's Solution 2% [W/V] BSA (bovine serum albumin), 2% [W/V]




2.2.1 Culture of asexual parasites
Cultures of P. falciparum parasites were maintained using standard methods 
(Trager and Jensen, 1976; Hyde, 1993). Parasites were grown in complete RPMI 
1640 medium supplemented with 10% human serum, 37.5 mM HEPES, 5% sodium 
bicarbonate and 25mg/ml of gentamycin sulphate. Washed human red blood cells 
(group O) were added to a final concentration of 5%. Red blood cells and serum 
were obtained from the Blood Transfusion Service. Cultures were maintained at 
37°C in a modified gas mixture of 96% N2 , 3% CO2 and 1% O2 . Medium was 
replaced daily. Parasitaemia was determined each day by examination of blood 
smears on glass slides fixed with 100% methanol. Blood smears were stained with 
Giemsa's solution (in Sorensen's buffer, pH7.2) for 45 minutes and evaluated by 
light microscopy. Cultures were initiated at a parasitaemia of around 0.5% and 
diluted upon reaching 10%.
2.2.2 Sorbitol synchronisation of asexual parasite 
cultures
The parasite culture was transferred to a 15-ml tube and centrifuged at 4000 rpm for 
3 mins and the medium removed by aspiration. The culture was then washed by 
adding 5 ml incomplete RPMI 1640 medium followed by centrifugation at 4000 
rpm. The cells were then re-suspended in 5% sterile sorbitol/PBS to the same 
volume as the original culture and incubated at 37°C for 10 mins. The suspension
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was then centrifuged at 3000 rpm and washed twice in incomplete RPMI 1640 
medium. The parasites were then transferred back to culture. After 24 hours the 
culture was examined by blood smear, (They should contain mainly large 
trophozoites). Sorbitol treatment was occasionally repeated 30-36 hours after initial 
treatment to make the culture more synchronous.
2.2.3 Plasmagel flotation
Parasite culture was transferred to a 15ml tube, centrifuged at 3000 rpm for 3 mins 
and the supernatant removed. Incomplete RPMI 1640 was added to give a 
hematocrit of -40%. To this an equal volume of pre-warmed Plasmagel (Bellon, 
France) was added. This suspension was mixed and incubated upright in a 37°C 
incubator for 10-30 minuets (until 2 separate layers were clearly visible). The upper 
layer containing Trophozoites was gently removed and transferred to a fresh tube. 
They were then washed in incomplete RPMI and the success of the separation 
assessed by blood smear.
2.2.4 Preparation of parasite DMA
DNA was extracted from healthy parasite cultures using 5ml of asexual culture at 
5-10% parasitaemia. The parasites were pelleted by centrifugation at 4,000 rpm for 
10 minutes. The erythrocyte pellet was resuspended in 1ml of 0.1% saponin in 
phosphate-buffered saline (PBS) and incubated at room temperature for 5 minutes. 
The erythrocyte lysate was transferred to a microfuge tube and spun for 5 minutes 
at 10,000 rpm. The parasite pellet was washed four times with 1ml of ice cold PBS.
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Lysis of the parasite pellet was carried out overnight at 50°C with 600p,l of lOmM 
Tris-HCL pH 7.6, 50mM EDTA pH 8.0, 0.1% SDS, Img/ml proteinase K. The 
lysate was extracted twice with phenol/chloroform, then once with chloroform. 
DNA was precipitated for 15 minutes at room temperature by the addition of an 
equal volume of isopropanol and 10% volume of 5M sodium acetate. DNA was 
pelleted by centrifugation at 15,000 rpm for 5 minutes, washed with 70% ethanol 
and resuspended in 100|Lil of PCR grade.
2.2.5 Preparation of parasite RNA
A flask of ring stage parasite culture was pelleted by centrifugation at 4000g for 5 
minutes. The pellet was then re-suspended in 1ml of 0.1% saponin in phosphate 
buffered saline (PBS) and incubated at 37°C for 10 mins. The parasite lysate was 
then transferred to a microfuge tube and washed X3 in 10ml ice cold PBS. The 
parasite pellet was then re-suspended in 1ml RNA isolator   (Genosys) the RNA 
was subsequently isolated according to the RNA isolator protocol. Essentially 
0.2ml of chloroform was added to the parasite /RNAisolator mix. the suspension 
was gently mixed for 15 seconds and allowed to stand for 10 mins. The eppendorf 
was then centrifuged at 12,000g for 15 mins at 4°C. the aqueous phase (which 
contains RNA) was removed. To this 0.5ml isopropanol was added. This was again 
allowed to stand for lOmins before being centrifuged at 12,000g, 4°C for 10 mins.
The RNA pellet was then washed in 75% ethanol and re-suspended in 0.2ml H20. 
To remove contaminating DNA, the RNA was subjected to DNAse treatment. 5fxl 
(50units) of DNAsel, RNAse-free (Boehinger Mannheim) was added to the RNA 
which was subsequently incubated for 30 mins at 37°C. The enzyme was then
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extracted by adding 30^,1 phenol chloroform. Followed by centrifugation at 12,000g 
for 2 rnins. The top aqueous layer was removed and placed in a fresh tube. To this 
30pl chloroform was added and again the eppendorff was centrifuged at 12,000g 
for 2 mins. The top aqueous layer was removed and transferred to a fresh tube. 1ml 
100% ethanol was added and the tube was then centrifuged at 12,000g , 4°C for 10 
mins. The ethanol was removed by aspiration and the RNA pellet washed by 
adding 1ml 75% ethanol, centrifugation at 12,000g for 5 mins and aspiration of the 
supernatant. The RNA pellet was then re-suspended in 30|il H20.
2.2.5 Preparation of plasmid DMA
Plasmid DNA was prepared either by the SDS-alkaline extraction method as 
described by Sambrook et al. (1989) or using the QIAprep Spin Miniprep kit 
(Qiagen Inc.) according to the manufacturers instructions. Briefly, a single colony 
of transformed E. coli was grown overnight at 37°C in 5 ml of LB broth. Cells were 
pelleted by spinning for 5 minutes at 2,000 rpm, and the medium discarded. The 
pellet was then lysed and plasmid DNA isolated following the manufacturers 
instructions.
2.2.6 DNA quantification
The concentration of DNA was estimated by measuring its absorbance at 260nm in 
a DNA quant (Eppendorf). It was assumed that an OD260 of 1.0 is equivalent to a 




2.2.7 Restriction enzyme digestion
Restriction enzyme digests were performed using the appropriate buffers supplied 
by the manufacturers (Boehringer Mannheim and Promega). Reactions were carried 
out at 37°C for 3-6 hours, using 4-12 units of enzyme per (Xg of DNA. Reactions 
were stopped by the addition of 10% volume of 50mM Na^EDTA, 40% w/v 
sucrose, containing 0.25% bromophenol blue and 0.25% xylene cyanol.
2.2.8 cDNA synthesis
The cDNA was reverse transcribed from total RNA using the Expand  Reverse 
Transcriptase kit (Roche) following manufacture's instructions. 2.5(4,1 degenerate 
var3 primer was added to 3|il total RNA which was then incubated at 65°C for 10 
minutes then placed on ice. To this 4 (il Expand reverse transcriptase buffer, ImM 
dNTPs, 20 units of Rnase inhibitor and 50 Units of Expand  Reverse Transcriptase 
was added. This was made up to 20|il with water. The mixture was transferred to a 
heat block and incubated at 42°C for 60 mins. The sample was then transferred to 
ice and subsequently used for PCR or stored at -70°C.
2.2.9 Polymerase chain reaction (PCR)
PCR is used for the enzymatic synthesis of DNA sequences using a thermostable 
DNA polymerase such as Taq (Saiki et al., 1988). DNA is first denatured, then 
annealed with specific primers corresponding to each end of the target sequence, 
and finally the annealed primer sequences are extended towards each other until
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they meet. This cycle is repeated 20-40 times and potentially amplifies the target 
sequence by x!07-109 fold.
Standard PCR reactions of 20-50^1 volume contained 1/10 volume of 10 x buffer 
(Roche), 1/10 volume of 10pM of each of forward and reverse primers, 1/10 
volume of 750|LiM dNTP, 1/100 volume of Taq polymerase (Roche) around 1/10 
volume of template (dependent upon DNA concentration), and PCR grade water to 
final volume. Standard PCR conditions used unless otherwise indicated in the text 
were, 1 initial cycle of 93°C for 1 minute, followed by 30 cycles of 93°C for 30 
seconds, 50°C for 30 seconds and 65°C for 5 minutes, then a final cycle of 65°C for 
10 minutes. Negative controls containing no DNA template were included in each 
set of reactions. The products of PCR reactions were analysed using agarose gels 
electrophoresis.
2.2.10 Automated DNA sequencing
Automated sequencing of plasmid DNA was carried out using dye terminators with 
the PRISM  cycle sequencing kit (Applied Biosystems Inc.) and the 377 
automated sequencer (ABI). Reactions were performed as per the manufacturers 
instructions modified to a final volume of lOjxl (ABI PRISM Dye Terminator 
protocol, P/N 402078). For each reaction, the reagents were aliquoted into a 0.5ml 
PCR tube as follows: 4jj,l Terminator Ready Reaction Premix, 2 |il dsDNA 
Template (0.2|Lig/ml), 2(0,1 sequencing primer (0.8 pmol/ml), and 2|il PCR grade 
H2O. Cycle sequencing was performed on the HYBAID DNA thermal cycler 
(Omnigene) with the following conditions: 25 cycles (96°C for 30 sec, 50°C for 20 
sec, 60°C for 4 min, respectively), then kept on 4°C for 10 mins. PCR products
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were precipitated, washed and resuspended in 2.5|Lil deionized formamide and 0.5jxl 
of SO^g/ml Blue dextran in 25mM EDTA, pH 8.0. Each sample was then heated at 
90°C for 5min and 1.8^,1 of each sample was loaded onto a 6% denaturing gel and 
run at SOW for 7h. Chromatograms were viewed and data edited using the Seqed  
program (ABI). Standard sequencing primers were used for the majority of 
reactions, with a DEL specific sequencing primer (F3) being used where necessary 
to complete "gaps" in the data. Obtained sequences were confirmed as DEL 
sequence by BLAST analysis.
2.2.11 Agarose gel electrophoresis and photography
Agarose gels were used to check the quality of genomic DNA and plasmid 
preparations and to analyse PCR products and restriction digestions. 1-2% agarose 
(IBI) was dissolved in Ix TAB buffer by boiling. After cooling to around 45°C, 
ethidium bromide was added to a concentration of 0.5|ig/ml and the mix poured 
onto an electrophoresis gel plate and left to set at room temperature. The 
appropriate amount of DNA was mixed with 0.1 volume of gel loading buffer (40% 
w/v sucrose, 50mM EDTA pH 8.0, 0.25% bromophenol blue, 0.25% xylene 
cyanol) and loaded into the submerged gel. Electrophoresis was carried out in 
IxTAE at 100 volts for an appropriate time dependent upon the size of the 
fragments under analysis. Fluorescence from DNA-bound ethidium bromide was 
visualised by short wave-length UV light and photographed.
To aid in estimation of DNA fragment size, 2|Hg of DNA markers were loaded 
adjacent to DNA samples on agarose gels. The markers used were Boehringer
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Mannheim DNA Molecular Weight Marker VII. Molecular Weight Marker VII 
contains DNA fragments of size 8576, 7427, 6106, 4899, 3639, 2799, 1953, 1882, 
1515, 1482, 1164, 992, 710,492 and 359 bp.
2.2.12 Purification of DNA fragments from agarose gels
DNA fragments from PCR reactions or restriction enzyme digestion were purified 
using one of the following methods:
Phenol/chloroform extraction: Electrophoresis of the DNA fragments was carried 
out using a gel made from low melting temperature agarose (IBI) and Ix TAB 
buffer. DNA fragments were visualised by fluorescence of DNA-bound ethidium 
bromide under long wave UV light (366nm) and excised. The gel slice was placed 
in a 1.5ml microfuge tube and broken into small pieces. An equal volume of 
phenol/chloroform was added and the mix was vortexed for a few seconds before 
incubation at -70°C for 10 minutes. The frozen mixture was spun at 13,000 rpm for 
5 minutes and the aqueous upper phase removed to a clean microfuge tube. 
Extraction was carried out first with an equal volume of phenol/chloroform/3- 
methyl-1-butanol (50:48:2) and secondly with an equal volume of chloroform. 
DNA was precipitated by addition of 0.1 volume of 3M sodium acetate and 2 
volumes of 100% ethanol, washed with 70% ethanol and finally re-dissolved in 
PCR grade water.
Magic PCR Preps™ DNA purification system: DNA contained in low melting 
temperature agarose gel slices was also purified using the Promega Magic PCR
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Preps DNA purification system according to the manufacturers instructions. The 
gel slice was incubated in a 1.5ml microfuge tube at 70°C until the agarose 
completely melted. 1ml of resin was added, mixed immediately, and the mix was 
passed through a mini column by syringe. The minicolumn was washed with 2ml of 
80% isopropanol and centrifuged for 20 seconds at 13,000 rpm. The minicolumn 
was placed in a clean microfuge tube and 50|il of PCR grade water was applied to 
the column and incubated for 3 minutes. The microfuge tube was spun at 13,000 
rpm for 1 minute to elute the DNA.
2.2.13 Preparation of competent bacterial cells
The method used was modified from Hanahan (1983). Cells of the appropriate E. 
coli strain were plated on LB agar overnight at 37°C. A single colony was picked 
and grown overnight in 5ml LB broth at 37°C with shaking. The following 
morning, the culture was diluted 50-fold in LB broth and incubation continued for 
approximately 2-4 hours until the cell density was 4-7x107 viable cells/ml (OD600 of 
0.4-0.6). At the same time, 150ml of 60mM calcium chloride in 15% glycerol was 
prepared and sterilised by filtering through a 0.22u.m filter and kept on ice. The 
culture was then chilled on ice for 10 min and pelleted at 4,500 rpm for 5 min at 
4°C. The pellet was resuspended in 50ml of the ice-cold calcium chloride/glycerol 
solution, and incubated on ice for 5min then re-pelleted as above. The pellet was 
resuspended for a second time in 50ml of ice-cold calcium chloride/glycerol and 
incubated on ice for 30min. The cells were pelleted once more as before and 
resuspended in 5ml of the ice-cold calcium chloride/glycerol solution and 1 GO-
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200^,1 volumes aliquoted into sterile pre-chilled microfuge tubes. The competent 
cells could be stored at -70 C for up to 2 months, or used directly.
2.2.14 Transformation of E. coli
Competent cells (50-100|j,l) were mixed with either 5|Lil of a ligation reaction or 
20ng of uncut plasmid DNA. The cells were then incubated on ice for 30 minutes, 
heat-shocked at 42°C for 60 seconds and incubated in ice for 2 minutes. To each 
transformation, 400^1 of pre-warmed SOC medium was added and the mixture was 
incubated at 37°C with gentle shaking for 1 hour. The cells were pelleted by brief 
centrifugation in a microfuge and all but 100ml of the medium removed. The cells 
were resuspended in the remaining medium and 25-100jLil plated out on appropriate 
selective LB agarose plates. Plates were incubated overnight at 37°C.
2.2.15 Identification of clones of interest
Transformed cells were plated out on LB plates containing appropriate antibiotic to 
select for the presence of plasmid. Where appropriate, a-complementation was 
used to detect the presence of insert DNA. The method used was that presented in 
Sambrook et al., 1989. Briefly, 40|Lil of 20mg/ml X-Gal and 40^1 of 20mg/ml IPTG 
were added to LB plates before plating of the transformants. Following overnight 
incubation at 37°C, the plates were incubated at 4°C for 2-4 hours to allow colour 
development. Using this method colonies containing inserts (white) can be 
distinguished from colonies without insert (blue).
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Recombinant clones were further analysed for the presence of inserts of desired size 
by one of the four following methods :
Direct size comparison of plasmid minipreps and control vector on agarose 
gels.
Restriction enzyme digestion of plasmid minipreps.
PCR amplification using plasmid minipreps as DNA template using either 
specific var primers or vector derived primers to amplify inserts.
Direct PCR performed on lysates of bacterial colonies. A sterile pipette tip was 
touched to a bacterial colony surface and then shaken in 50(J,1 of PCR grade water 
in a microfuge tube. The microfuge tube was heated to 100°C for 5 minutes and 
then spun for 5 minutes at 13,000 rpm. 5)Lil of supernatant was then used as 
template in a standard PCR assay.
2.2.16 Sequence Alignments
Deduced amino acid alignments of DBLa sequences were made using the GCG 
pileup and Mac Vector clustal functions Sequences were aligned with gap weight of 
3.0 and gap length weight of 0.1 and edited by hand.
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2.2.17 Dot Blot hybridisation
Quantified plasmid DNA was denatured on a heat block at 95°C then chilled on ice. 
This was added to 1 volume 20 X SSC. lOpl DNA was then spotted on to a nylon 
membrane pre-wetted with 10X SSC using a vacuum supplied blotter. The 
membrane was transferred to a tray of denaturing solution for 5 minutes, before 
being transferred to neutralising solution for 1 minute. The DNA was then fixed to 
the membrane by exposure to UV for 2 mins (each side)
2.2.18 Southern Hybridisation
Pre-hybridisation solution was made up following manufacture's instructions to a 
final concentration of 5X SSPE, 5X Denhardt's solution 0.5% SDS and 5mg 
salmon sperm DNA. The nylon membrane (Amersham) was incubated in pre- 
hybridisation solution for 60 minutes at 65°C. The probe, labelled by random 
priming according to manufacture's instructions (Roche) was denatured at 100°C 
for 5 mins and incubated with the membrane at 65°C over night (minimum 12 
hours). Following hybridisation, the membranes were washed twice with 2X SSPE, 
0.1% SDS for 15 minutes at 65°C, IX SSPE, 0.1% SDS for 15 mins at 65°C and 
0.1X SSPE, 0.1% SDS for 15 minutes.




A vial of CHO cells was removed from liquid nitrogen (or -70) and transferred to a 
37°C water bath until thawed. The cells were transferred to a 15ml tube and re- 
suspended in 10ml complete medium. The cells were centrifuged at 2000 rpm and 
the supernatant removed. The cell were again re-suspended in 5 ml complete 
medium and transferred to a small flask and incubated in a C02 incubator (5% C02) 
at 37°C.
Growing cells
Cell become confluent after 3-4 Days. Medium was changed by aspirating off the 
old medium and replacing with 5ml fresh complete medium when cells were 
confluent or every 72 hours. Progress of the culture could then be viewed under an 
inverted microscope.
Splitting cultures for continuous growth
When cells become confluent they were split by removing old medium by 
aspiration and washing the cells twice in 10 ml incomplete medium, followed by 
addition of 1.5 ml of pre-warmed 2mM EDTA/PBS (medium size flask, 4ml, large 
flask, 7ml). This was then incubated for 5-10 mins at 37°C. The cells were 
dislodged by gentle tapping of the side of the flask. The cells plus medium were 
removed and placed in a 15ml tube and centrifuged at 2000 rpm. The supernatant 
was then removed and the cells re-suspended in 10ml complete medium. The cells 
were then seeded into fresh flasks. When transferring into a medium sized flask 
25ml medium was used and 40ml for large flasks. Cells were counted using a 
haemocytometer. 5-10(il of re-suspended cells were place on the haemocytometer
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and the number of cells in 2 large squares was counted (average = Z) the number of 
cells equalling Z x 104/ml.
Freezing cells
Cells to be frozen were washed in complete medium and counted as above. 1 X 
106/ml cells were re-suspended in complete medium + 10% DMSO, mixed well and 
transferred to -70 overnight and then to liquid nitrogen.
2.2.20 CHO cell selection assay
The selection assays were conducted essentially as described by Scherf et al., 1998. 
A large flask of CHO cells was cultured until the flask was semi-confluent. The 
cells were then subjected to 3-4000 rads of gamma radiation (this reduces the 
contamination of parasite cultures with CHO cells after selection). The cells were 
then washed twice in binding medium (pH6.9). The parasite culture was treated 
with Plasmagel to concentrate the mature parasite stages (see above). The 
trophozoite pellet was washed twice in binding medium and resuspended in 15 ml 
binding medium. The cells were then transferred to the flask of semi-confluent 
CHO cells and allowed to bind. The flasks were incubated for 60 minutes in a C02 
incubator at 37°C, with agitation every 15 mins. The unbound parasites were gently 
washed off by 7-9 washes with 10 ml binding medium. Success of selection could 
sometimes be assessed using an inverted microscope. 0.5ml of fresh blood and 
15ml complete parasite culture medium was then added and the flask gassed and 
incubated as a parasite culture. 24 hours later the culture was transferred into a 
fresh culture flask and the parasitaemia assessed by blood smear .
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2.2.21 CHO cell adhesion assay
CHO cells were cultured in a 30ml culture dish until semi confluent. The culture 
was then washed twice in binding medium. A culture of predominantly trophozoite 
stage parasites at parasitaemia -5-10% was transferred to a 15ml tube and washed 
twice in binding medium. The parasite culture was then re-suspended to a 
hematocrit of 5%. 3ml of culture was added to the culture dish which was incubated 
in a C02 incubator for 60 minuets at 37°C. with gentle agitation every 15 mins. The 
culture was then washed 5 times with binding medium and fixed for 30 minutes in 
1% gluteraldyhyde. The culture dish was then stained with 2% filtered Giemsa for 
30 minutes. The bound cells were then counted under oil immersion.
2.2.22 Trypsin digestion
Trypsin treatment was conducted essentially as described in Gardener et al.(l996). 
A large parasite culture at 5-10% parasitaemia was prepared for binding, transferred 
to a 15ml tube and washed twice in incomplete RMPI 1640 medium. Trypsin was 
added to a concentration of 100(a,g/ml (Sigma) and the parasites incubated for 10 
mins. at 37°C. The parasites were then used in the binding assay.
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2.2.23 Enzymatic digestion of CHO cells.
1X105 CHO cells were transferred into a 15 ml tube and washed twice in 
incomplete RPMI medium. Enzyme (chondroitinase ABC, hyaluronidase, 
heparinase, or neuraminidase,) was added to a concentration of lU/ml. Cells were 
incubated at 37°C for 1 hour. The cells were then washed, resuspended in binding 
medium and used for the binding assay.
2.2.4 Inhibition of adhesion with glycosaminoglycans
CHO cells were prepared for the adhesion assay as above. Parasites prepared for 
binding were transferred into a 15 ml tube in binding medium to a 4% hematocrit 
and gylcosaminoglycans (chondroitin sulphate A, chondroitin sulphate C, heparane 
sulphate, hyaluronic acid or neuraminic acid) were added to a concentration of 
25mg/ml. Cells were then incubated for 15 mins at 37°C before being added to the 
petri dish for the binding assay.
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Chapter 3
Development of a model system for studying cytoadhesion
of P.falciparum infected red blood cells: selecting 3D7A
lines which bind Chinese Hamster Ovary Cells
3.1 Introduction
Post mortem microscopy first revealed that concentration of P.falciparum infected 
erythrocytes in the small blood vessels of vital organs appeared to be due to adhesion of 
infected erythrocytes to capillary and post-capillary endothelial tissue. Since then a great 
deal of effort has gone into understanding this phenomenon.
The modern analysis of parasite cytoadhesion and sequestration has centred on the 
development of in vitro assays of cytoadherence. Some of these involve measurement of 
the ability of infected erythrocytes to adhere to purified protein or candidate 
carbohydrate adhesion receptors. Such receptors are simply electro-statically bound to 
polystyrene micro-culture plates. Other adhesion assays have been developed which 
attempt more realistically to reproduce adhesion receptor presentation and in vivo 
cellular interactions. Such assays may simply involve counting infected erythrocytes 
which adhere to in vitro cultured cell lines such as HUVEC or C32 melanoma cells. 
More "controlled" types of cellular adhesion assay involve the use of cell lines 
transfected with particular candidate receptor sequences carried on plasmid expression 
vectors. These constructs produce large amounts of the particular cell surface antigen 
expressed at the surface of the transfected cell. In this way exogenous receptors can be
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inserted into a 'background' cell surface normally lacking certain known candidate P. 
falciparum adhesion receptors. The most frequently used example of such a system are 
Chinese hamster ovary (CHO) cells transfected with intracellular adhesion molecule-1 
(1CAM- 1) and the endothelial marker and leukocyte differentiation antigen CD36 
(Hasler et al, 1993).
To date, the protein or glycoprotein cell surface antigens CD36, ICAM-1, vascular cell 
adhesion molecule-1 (VCAM-1), E-Selectin, P-Selectin, PEC AM-1, thrombospondin 
and complement receptor 1 have all been identified as potentially important infected 
erythrocyte adherence receptors. The glycosaminoglycans, chondroitin sulphate-A, 
hyaluronic acid and heparan sulphate have also been identified as potential receptors 
(Rogerson et al., 1995, Beeson et al, 2000, Chen et al, 1998b). Under some conditions, 
probably under the influence of host factors such as cytokine release, cytoadhesion and 
tissue sequestration events result in clinical consequences. Some of these may be 
relatively mild such as malaise, cough, diarrhoea and myalgia. Others may be more 
severe and include cerebral malaria, renal and hepatic impairment and metabolic 
acidosis. Pregnant women who contract malaria may suffer severe complications such as 
intrauterine growth retardation, premature delivery and perinatal mortality (Rogerson & 
Beeson, 1999 b). Largely due to the identification of CSA as a placental adhesion 
receptor, pregnancy-associated malaria has become a topic of considerable interest in 
malaria research (Fried & Duffy, 1996, 1998)
A major objective of this project was to study the interaction between a P. falciparum 
parasite population known to be undergoing continuous antigenic variation and CSA.
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Since an in vitro model of cytoadhesion would seem to be most analogous to the natural 
situation it was decided to select sub-populations of the P. falciparum clone 3D7A 
capable of binding to the surface of CHO cells. CHO cells are known to express high 
levels of chondroitin sulphate A (Rogerson et al, 1995). They therefore appeared to 
offer a particularly good in vitro model system for the analysis of PfEMP-1 mediated 
binding to CS A.
3D7A (Walliker et al, 1987), a clone derived from the NF54 (Plasmodium falciparum} 
strain isolated from a Dutch malaria patient thought to be suffering from imported 
'airport' malaria, is one of many cloned parasite lines kept in the WHO Registry of 
Standard Strains of Malaria kept in Edinburgh University. It is also the parasite clone 
being sequenced by the Malaria Genome Project. Investigating the molecular basis of 
cytoadhesion of this particular clone would therefore permit exploitation of the sequence 
data being generated by the genome project in identifying the parasite derived protein or 
proteins involved.
3.2 Results
3.2.1 Selection of adherent lines from the parasite clone 3D7A
To start the selection process, parasites previously synchronised by 5% sorbitol 
treatment were grown to 10% parasitaemia, with most parasites at the trophozoite 
developmental stage. These mature stages were increased in concentration using the 
Plasmagel flotation technique . The degree of enrichment for trophozoites was assessed
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by examining a thin blood smear, which normally indicated that 80-90% of the 
concentrated erythrocytes were infected with mature trophozoites. These parasites were 
further concentrated by centrifugation and the final trophozoite pellet was washed in 
binding medium and stored at 37°C prior to selection.
CHO cells to be used for selection were cultured until semi-confluent. The culture flask 
was then treated with 3000-4000 rads of gamma-radiation to kill the cells prior to 
selection. This was done because the use of live CHO cells in a selection assay can result 
in the transfer of some of these cells into the parasite culture after selection. These Two 
cell types compete for nutrients in the same medium, usually resulting in poor parasite 
growth. Irradiation of CHO cells prior to selection limits the subsequent contamination 
of selected parasite cultures with live CHO cells (Rogerson et al, 1995).
The irradiated CHO cells were then washed with binding medium to remove unbound 
CHO cells. The Plasmagel-purified trophozoites were then transferred into the CHO cell 
flask and resuspended in binding medium (see Methods). After allowing the infected red 
cells to bind to the CHO cells for 1 hour the culture supernatant containing unbound 
erythrocytes was aspirated off and the flask washed several times with binding medium 
to remove any unbound erythrocytes from the flask. The CHO cell-adherent erythrocytes 
were then viewed unstained under an inverted microscope. 500(0,1 fresh erythrocytes 
(50%v/v) were then added to the culture flask. Merozoites released from cytoadherent 
parasites infect a proportion of these erythrocytes during the over night incubation. The 
parasite-containing supernatant was then cultured to a parasitaemia of 10% after 
subdivisions into two large culture flasks. The process was repeated 6-8 times before the
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level of binding was assessed.
3.2.2 Binding assay for parasites selected for adhesion to CHO cells
CHO cells were added to 30mm culture dishes and grown until semi-confluent. The cells 
were then washed in binding medium and stored at 37°C ready for binding. To measure 
the relative level of binding of selected versus unselected 3D7A lines, synchronised 
parasite cultures (at the trophozoite stage) were washed in binding medium and 
resuspended to a 4% hematocrit. 3 mis of parasite suspension were allowed to bind for 
1- hour, with resuspension by hand every 15 mins during this period. After completing 
the binding assay the dishes were washed 5 times with binding medium to remove 
unbound erythrocytes and then fixed by the addition of 1% gluteraldyhyde for 30 mins. 
They were then stained with 1% Giemsa for 30 minutes. The dishes could then be 
observed under X 100 objective to count the number of bound infected erythrocytes per 
1000 CHO cells (Fig. 3.1).
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Figure 3.1 Selected 3D7A infected erythrocytes bound to Chinese 
Hamster Ovary cells (magnification X400)
Figure 3.1 Geimsa stained binding assay. Selected 3D7A 
parasites (small dark violet stained spheres) adhering to 
CHO cells (large violet stained cells). Size bar 20^im.
The binding experiments were conducted in duplicate on 3 separate occasions. All 
binding experiments were carried out blind (i.e. selected and unselected parasites were 
coded). The degree of binding between duplicate experiments was consistent. However,
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there was variation between experiments conducted on different days with different 
batches of CHO cells and parasites, which led to a large standard deviation (Table 3.1). 
The parasite cultures were normally used for binding at 5-10 % parasitaemia and 4% 
hematocrit. However variables such as the confluence and condition of CHO cells 
probably influence the degree of parasite binding. In addition the adhesion phenotype is 
sensitive to the stage of infecting parasite, and so variation in the stage of parasite used 
in a binding assay may also influence variability in binding.
70
Chapter 3: Cytoadhesion O/3D7A to CHO cells
Figure 3.2 Selected 3D7A infected erythrocytes adhering to CHO cells 
(magnification X1000)
Figure 3.2 Giemsa stained binding assay (magnification X1000). 
Selected 3D7A parasites (small dark blue stained spheres) 
adhering to the surface of 2 CHO cells (large blue stained cells). 
Size bar lOfim.
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The numbers of unselected 3D7A parasites which were capable of binding to CHO cells 
was very low, being approximately 1-2 parasites per 1000 CHO cells. After 8 rounds of 
selection binding to CHO cells had increased by over 2 orders of magnitude (Fig. 3.2 & 
Table 3.1), between 2-20 parasites being found bound to the surface of each CHO cell 
(Fig. 3.1). This increase was found to be statistically significant using a one tailed 
students T-Test (P= 0.00078). This highly significant increase in the selected versus the 
unselected line showed that selection had clearly enriched the proportion of parasites 
capable of binding to the surface of CHO cells.







Table 3.1 Binding of selected and unselected parasites to CHO cells, parasites counted 
per 1000 CHO cells (selected parasites subjected to 8 rounds of selection). N = 3, ± = 
standard deviation.(T Test P= 0.00078 )
3.2.3 Trypsin sensitivity of infected erythrocyte cytoadhesion to CHO 
cells
Having established that a CHO cell binding line of 3D7A can be selected, the next 
question to be answered was whether the observed increase in binding was mediated by 
a parasite derived molecule expressed at the erythrocyte surface, such as PfEMP-1, Prior 
experimental evidence suggests that cytoadhesion mediated by PfEMP-1 is disrupted by 
treatment of the mature infected erythrocyte with the proteolytic enzyme trypsin. 
Different PfEMP-1 variants have shown variable levels of sensitivity to trypsin 
digestion, although treatment of parasites with trypsin concentrations in excess of
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will abolish binding in most cases (Gardener et al, 1996; Baruch et al, 1996).
The CHO cell binding 3D7A line was therefore subjected to trypsin treatment prior to 
binding. Experiments assaying the trypsin sensitivity of the adhesive phenotype were 
conducted in duplicate and repeated on 3 separate occasions. Parasites were incubated in 
the presence of 100|Lig/ml for 10 mins. The parasites were subsequently washed in 
binding medium before being used in a binding assay. The trypsin treatment reduced 
binding of mature infected erythrocytes to CHO cells by >95% (P= 0.00528, Table 3.2). 
The cytoadhesion that had occurred during the eight rounds of selection therefore 
appeared to be mediated by a trypsin sensitive protein present at the surface of P. 
falciparum infected erythrocytes.
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NUMBER OF BOUND PARASITES 
PER 1000 CHO CELLS
573 ±291
12.5±6.1
Table 3.2 Results of binding of 3D7A parasites treated with trypsin versus no untreated 
controls to CHO cells. Experiments repeated 3 times in duplicate, N=3, ± refers to the 
standard deviation. (T Test, P = 0.00528)
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3.2.4 Experiments to Identify the CHO cell adhesion receptor by 
inhibition of infected erythrocyte binding with soluble carbohydrates
The apparent lack of expression of a number of major cell surface antigens by CHO cells 
means that they are often used as host cells in mammalian transfection experiments. For 
example they have been used to express the human endothelial receptors ICAM-1, CD36, 
VCAM-1, E- Selectin, P- Selectin, PEC AM-1 and CR1. Antibody labelling experiments 
suggest that CHO cells do not constitutively express any of these endothelial receptors 
(Hasler et al, 1993; Johnston et al, 2000; Crutchfield et al, 2000; Raingner et al.,1991 
Makrides et al., 1992 Pouvelle et al., 2000). However CHO cells are known to express a 
number of carbohydrates at their surface. These include glycosaminoglycans (GAGs), 
which are un-branched polysaccharide chains composed of repeating disaccharide units, 
one of these units being an amino sugar. The only P. falciparum cytoadhesion receptor 
identified to date expressed at the CHO cell surface is the GAG chondroitin sulphate A 
(Rogerson et al., 1995).
It has been previously demonstrated that pre-incubation of parasites in 10|a<g/ml CSA is 
sufficient to inhibit CSA mediated cytoadhesion of infected erythrocytes to CHO cells 
(Rogerson et al, 1995). Thus, to test whether CSA was metiating this adhesive phenotype 
, the parasite suspension was pre-incubated in soluble CSA (extracted from porcine rib 
cartilage). Soluble CSA was added at a concentration of 10|LLg/ml. This failed to inhibit 
adhesion of selected 3D7A infected erythrocytes to the CHO cell surface (data not 
shown). The inhibition assay was repeated, pre-incubating CHO cells in the presence of
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25n,g/ml soluble CSA. This increased concentration of CSA also failed to inhibit adhesion 
(Table 3.3 ,P= 0.0037).
Chondroitin sulphate C (CSC), (extracted from shark cartilage) is very similar in structure 
to CSA being sulphated at carbon six in the p-glactosamine ring and not carbon four 
which is sulphated in Chondroitin sulphate A. This molecule represents a possible 
cytoadhesion receptor as experiments have shown that CSC inhibits binding of infected 
erythrocytes to CHO cells at very high concentrations. However is has been suggested 
that this could be due to the small amount of contaminating CSA in most commercial 
CSC preparations (Rogerson et al, 1995). To test the binding inhibition capacity of CSC, 
parasites were pre-incubated in 25|ig/ml CSC prior to being used in a binding assay. CSC 
also failed to inhibit adhesion of selected 3D7A infected erythrocytes to CHO cells (Table 
3.3, P = 0.004917).
Heparan sulphate, although not associated with cytoadherence, has been identified as a 
resetting receptor mediating the binding of uninfected erythrocytes to infected 
erythrocytes. It is possible that if this GAG can mediate the adhesion of infected 
erythrocytes to uninfected erythrocytes then it could also mediate the interaction between 
the infected erythrocyte and the CHO cell surface. To test this hypothesis the 3D7A line 
selected for adhesion to CHO cells was pre-incubated in heparan sulphate at a 
concentration of 25 |Xg/ml before being allowed to adhere to the CHO cell surface. 
However the addition of heparan sulphate failed to inhibit binding of selected 3D7A 
infected erythrocytes to the CHO cell surface (Table 3.3,P = 0.02993).
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Hyaluronic acid has also recently been described as a cytoadherence receptor for infected 
erythrocyte cytoadhesion and is known to be expressed at the surface of CHO cells (Esko 
et al, 1991). A selected line of 3D7A was pre-incubated in the presence of 25 jug/ml 
hyaluronic acid, but again no inhibition of selected 3D7A infected erythrocyte 
cytoadhesion was observed (Table 3.3, P = 0.0072).
N-acetylneuraminic acid (Sialic acid) is not a GAG and has not been identified as a 
cytoadherence receptor, but in P. falciparum malaria, merozoites bind to neuraminidase 
sensitive sialic acid in order to invade the erythrocyte (Adams et al, 1992). Furthermore 
another protozoan parasite, Trypanosoma cruzi, attaches to and invades mammalian cells 
via sialyl residues at the cells surface (Ming et al., 1993). This use of sialic acids for 
adhesion is not restricted to protozoa. Enteropathogenic E. coli and Adenovirus type 37 
also use sialic acid as an adhesion receptor (Vanmaele et al., 1994; Arnberg et al., 2000).
Sialic acid is another carbohydrate expressed at the surface of CHO cells and could 
possibly represent a receptor mediating P. falciparum cytoadhesion. To test this 
hypothesis a selected isolate of 3D7A was pre-incubated in the presence of N- 
acetylneuraminic acid prior to binding. This carbohydrate also failed to inhibit adhesion 
of selected 3D7A infected erythrocytes to the CHO cell surface (Table 3.3, P = 6.5 xlO'5).
Throughout all of these experiments pre-incubation with trypsin was used as a control for 
inhibition. This treatment consistently reduced adhesion of selected 3D7A infected 
erythrocytes by approximately 95% (Table 3.3, P = 0.00194).
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Table 3.3 Inhibition of binding of selected 3D7A to CHO cells in the 
presence of soluble carbohydrates
carbohydrates
Heparan sulphate (25 |ig/ml)
Hyaluronic acid (25 |lg/ml)
Chondroitin Sulphate A (25 (ig/ml)
Chondroitin Sulphate C (25 |ig/ml)
N-acetylneuraminic acid (Sialic acid) (25 
M£/ml)
Trypsin treatment of parasites (lOO^ig/ml) 
(binding inhibition control)
no carbohydrate added (binding control)
PARASITES 
















Table 3.3. Inhibition of cytoadhesion of selected 3D7A to the CHO cell surface by 
incubation of parasites in the presence of different carbohydrates. Experiments conduced 
in duplicate on 3 separate occasions, N = 3, ± = standard deviation, (P= value refers to the 
statistical significance of the level of adhesion to CHO cells, as compared to the trypsin 
treated negative control, P< 0.05 = statistical significance)
3.2.5 Experiments to Identify the CHO cell adhesion receptor by 
inhibition of 3D7A selected cytoadhesion by enzymatic treatment of 
CHO cells
To complement inhibition experiments using carbohydrates, experiments testing the 
binding of infected erythrocytes to CHO cells were also conducted after enzymatic 
treatment of CHO cells. To inhibit binding by chondroitin sulphate, 1 x 105 CHO cells 
were incubated in lU/ml chondroitinase ABC (which digests chondroitin sulphate A, B 
and C) for 1 hour at 37°C. The cells were then allowed to attach to a 30 mm plastic petri
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dish before being incubated with CHO cell-selected 3D7A parasites. However this 
treatment failed to inhibit adhesion of infected erythrocytes to CHO cells (Table 3.4, P = 
0.002). CHO cells were also treated with heparinase-1 to remove heparan sulphate from 
the surface of CHO cells, which also failed to inhibit subsequent adhesion of selected 
3D7A infected erythrocytes 3D7A (Table 3.4, P = 0.0018). In order to confirm that 
hyaluronic acid was not involved in adhesion CHO cells were also treated with 
hyaluronidase. Consistent with the GAG inhibition assay, treatment of cells with this 
proteolytic enzyme failed to inhibit adhesion (Table 3.4, P = 0.0016). Cells treated with 
neuraminidase were also used in an attempt to inhibit binding, without any effect on 
adhesion of infected erythrocytes (Table 3.4, P = 0.00010).
As a positive control for inhibition, some parasites were treated with 100 |Lig/ml trypsin for 
10 minutes and prepared for binding as above The trypsin treatment inhibited binding of 
selected 3D7A to CHO cells by > 95% (Table 3.4, P = 0.0019). These results support 
those of the previous section, that selected 3D7A is adhering to the CHO cell surface via 
an as yet undescribed adhesion receptor expressed at the surface of CHO cells.
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Trypsin treatment of parasites 
(lOOng/ml)
Control (No enzyme added)
NO. OF PARASITES 














Table 3.4 CHO cells treated with various enzymes to inhibit infected erythrocyte 
adhesion. Cells transfered into 30 mm culture dishes and allowed to adhere, selected 
3D7A allowed to adhere to the CHO cell surface. Experiment conducted in duplicate N 
3, ± = standard deviation (P= value refers to the statistical significance of the level of
adhesion to CHO cells, as compared to the trypsin treated negative control, P< 0.05 = 
statistical significance)
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3.2.6 Binding to a CHO cell mutant, CHO-745, defective in 
glycosaminoglycan biosynthesis
Another approach to investigating the binding properties of the CHO-selected 3D7A 
involved incubating the selected parasites with a CHO cell line, CHO-745. CHO -745 is 
deficient in xylosyltransferase activity, an enzyme which is essential for the biosynthesis 
of glycosaminoglycans (Esko et al, 1985). CHO-745 does not express CSA, CSC, 
hyaluronic acid or heparan sulphate (Esko et al., 1985; Rogerson et al, 1995; Scherf et 
al., 1998). The CHO-745 cell line was prepared in a manner identical to that used for 
preparing standard CHO cells (which were used as a control). The binding of selected 
and unselected 3D7A parasites to these two cell lines was then compared. The selected 
3D7A parasites bound to the CHO-745 mutant cell line and the CHO cell line at similar 
levels (P = 0.1197), supporting the conclusion derived from earlier experiments, that 
binding of selected 3D7A to CHO cells is not mediated by CSA, CSC, Hyaluronic acid or 
heparan sulphate (Table 3.5).
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CHO (trypsin treatment of parasites 
100|j,g/ml)
NO OF PARASITES 








Table 3.5 30 mm culture dishes seeded with CHO and CHO -745 cells, grown until 
semi-confluent. 3D7A parasite used for cytoadhesion to CHO cells with a typsin treated 
CHO cell line as control. Adhesion assays conducted in duplicate, N = 3, ± = standard 
deviation. (P= value refers to the statistical significance of the level of adhesion to CHO 
cells, as compared to the trypsin treated negative control, P< 0.05 = statistical 
significance)
3.3 Conclusions
The evidence from this chapter suggests that 3D7A, after 8 successive rounds of 
selection, can be selected for significant levels of adhesion to the surface of CHO cells. 
Protease digestion of the infected erythrocyte with trypsin abolishes adhesion, which 
suggests that the adhesion is being mediated by a trypsin sensitive parasite derived 
adhesion receptor. PfEMP-1 mediated adhesion is trypsin sensitive. It is therefore 
possible that the this adhesive phenotype is mediated by a member of the PfEMP-1 
family.
The adhesion was not inhibited by the addition of soluble CSA to parasites prior to 
binding, suggesting that this adhesion is not mediated by CSA. This contention is
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supported by the observation that enzymatic digestion of CHO cells with chondroitinase 
ABC also failed to have any effect on adhesion or selected 3D7A to the CHO cell surface. 
The adhesion assays with the chondroitin sulphate A deficient CHO-745 cell line provide 
further evidence that CS A is not involved in this cytoadhesion process.
Another GAG investigated as an adhesive receptor was chondroitin sulphate C. Neither 
inhibition by adding this GAG to the binding experiment nor the treatment of CHO cells 
with chondroitinase ABC inhibited binding. The selected parasites also adhered to the 
CSC deficient CHO-745 cells. Chondroitin sulphate C can thus be eliminated as the 
adhesive receptor mediating this interaction between selected 3D7A and the CHO cell 
surface.
The possibility that the resetting receptor heparan sulphate is a cytoadherence receptor 
was explored. Enzymatic digestion of CHO cells with heparinase -1 and the addition of 
heparan sulphate to the binding medium failed to inhibit binding. The ability of selected 
3D7A to adhere to the CHO-745 mutant provides compounding evidence that heparan 
sulphate is not the adhesive receptor mediating this adhesive phenotype. Similar results 
were obtained with the novel placental adhesion receptor hyaluronic acid and neuraminic 
acid. Neither of the inhibition experiments inhibited binding, thus eliminating these cell 
surface molecules as adhesion receptors mediating the adhesion of selected 3D7A and the 
CHO cell surface. Collectively these results suggest that the carbohydrates tested are not 
involved in this adhesive phenotype and that another cytoadherence receptor expressed at 
the surface of the CHO cells mediates must be involved.
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Chapter 4
Characterisation of PfEMP-1/var gene transcription in
unselected 3D7A cultures
4.1 Introduction
Although var genes exhibit a great deal of sequence diversity, PCR and RT-PCR assays 
have been successfully used to amplify different members of the gene family to analyse 
sequence diversity (Kyes et al, 1997; Ward et al, 1999), transcriptional regulation 
(Fischer et al., 1997; Chen et al, 1998 a; Scherf et al, 1998) and protein function (Chen 
et al, 1998 a; Rowe et al, 1997; Buffet et al, 1999; Reeder et al, 1999; Smith et al, 
2000 a). These amplification reactions employ primers based on conserved sequence 
motifs within DEL domains.
Based on previously published findings, it was predicted that an unselected parasite 
culture would transcribe some or even all of the var genes in its genome. On the other 
hand, parasite cultures selected for adhesion to a particular receptor, seem to transcribe 
predominantly a single var gene, presumed to be involved in the adhesion process 
(Scherf et <z/.,1998; Chen et al, 1998 a). To compare the var transcripts in CHO-cell 
adhesive 3D7A with those in unselected cultures, degenerate PCR primers were 
designed based on the sequences described by Su et al (1995). A RT-PCR assay was 
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4.2.1 PCR of var gene sequences from 3D7A genomic DMA
Genomic DNA from 3D7A for PCR was prepared by standard methods. The DNA 
concentration was roughly quantified on an agarose gel (Fig. 4.1). Primers mod 15 and 
mod 13 (Kyes et al, 1991 \ Ward et al, 1999) were used to assay for the integrity of the 
isolated genomic DNA by comparing the amplification of genomic DNA against cloned 
DNA (data not shown).
Figure 4.1 Quantification of genomic DNA isolated from
trophozoite/schizont stage 3D7A parasites for PCR 
123456
Figure 4.1 DNA was extracted 
from 3D7A parasites by saponin 
lysis and proteinase K treatment, 
run on a 1.2% agarose gel for 
quantification. 1. molecular weight 
marker VII, 2. Blank, 3. 3D7A 
DNA 125 ng/ml (4 jal), 4. 3D7A 
DNA 0.5 jag/ml (4 jal), 5. pGem 
(plasmid DNA) 200 ng and 6. 
pGem. 500 ng
Degenerate primers for PCR were designed to amplify as many members of the var gene 
family as posible. Five primers were designed to conserved regions within DBL-oc, 
DBL-8 and exon 2 (Fig. 4.2 and Table 4.1). The PCR conditions were optimised using 
an annealing temperature gradient and by adjusting the extension time. It was found that 
a reduction the denaturation temperature from 94°C, used in many Plasmodium
falcipamm PCR protocols (Kyes et al., 1997) to 93°C improved the efficiency of the
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PCR reaction. Due to the degeneracy of the primers and the high AT content of the P. 
falciparum genome the annealing temperature used was also relatively low (51 C) 
(Gardener et al, 1998; Bowman et al, 1999).
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PRIMER SEQUENCE 5TQ 3' —
GCACTCGAGTTATTCTTYTY





















Table 4.1 primer sequences used to amplify var gene sequences from 3D7A. Reverse 
primer Mod 13 contains a restriction site for the enzyme Xho-I (in blue lettering). The 
Forward primer Mod 15 has a restriction site for the enzyme Bam HI (in pink lettering). 
All other primers were designed without restriction sites.
REDUNDANCIES












































































































































































Chapter 4: Transcribed var gene sequences
Table 4.2. PCR products amplified from genomic DNA using different 
primer pairs and the expected size of these PCR products.
PRIMER PAIR
Mod 15- I/™- 4
ModlS- Var 3
Var r8- Var 4
Var 8-v Var 3
Var 6- Var 4
Var 6- Var 3
V0r5-Mod15
Var 5- Var 8
Mod 15-mod13




















Table 4.2 The observed band size of PCR products amplified from genomic DNA by 
specific primer pairs.The expected band size was calculated by aligning these primer 
pairs against var gene sequences submitted to the NCBI genebank database .
Using these degenerate primers several PCR products were amplified, many of which 
fell within the expected size range (Fig. 4.3, Table 4.2). The expected size of PCR 
products was calculated by aligning the primers used against published var gene 
sequences using the Macvector™ program. The distance between the primer pairs was 
used to calculate the expected band size for each primer combination, var 8-var 4 and 
var 8-var 3 produced a PCR band of 6.1 kb (within the expected range of 4-9 kb, Table 
4.2). The primer combination var 6-var 4 and var 6-var 3 produced a PCR product 3.6 
kb which is within the expected range of 3-4 kb. The primer combination var 5-mod 15 
and var 5-var 8 produced a PCR band 2.4 kb (within the expected size range 2-3 (Table 
4.2). The primer pair mod 15-mod 13 produced a PCR product of 600bp, again the size 
expected. (Table 4.2). Having thus determined that the primers chosen for PCR 
amplification produced amplified fragments of expected size, they were then used in the 
RT-PCR experiments.
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Figure 4.3 PCR amplification of var genes from 3D7A DNA
1 23456789 10 11
Figure 4.3 PCR amplification of var gene sequences from genomic DNA using a 
variety of primer combinations. 1. Molecular weight Marker II, 2. Blank 3. mod 
15- var 4, 4. Mod 15- var 3, 5. var 8- var 4, 6. var 8-var 3,7. var 6- var 4, 8. 
var 6- var 3, 9. var 5-modl5, 10. var 5- var 8, 11. mod 15-mod 13
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4.2.2 RT-PCR of RNA from unselected 3D7A
Parasites prepared for RT-PCR were cultured using essentially the same protocol for 
producing DNA, with the two variations being that parasites were cultured as bulk 
cultures of 6-8 large flasks and then synchronised using 5% sorbitol. Cultures were then 
harvested at 10% parasitaemia when approximately 95% of the parasites in culture were 
at early developmental stages 6-9 hours post invasion. RNA was isolated using an RNA 
isolator™ kit, a nucleic acid extraction protocol employing phenol and guanidinium 
thiocyanate . An aliquot of the RNA was used to quantify roughly the amount of RNA 
on a gel (Fig. 4.4). RNA isolated in this way can be contaminated with DNA, although 
this problem can be overcome by treatment of the RNA sample with RNAse free 
DNAse. An aliquot of DNase treated RNA was used in a reverse transcriptase reaction. 
The remainder was stored at -70 C.
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Figure 4.4 Quantification of total RNA isolated by RNA isolator from 6 
flasks of ring stage parasites.
1 2 3
Figure 4.4 RNA isolated from 
6 flasks of parasites using 
RNA isolator™ 1. molecular
weight marker VII, 2. RNA 
200 ng/ml (5 jjl), 3 . pGem 
200 ng
Since var genes are large genes, encoding up to 4000 amino acids and up to -13kb in 
size, reverse transcribing mRNA of this length efficiently is extremely difficult. In order 
to polymerise the longest reverse transcripts possible, long range RT-PCR using 
Expand™ reverse transcriptase was used. This employs a modified enzyme and 
optimised buffers. Furthermore it was found that the small scale cultures initially used to 
optimise the RT-PCR using the mod 13 and mod 15 primers (yielding a 700bp RT-PCR 
product) were insufficient to provide enough high quality intact RNA to generate longer 
transcripts (data not shown). Therefore the number of flasks used was increased to 6-8. 
RNA was then reverse transcribed from these large scale cultures to produce cDNA.
The same primer pairs and conditions used in the amplification of genomic DNA were 
used in the amplification of cDNA (Fig. 4.5, Table 4.3). The primers were aligned to 
published sequences (minus the 1 kb intron separating the genomic DNA encoding the 
external domains from the transmembrane ipgion) to calculate the expected band size.
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Primer combination var 8-var 3 produced a PCR band of 2.4 kb (this was not within the 
expected range of 4-9 kb, Table 4.2). This may have been due to mis-priming of either 
of the PCR primers. The primer combination var 5-mod 15 and var 5-var 8 produced a 
PCR band 2.4 kb (within the expected size range 2-3 kb, Table 4.3). The primer pair 
mod 15-mod 13 produced a PCR product of 600 bp, again the size expected. The primer 
combination var 6-var 3 produced a PCR product 2.9 kb (within the expected range 2-3 
kb, Table 4.3). When PCR amplifying across the single var gene intron which is spliced 
out of the m-RNA sequence, the PCR band appears, as expected, approximately 1 kb 
shorter than the identical reaction performed on genomic DNA (Fig. 4.6). As a control 
for the presence of contaminating DNA, PCR of RNA not previously reverse transcribed 
failed to amplify the product. These results confirm that the PCR band present in the 
cDNA reaction was due to amplification of reverse transcribed RNA and not 
contaminating DNA (Fig. 4.6 lane 5 and Fig. 4.7 lane 6).
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Table 4.3 Observed band sizes of PCR products amplified form cDNA reverse 
transcribed from RNA extracted from unselected 3D7A. Expected band sizes calculated 
by alignment of var gene sequences submitted to the NCBI Genebank database.
Figure 4.5 RT-PCR of total RNA isolated from ring stage parasites.
12 3456 78
2027 bp
Figure 4.5 PCR amplification 
of var gene sequences from 
cDNA using a variety of primer 
combinations, 1. molecular 
weight marker II, 2. mod 15- 
mod 13, 3. var 5- var 8, 4. var 
6- var 3, 5. var 8- var 3, 6. 
mod 15-mod 13, 7. mod 15- 
mod 13 amplified from DNA 
and 8. molecular weight 
marker VII.
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Figure 4.6
PCR amplification ofgenomic DNA and cDNA across the var gene intron 




Figure 4.6 PCR amplification 
using primers var 3 and var 6 1. 
molecular weight marker II, 2. 
molecular weight marker VII, 3. 
DNA 3.6 kb PCR porduct, 
amplification across the var gene 
intron, 4. cDNA amplification, 
2.9kb, no intron present thus 
giving a 0.7 kb smaller PCR 
product.




Figure 4.7 PCR amplification of DNA 
cDNA and RNA using primers var 5 
and var 8, 1. molecular weight marker 
VII, 2. amplified DNA (2.4 kb PCR 
product) 3. cDNA (2.4 kb PCR 
product) and 4. RNA (not reverse 
transcribed). Note no amplification, 
i.e. no contaminating genomic DNA.in 
this preparation.
94
Chapter 4: Transcribed var gene sequences
4.2.3 Cloning and sequencing transcribed var gene sequences from 
unselected 3D7A
Although a number of primers permitted amplification of products from both genomic 
DNA and cDNA templates, the primer combination var 8-var 5 and var 6-var 3 
consistently produced strong PCR bands and these products together covered exon 1, 
(Figs. 4.4 - 7). The PCR products from these two reactions were excised from the gel, 
purified and where necessary concentrated by ethanol precipitation. PCR products were 
ligated into a TA cloning vector, transformed into competent E .coli cells and plated on 
to LB ampicillin plates, p-galactosidase dependent blue-white screening was used to 
select clones containing insert. White (insert positive) colonies were picked and first 
screened for insert by PCR using the vector primers T7 and M13R. (data not shown). 
PCR positive clones were screened by restriction digest with Xho-I (Fig. 4.8).
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Figure 4.8
Xho-I digest of positive clones obtained after ligation and transformation 
of PCR products amplified from unselected 3D7A cDNA using primers 
var 8-var 5 primers.




of products cloned 
from the 
amplification of 
var gene sequences 
from cDNA using 
var 8-var 5 
primers. 1. 
molecular weight 
marker VII, 2-11. 
clones bl-b 10, 
(2.2-2.3kb), 12. 
molecular weight 
marker VII, and 
13. Uncut pGem
4.2.4 Sequencing of var gene clones
Positive clones were sequenced on an ABI automated sequencer, using T7 and M 13R 
sequencing primers. Initially 10 clones from PCR amplifications using var 5-var 8 and 
var 6-var3 primers were sequenced in both directions. The sequences were then 
translated into amino acid sequence using Macvector™. Sequencing revealed that 4 
different clones from the 10 var 6 -var 3 clones were obtained and 8 different clones 
from the 10 var 5-var 8 clones were obtained (Figs 4.9a, 4.9b and 4.10a, 4.1 Ob 
respectively). The sequences were aligned against var sequences submitted to NCBI 
sequence database and were found to be homologous to PfEMP-1 proteins, i.e. var 8-var 
5 clones showed greatest homology with DBL-oc and DBL-8 at the 5' end and 3' end of
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each clone respectively. Var 3-var 6 PCR bands showed the greatest homology with 
DBL-8 and exon 2 of PfEMP-1 sequences.
In order to obtain a representative sample of the var gene transcripts transcribed by 
unselected 3D7A cultures more var 5-var 8 clones were sequenced. A total of 217 
clones were sequenced and a total of 27 different var sequences isolated (Fig. 4.11). 
Some sequences appeared more frequently than did others, although whether this 
represents a difference in abundance of transcripts or differences in efficiency of PCR 
primers to amplify different sequences is unclear.
4.2.5 Analysis of DBL-oc var gene sequences
Analysis of the DBL-oc sequence of these transcribed var genes revealed that the genes 
transcribed within the clone 3D7A were very diverse both at the nucleotide and the 
amino acid level. The diversity of var gene sequences can be illustrated by the very low 
sequence homology observed between the var gene clones 149 and 145, in which 
identity is only 19% at the amino acid level (Fig. 4.11). Var clones 211 and 177 
appeared most similar, with nucleotide sequence homology of 84% and 78% amino acid 
identity (Fig. 4.11). Conserved sequences tended to appear in sequence blocks of 
between 10-20 amino acids. These sequence blocks appear periodically throughout the 
sequence. There are also several cysteine residues conserved between most sequences. 
There are also length polymorphisms located between the conserved sequence blocks 
(Fig.4.11).
4.2.6 Sequence comparison of 3D7 DBL-oc sequences with DBL-oc 
sequences cloned from parasites of diverse geographical origins
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The 27 different transcribed var sequences cloned from the unselected 3D7A parasite 
clone were aligned with 20 geographically diverse P. falcipamm var sequences obtained 
from the Genebank Database and an additional 22 Sudanese sequences obtained from 
parasites isolated in a single village (Ward et al, 1999). The Sudanese sequences were 
cloned from parasite clones SD101, SD102, SD105, SD106, SD126 and SD128 which 
were cloned from six unrelated malaria patients in the village of Asar, between October 
and November 1989. Each clone has a distinct phenotype, genotype and molecular 
karyotype (Babiker etal, 1991; Bayoumi etal, 1993; Bayoumi et al, 1994). Var genes 
were amplified from the genomic DNA of these clones by PCR using primers which 
anneal to the 5' end of the DBL-oc domain, and then cloned and sequenced. (Ward et 
a/,.1999).
This analysis revealed a surprising degree of sequence similarity between certain 3D7A 
sequences and sequences cloned from the Sudanese parasite SD105. 3D7A var-149 
sequence is identical to the SD105 sequence SD105J at the nucleotide level. The 3D7A 
var-59 sequence and the SD105M sequence share 332 of the 335 nucleotides sequenced. 
Other sequences with similar amino acid sequences were observed. For example 3D7A 
var-37 and SD105L share 124 of 125 amino acids, 3D7A var-43 and SD105R share 128 
of 131 amino acids and 3D7A var 3 and SD105F have 100 of 111 identical sequences. 9 
of the differences in the latter comparison occur over a continuous stretch of sequence.
4.2.7 Mapping of var genes to 3D7A chromosomes sequenced by 
the Malaria Genome Project.
Alignment of the 3D7 A transcribed sequences obtained in the current work against the 4 
complete 3D7A var genes sequenced and pgfclished to date has permitted the mapping of
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two of these transcribed genes to a particular chromosome. The amino acid sequence of 
the 4 var genes sequenced to data were aligned against the 27 var gene clones from the 
unselected 3D7A parasite culture using the Mac Vector program™. The transcribed 
3D7A var clones 177 and 51 were mapped to the left and right arms of chromosome 3 
respectively. Attempts were made to map the remaining 25 clones to specific contigs or 
sequence reads derived from the different chromosome sequencing projects; however 
this has been found to be much more difficult than expected due to the contamination of 
purified chromosomal DNA preparations used to generate chromosome specific clone 
banks with genomic DNA from neighbouring chromosomes (Bowman et al, 1999). 
Therefore until each 'chromosome' is fully sequenced and more importantly annotated, 
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4.3 Conclusions
Twenty-seven different var gene sequences have been cloned from 3D7A ring stage 
cDNA. These clones contain a 5' DBL-a sequence at the 5' end of the sequence cloned 
and a DBL-8 sequence at the 3' end of the clone. These cloned gene fragments contain 
var gene sequence spanning the region between DBL-a and DBL-8. These gene 
sequences were shorter than most sequences compiled from the Genebank sequence 
database, but are consistent with the size of the other var genes sequenced from the 
3D7A genome. Twenty-seven different cDNA clones of an estimated 50 var genes have 
been cloned representing almost 3/5 of the var gene repertoire.
Sequence analysis shows that PfEMP-1 possesses great potential for sequence variation 
at both nucleotide and amino acid levels. It has been observed that the sequence 
homology between var sequences transcribed by the unselected 3D7A can be as low as 
19% at the amino acid level. The sequence diversity is compounded by sequence length 
polymorphisms between var genes which create the potential for antigenic diversity by 
altering the protein structure. However an essential structural framework of the PfEMP- 
1 protein may be conferred by the conserved sequence blocks of between 10-20 amino 
acids observed at regular intervals throughout these sequences.
Sequence comparison of var genes from disparate geographical regions reveals that 
although the 3D7A parasite expresses a diverse set of var genes, sequence blocks within 
these var genes are not specific to this clone. Var gene sequence homology between 
3D7A var genes and var genes cloned from Sudanese parasites in some cases ranged 
from 90-100% over stretch of 400 bp of sequence analysed. This exchange of var gene 
sequence between clones may occur via recombination of randomly mixing parasite 
clones in the field (Ward et al, 1999). 103
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The mapping of the transcribed var gene clones has permitted two sequences var-lll 
and var-51 to be mapped to the left and right arms of chromosome 3 respectively 
providing evidence that at least these chromosome 3 var genes are transcribed in an 
unselected parasite culture. Mapping of the remaining transcripts on to the as yet 
unassembled and unannotated P. falciparum genome sequence database has proved very 
difficult.
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Chapter 5 
Var gene transcribed by CHO cell adherent 3D7A
5.1 Introduction
Previous studies have shown that selection for a specific PfEMP-1 mediated adhesive 
phenotype also selects for the transcription of a predominant var gene sequence. This is 
the candidate sequence encoding the parasite protein mediating the adhesive phenotype 
/., 1998a;Scherf*tf0/., 1998).
To identify the complete primary sequence of the PfEMP-l protein from 3D7A parasites 
involved in adhesion to the CHO cell surface a novel approach has been used. The 
3D7A clone was chosen as the model clone for these experiments primarily because it is 
being sequenced by the P. falciparum genome project. Instead of using traditional "wet 
laboratory" methodology, after identifying a partial cDNA sequence from a RT-PCR 
clone it was decided that the full-length gene sequence be obtained "in silico" using 
sequence data being generated by the Malaria Genome Project.
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5.2 Results
5.2.1 RT-PCR of 3D7A parasites selected for adhesion to CHO cells
Using PCR conditions employed in the amplification of the 27 var cDNA sequences, as 
developed in chapter 4 from unselected 3D7A cultures, primers var 5 and var 8 were 
used to amplify cDNA reverse transcribed from 3D7A selected for adherence to CHO 
cells. Others have demonstrated that selection for a PfEMP-1 mediated adhesive 
phenotype selects for a parasite population transcribing one predominant var gene 
transcript, the transcript that is subsequently translated into protein and expressed at the 
infected erythrocyte surface (Chen et al, 1998 a; Scherf et al, 1998). Chen et al. (1998 
a) demonstrated that recombinant fusion protein expression of the DBL-oc domain 
sequence could be successfully used to block resetting in a sequence specific manner. 
Scherf et al. (1998) further demonstrated that transfection of CHO cells with partial 
cDNA sequences corresponding to DBL-y domain from the selected transcript supported 
adhesion in this cell line.
RT-PCR products from the CHO selected 3D7A were run on an agarose gel (Fig. 5.1). A 
single band was seen which was approximately 1.0kb (Fig. 5.1). The PCR product was 
1.4 kb shorter than the 2.4 kb PCR product amplified from unselected 3D7A (Chapter 
4). Thus the selection of 3D7A had apparently resulted in the selection for a sub- 
population of parasites transcribing var genes distinguishable by size from those 
sequences previously cloned from unselected 3D7A.
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Figure 5.1 RT-PCR O/3D7A selected for increased adhesion to CHO cells
1 345
1.0 kb
Figure 5.1 RT-PCR of
parasites selected for adhesion 
to CHO cells. 1. Molecular 
weight marker VII, 2. 1.0kb 
PCR product amplified from 
cDNA, 3. 2.4 PCR product 
amplified from DNA (control), 
4. RNA(not reverse 
transcribed), 5. H2O
5.2.2 Cloning & sequencing of RT-PCR products amplified from 
CHO cell selected 3D7A
The 1.0 kb PCR product was excised from the gel, purified, ligated into a TA cloning 
vector and transformed into competent cells, which were plated on LB ampicillin plates 
and grown over night, p-galactosidase-dependent blue/white screening was used to 
select colonies with insert. 10 insert positive colonies were picked and screened by PCR 
amplification using primers T7 and Ml3, and by restriction digestion with the enzyme 
Xho-I (data not shown).
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10 insert positive colonies were sequenced in both directions using primers T7 and 
M13R. The sequences were translated and aligned using the Mac Vector™ program. One 
clone failed to sequence but 8/9 clones contained an identical sequence. This sequence 
was different from any of the 27 sequences originally cloned using these primers to 
amplify cDNA isolated from unselected 37DA (Fig. 5.2) clone. The cloning and 
sequencing of the PCR product was repeated once more with identical results i.e. 9 of 9 
clones sequenced contained the one unique var gene sequence. These sequencing results 
indicate that selection for increased adhesion to the CHO cell surface (which is mediated 
by a parasite derived trypsin sensitive protein) also selects for the transcription of a 
predominant var gene sequence. Interestingly this predominant var transcript amplified 
from selected 3D7A was not identified as a var product in cDNA amplified from 
unselected 3D7A. The translation of the DNA sequence of the 1 .Okb PCR product is 
shown in figure 5.3 . The cloned sequence was subsequently named var-CHO.
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Figure 5.2 ammo acid sequence of the var-CHO cDNA clone
RSFAD1GDIIKGTDLWDKNGGEQKTQGKLEKIFCKIKNKLPEDIQEKYINDDKNSPQY KKLREDWWEANRKEV WRAMTCATTSGKIPC
SIVTPLDDYIPQRLRWMTEWSEWra<EQSKLYGELVKIX:ASaCKKGKEKCTQGDNI^
QMLY LQAQTTARN AGDT AFDNPNDQY VIDFFKKLQKANGDNNR3VNTSPY FTPAGYIHQEARVGECEVQKHFCNNNGNQDKY SFRN
QFYDHEEACACKKNTKAPEKKKEETPPAGFNVCEIVDKLFEDTTTPHAACQQKYINGHEKFPNWKCVTPSGEKSGDKGAIC^
Var CHO clone
DBL-a I CIDR-a I^^^MP^B^WV^P^ DBL-6 I CIDR-B I ATS
Figure 5.2 Amino acid sequence of the var CHO cDNA clone superimposed on to a 
schematic of the exon-one of the var-CHO gene. Blue line indicates position ofcDNA 
clone (not to scale).
The cloned sequence obtained exhibited homology to both the DBL-p sequence at the 5' 
end and DBL-6 at the 3' end, when compared to var genes submitted to the NCBI 
Genebank database. This implies that the relatively short sequence amplified actually 
results from the mis-priming of the var 8, 5' primer to the ARSFADIGII sequence motif 
within the DBL-P domain. This motif is identical to the ARSFADIGII motif observed 
in all DBL-a domain sequences on which the var 8 primer was originally based. The 
smaller 1.0 kb fragment can be occasionally observed as a faint band in some RT-PCR 
amplifications of unselected 3D7A parasites (Fig. 4.7 chapter 4). However this relatively 
small band was not cloned from that RT-PCR amplification because at that time it was 
considered to be too small to have been derived from the PfEMP-1 target region to be 
amplified. It was thought that such bands probably represented amplification of non-var 
gene sequences, witch contain DBL type domains e.g. the EBA-175 gene.
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5.2.3 Extending var-CHO sequence using genomics: accessing 
sequence data from the Malaria Genome Project
3D7A is the parasite clone being sequenced by the Malaria Genome Project. This is a 
collaborative project being conducted by three research institutes. The project has been 
divided between these institutes and each is sequencing particular chromosomes. The 
Sanger Centre in Cambridge is sequencing chromosomes 1, 3, 4, 5, 6, 7, 8, 9, & 13, 
Genome Technology Centre in Stanford California is sequencing chromosome 12 and 
the TIGR Institute For Genome Research in Rockville Maryland is sequencing 
chromosomes 2,10, 11 and 14. It was possible to exploit the availability of the rapidly 
accumulating sequence data from these centres to compile the complete wzr-CHO gene 
sequence.
The primary technique in such "in silico" molecular genetics is the blast search. This 
involves the submission of a nucleotide sequence to an Internet based algorithm, which 
identifies, within a particular database, sequences of significant homology with the 
sequence submitted. The Sanger Centre sequence database was the only one in which 
sequences with significant homology to the var-CHO sequence were identified in the 
period 1998-99. Sequence homology of > 98% in overlapping sequence was considered 
as evidence that the sequence reads came from truly contiguous fragments. Sequence 
overlap was analysed by eye. Overlapping sequences with a significant degree of 
homology were aligned in the Assemblylign™ program for nucleic acid alignment. The 
overlapping sequence was then again analysed by eye. These contiguous sequence reads
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were then assembled to produce a contig, a variable number of overlapping sequence 
reads. Contigs were then assembled using the Mac Vector™ program and translated to 
ensure that the amino acid sequence remained in frame. The 3' and 5' sequence reads 
from the contig were then re-submitted to the Sanger Centre P. faciparum genome 
database and sequences obtained were then re-analysed for their sequence homology to 
the sequences originally submitted. Sequences with significant sequence homology were 
then re-aligned to the first sequence contig in the Assemblylign™ program to try to 
extend the sequence. Sequences were then once again re-analysed by eye and if 
necessary, adjusted by hand where they were poorly aligned by the computer program. 
This process was repeated with constant translation of the sequence to check that the 
sequence remained in frame.
The var-CHO sequence was extended to the presumptive 5' start methionine of the 
PfEMP-1 protein. The start methionine was deduced by alignment of the contiguous 
sequence against full-length var gene clones previously submitted to the NCBI 
Genebank database. Using the Sanger Centre genome database data it was also possible 
to extend the var-CHO sequence by a further 3kb from the 3' end of the cloned var-CHO 
cDNA clone. Eighty sequence reads including the cloned var-CHO sequence were used 
to extend this sequence from 1.0 kb to a total of 6.2 kb (Fig. 5.3).
To date it has not been possible to extend the sequence any further 3' using the Sanger 
Centre database. One of the major problems that the malaria genome sequencing 
program has faced is that the organisation of the task has been done by assigning 
particular chromosomes to particular centres. Individual chromosomes were separated
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on pulse field agarose gels. The bands were subsequently cut out and DNA was purified 
from the excised bands prior to shot gun sub-cloning. Unfortunately clean separation is 
difficult for chromosomes 5-8 (the "blob") and all individual chromosomal preparations 
are variably contaminated with DNA from other chromosomes. It was therefore possible 
that the sequence contig could be extended using sequence reads from TIGR or Stanford 
sequencing projects as these chromosome preparations may actually contain 
contaminating DNA from chromosomes being sequenced by the Sanger Centre. 
Attempts were then made to continue the extension of the sequence using reads available 
from the P. falciparum chromosome 12 data base at the Stanford Genome Technology 
Centre Stanford, University. Also a blast search for homologous sequences was 
conducted using the "TIGR" database. However analysis of homology matches on these 
databases produced no significant sequence identity with the contig alignment 
assembled. The lack of any significant sequence homology with sequence reads obtained 
from these chromosomes did however aid the mapping of this gene to a specific 
chromosome (see below). The complete extension of the 3' end of the var-CRO 
sequence to the end of the exon-1 sequence did not prove possible "in silico" at least at 
this stage of development of the Malaria Genome Project. A more conventional directed 
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5.2.4 Cloning the 3' end of exonl of var-CHO
To extend the sequence 3' to the end of the exon-1 sequence, a forward primer (EX2) 
was designed to anneal to the 3* end of the var-CHO contig. The reverse primer used in 
this amplification was the var 3 primer, designed to anneal to a conserved region at the 
5' end of exon 2. The primer pair Ex2 and var 3 were therefore used to PCR amplify the 
cDNA preparation used to clone the var-CHO cDNA sequence. Using the genome 
sequence data it had been possible to extend the var-CHO sequence into the DBL-8 
sequence domain. This domain is usually the 3' DEL domain in the var gene sequence. 
Thus it could be predicted that the fragment to be amplified would be a relatively small 
one. The amplified PCR product was 506 bp (Fig. 5.4). The PCR product was excised 
from the agarose gel and purified as described in section 5.1.3. The amplified DNA was 
ligated into a TA cloning vector transformed into competent cells and plated on LB amp 
plates. 10 colonies were screened by PCR and restriction digest (as above) and positive 
clones were sequenced.
Sequencing revealed that the PCR band consisted of a number of different sequences. 
This was expected because the 3' reverse primer (var 3) is a degenerate primer. The 
insert sequence of each clone was aligned against the var-CHO clone contig using the 
Assemblylign™ program. Three of these sequences (each identical to the other) aligned 
with 100% sequence homology over the 133 bp overlap on the var-CHO contig (Fig. 
5.5), thus extending the var-CHO contig 367 bp into the exon 2 sequence of the gene 
(Fig. 5.6). The sequence was also submitted to the NCBI Genebank database for blast
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analysis. As expected the sequence was found to be homologous to the conserved region 
of exon 2, providing supporting evidence that the v0r-CHO contig had been extended 
into exon 2. The var-CHO contig was 6619 bp in length. The sequence contig was 
assembled from these sequence reads on one subsequent occasion to verify the 
contiguous sequence obtained. (The independent assembly of this sequence by Dr D. 
Baruch, National Institutes of Health, Washington, and Dr S. Bowman, Sanger Centre, 
Cambridge has verified the nucleotide sequence of this clone).
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Figure 5.6 Var-CHO exon 1 amino acid sequence. DEL, C2 and CIDR domains are colour 
coded, DBL-a (303 aa) Blue, CIDR-cx (427 aa) Red, DBL-0 (278 aa) light green, C2 (134 
aa) Pink, DBL-6 (373 aa) Turquoise, (CIDR-p 537 aa), violet, Exon 2 Dark yellow.
Cysteine residues are in bold C.
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5.2.5 Annotating the exon 1 gene sequence
The complete Exon 1 of the var-CHO gene has been sequenced. This sequence encodes 
for the extracellular portion of the var gene. It is this section of the protein that is 
involved in adhesion. The sequence is 2132 amino acids in length. It contains 102 
cysteine residues, which form disulphide bonds and are thus important in maintaining the 
structural framework of the protein.
The sequence was annotated by hand. The domains which characterise the extracellular 
domain of the PfEMP-1 protein can be identified by specific sequence motifs. 
Identification of these sequence motifs within the var-CHO sequence permitted the 
annotation of the sequence. The var-CHO sequence contains three DEL domains, two 
CIDR domains and one C2 domain. The N-terminal domain is a DBL-oc domain 303 
amino acids in length containing 17 cysteine residues. The DBL-oc domain is linked with 
a CIDR-a domain, 427 amino acids in length containing 17 cysteine residues. These 
domains have both been implicated in adhesive phenotypes, DBL-oc in resetting via 
complement receptor-1 (CRI) and heparan sulphate, and CIDR-a in cytoadherence via 
CD36. The third domain in the sequence is a DBL-p domain, which consistently appears 
in tandem with the C2 domain. The wzr-CHO DBL-p domain is 278 amino acids in 
length and contains 13 cysteine residues. The next domain is the C2 domain, 134 amino 
acids in length and containing 5 cysteine residues. The DBL-P-C2 tandem domain has 
been implicated in infected erythrocyte adhesion to the endothelial adhesion receptor 
ICAM-1. The fifth domain DBL-8 is 373 amino acids in length and contains 10 cysteine 
residues. The final C terminal domain, consistently located immediately 3' of the DBL-8
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domain is the CIDR-p domain, which is 537 amino acids in length containing 40 cysteine 
residues. The CIDR- p is yet to be associated with an adhesive phenotype, however the 
high cysteine content may suggest a fundamental role of this domain in maintaining the 
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5.2.6 Mapping of the Var-CHO gene to Chromosome 13
As detailed above in sections 5.2.3 and 5.2.4 it has been possible to use genomics i.e. the 
whole genome sequencing project to extend the var-CHO sequence. All the genome 
project derived sequence reads used came from the Sanger Centre malaria genome 
database. The Sanger Centre is sequencing chromosomes 1, 3, 4, 5, 6, 7, 8, 9 and 13. 
However, due to DNA contamination of chromosomal DNA from pulse field agarose gel 
chromosome preparations with DNA from other chromosomes it was not possible to map 
"in silico" the gene to a specific chromosome. The sequence reads used in the assembly 
of the sequence came from a number of different chromosome preparations within the 
Sanger Centre genome database. It was also not always possible to identify the 
chromosomal origin of sequence reads by the codes used to identify them, a significant 
problem for "community" access to the genome project databases.
To map the gene to a specific chromosome var-CHO clone was radio-labelled and used 
to probe a pulse field gel separation of 3D7A chromosomal DNA. To avoid any 
background hybridisation between plasmid DNA and chromosomal DNA the var-CHO 
insert was amplified from their respective plasmids using var 5-var 8 primers. The PCR 
products were excised from the gel and purified using methods previously described and 
resuspended in 50|il H2O. 2jnl of DNA was labelled by random hexamer priming with 
32P (See Methods). The labelled probe was then hybridised overnight with a 3D7A pulse 
field gel blot (provided by Dr D. Arnot). The PFG blot was washed under stringent 
conditions before being exposed to autoradiographic film.
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The var-CHO sequence hybridised to a single chromosome of 3D7A on the pulse field 
blot, chromosome 13. High molecular weight chromosomes 14 and 13 migrate close to 
each other at the top of the pulse field gel due to their similar molecular weights, 
separated from chromosome 12 which is significantly smaller (Fig. 5.8,). The Pulse field 
Gel data also shows that the var-CHO sequence is absent from the SD 128 genome. 
However this sequence or a gene of similar sequence is present on chromosome 13 of the 
Sudanese clone SD105.
Figure 5.8 Probing pulse field gel of3D7A, SD 128/5 and SD 105/9 DNA








9 (1.8 Mb) 
8/7 (1.7 Mb 
6 (1.6 Mb) 
5 (1.4 Mb) 
4 (1.2 Mb) 
3 (1.06 Mb) 
2 (0.95 Mb)
Figure 5.8A tithidmm bromide stained pulse field gel of 3D7A (lane 1), SD 128 (lane 2) and SD105 Iane3) 
DNA. Figure 5.8B Southern blot of 3D7A (lane 1), SD 128 (lane 2) and SD105 (lane 3) DNA separated 
by pulse field gel electrophoresis and transferred to nylon membrane, then hybridised with the var CHO 
cDNA clone.
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5.2.7 Verification of sequence alignment
One of the difficulties associated with sequencing multicopy gene families is that there is 
a potential risk of assembling a contig from a number of homologous but different genes 
from the same gene family. To verify that the assembled contig represented the 5' and 3' 
end of the same gene a 3D7A pulse field gel was probed with the var-CHO 3' clone. The 
Var CHO 3' clone also hybridised to Chromosome 13 on the pulse field gel (Figure 5.9) 
providing supporting evidence that the contiguous alignment of the var-CHO sequence 
represents an alignment of the same gene.
Figure 5.9 Probing pulse field gel of SD 105/9 and 3D7 DNA
1 2 1 2
Chromosome 
(Size)
14 (3.4 Mb) 
13 (3.2 Mb) A
12/11(2.4 Mb)
10 (2.1 Mb) 
9 (1.8 Mb) 
8/7 (1.7 Mb 
6 (1.6 Mb) 
5 (1.4 Mb) 
4 (1.2 Mb) 
3 (1.06 Mb) 
2 (0.95 Mb)
B
Figure 5.9A Ethidium bromide stained pulse field gel of SD 105/9 (lane 1) and 3D7A lane 2) DNA. 
Figure 5.9B Southern blot of SD105/9 (lane 1) and 3D7A lane 2) DNA separated by pulse field gel 
electrophoresis and transferred to nylon membrane, then hybridised with the var CHO 3' cDNA clone.
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5.3 Conclusions
PCR amplification of cDNA extracted from parasites selected for increased adhesion to 
CHO cells amplified a single 1.0kb PCR product. This suggests that selection for a 
specific adhesive phenotype also selects for the transcription of a specific var gene. It 
was possible to extend the var-CHO sequence by accessing the Sanger Centre Malaria 
Genome Project database using genomics. Most of the exon 1 sequence was obtained 
from the genome database and the remaining sequence (367 bp) was cloned from cDNA 
from selected 3D7A. The exon 1 sequence of the var-CHO gene is 2132 amino acids 
long and consists of three DEL domains DBL-cc, DBL-p and DBL-8. This gene 
represents the first var gene to be reported from 3D7A which contains 3 DEL domains. 
This is also the first var gene to be reported from 3D7A with sequence encoding for a 
DBL-P domain. DBL-y has been implicated in adhesion to CSA in two independent 
reports (Reeder et al, 1999 Buffet et al, 1999). The absence of the DBL-y domain from 
the var-CHO gene sequence supports the results presented in Chapter 3, that CSA is not 
involved in this adhesive phenotype. Southern hybridisation of the var-CHO clones to a 
pulse field blot of 3D7A DNA permitted the mapping of the var-CHO gene. By using a 
combination of the pulse field blot data and genomics data from the Malaria Genome 
Project the var gene was given a location of chromosome 13.
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Chapter 6
RT-PCR/ dot blot analysis of vargene switching in
CHO cell selected 3D7A
6.1 Introduction
During the development of this thesis it has been demonstrated that 3D7A can be 
selected for increased adhesion to the surface of CHO cells, an adhesive phenotype 
mediated by an as yet unidentified CHO cell surface receptor (Chapter 3). In chapter 4 it 
was demonstrated that unselected 3D7A cultures transcribe at least 27 different var 
genes. It has also been demonstrated that selection for increased adhesion to the CHO 
cell surface also selects for the transcription of a specific PfEMP-lgene, var- CHO 
(Chapter 5).
It was predicted that parasites within the CHO cell-selected 3D7A culture would switch 
the var gene being expressed, and thus undergo antigenic variation, during maintenance 
of the culture in the absence of selection for adhesion. The cytoadhesion assay 
developed and the 28 sequences cloned during this thesis were therefore employed in a 
novel assay to try to analyse var gene switching in this model system. This involved a 
RT-PCR/dot blot assay to detect switching from the transcription of the selected var 
gene (var-CHO), to the transcription of any of the var genes previously cloned from 
unselected 3D7A. Var genes in the parasite clone A4 have been measured to switch at a 
rate of around 2% per generation (Roberts et al, 1992). These experiments were 
intended to analyse the rate of var gene switching over time in the parasite clone 3D7A
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and to test whether there is any repeated pattern in var gene switching and thus P. 
falciparum antigenic variation, as has been reported in the primate malaria P. fragile 
(Handunnetti et al, 1987).
6. 2 Results
6.2.1 Development of dot blot assay for the hybridisation of var 
transcripts
The dot blot was prepared by binding aliquots of DNA containing equal concentrations 
of twenty eight cloned var gene sequences to a nylon membrane. Twenty seven of these 
were cloned from an unselected 3D7A parasite culture and the other transcribed var 
gene, var-CHO was cloned from 3D7A cultures, selected for increased adhesion to CHO 
cells. Cloned plasmid DNA from the 28 var sequences cloned, was spotted on to a nylon 
membrane using a dot blot apparatus. DNA on the membrane was subsequently alkali 
denatured, neutralised and air dried. The DNA was then cross-linked to the nylon 
membrane by ultraviolet light. To exclude background hybridisation between the 
plasmid DNA spotted on to the membrane and plasmid DNA contaminating the "probe" 
during radio-labelling, the cloned var gene DNA used for probing the membrane was 
PCR amplified from the plasmid vector using var 5 and var 8 primers. The amplified 
DNA was excised from the agarose gel, purified and re-suspended in 50(4,1 H20. The pure 
"probe" DNA was then ready for radio-labelling. 1 JLI! of var gene DNA (approximately 
50ng) was labelled with 32P by incorporation of 32P labelled dATP by polymerisation 
following random hexamer priming. 32P labelled DNA was hybridised to the var gene
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dot blot membrane overnight. The membrane was then washed under stringent 
conditions. Briefly following hybridisation, the membranes were washed twice with 2X 
SSPE, 0.1% SDS for 15 minutes at 65°C, IX SSPE, 0.1% SDS for 15 mins at 65°C and 
0.1X SSPE, 0.1% SDS for 15 minutes. The membranes were then exposed to auto- 
radiographic film. After trial hybridisation experiments it was decided that lOng of 
target DNA produced the cleanest hybridisation signal.
6.2.2 Cross hybridisation of vargene clones
To assess the degree of cross hybridisation between var gene sequences prior to probing 
the dot blot with radio-labelled RT-PCR products from the selected 3D7A parasite line, 
the dot blot was first probed with each cloned var gene sequence individually. Using the 
protocol described above each dot blot was probed in duplicate (Fig. 6.1) .As expected 
all of the sequences hybridised to themselves, although some cross hybridisation was 
observed between sequences (Fig. 6.1 & Fig. 6.2). Eight of the 28 DBL-1 derived 
sequences used to probe the filter cross-hybridised with one other sequence on the filter 
(Fig. 6.2). Interestingly, none of these sequences cross-hybridised with more than one 
other sequence, again emphasising the high level of sequence divergence between 
different members of the PfEMP-1/var gene family.
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Figure 6.2 Cross hybridisation of var sequences used to probe the var 






Figure 6.2 Schematic of var gene dot blot membrane 
with cross-hybridising clones indicated. Var clones 211 
and 177 (Yellow), 25 and 71 (Red), 58 and 169 (Pink) 
38 and 67 (Turquoise) cross hybridise with each other. 
No cross hybridisation was observed between other 
clones.
6.2.3 RT- PCR amplification of var gene transcripts and hybridisation 
of amplified transcripts to the var gene dot blot membrane
Six to eight culture flasks of 3D7A parasites selected for increased adherence to CHO 
cells were prepared as described in chapter 5. Parasites were grown through 4 
generations (96 hours) after selection, before RNA was extracted at ring stage. An 
aliquot of this RNA was used to synthesise cDNA using the var 3 primer. A fraction of 
the cDNA was used in a PCR reaction. The band produced by this PCR reaction was 1.0
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Figure 6.1 A. Duplicate dot blot of var gene sequences probed with var 
















Figure 6.1 Duplicate var gene 
dot blot membrane probed 
with 32P radio-labelled var 111 
sequence. Var 111 sequence 
hybridises to var 111 clone 
spotted on to membrane 
(membrane 1: 6A, membrane 
2: 6F). The var 111 clone cross 
hybridises with var 211 
(membrane 1:2B, membrane 2: 
2G).
Figure 6.1 B Schematic of 
var gene dot blot membrane 
with positions of 
transcribed var sequences. 
Position that var 111 
hybridises to (Red) and the 
position the var 111 
sequence cross-hybridises 
to (Yellow) are indicated.
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kb, smaller than the original 27 clones, cloned in chapter 4, but consistent with the size 
of the PCR band amplified after selection for adhesion to CHO cells (Fig 6.3) and 
(chapter 5).
Figure 6.3 RT- PCR amplification ofRNA extracted from selected 3D7A 





Figure 6.3 RT-PCR of 3D7 A
parasites selected for adhesion to 
CHO cells, 1. molecular weight 
marker VII, 2. 2.4 kb PCR product 
amplified from DNA, 3. 1.0kb 
PCR product amplified from cDNA 
reverse transcribed from RNA 
extracted from CHO cell, selected 
3D7A, 4 generations after selection, 
4. RNA (not reverse transcribed).5. 
H20.
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Figure 6.4 A. Dot blot hybridisation of RT-PCR product amplified from 
RNA extracted from 3D7A selected parasite Une9 4 generations after 
selection.












Figure 6.4 A. RT PCR of 3D7A, 96 hours (4 generations) 
after selection for adhesion to CHO cells .RT-PCR product 
hybridises to var gene dot blot membrane at the position of the 
var-CHO sequence, top left hand corner (1A). Figure 6.4 B. 
Schematic representation of dot blot with position of var 
sequences shown, hybridisation signal of RT-PCR product 
shown in red.
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The remaining PCR product was labelled as described in 6.2.1 and hybridised to the dot 
blot membrane. The amplified sequence hybridised only to the var-CHO sequence on 
the var gene dot blot membrane (Fig. 6.4) providing further evidence that the 
predominant transcribed sequence amplified was that of the var-CHO gene. Using the 
proposed switch rate of 2% per generation (Roberts et al 1992) and assuming equal 
growth rates for all variants, after 4 generations it was predicted that about 8% of the 
parasite population could have switched to the expression of another var gene variant. 
At such an early stage after selection it may not be possible to detect a switch in the in 
var gene expression by RT-PCR, due to the exponential amplification of abundantly 
transcribed var-CHO sequence.
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Figure 6.5 RT- PCR amplification ofRNA extracted from selected 3D7A 





Figure 6.5 RT PCR of RNA 
from 3D7A selected for 
adhesion to CHO cells 8 cycles 
after selection , 1. molecular 
weight marker VII, 2. 1.0 kb 
PCR product amplified from 
cDNA reverse transcribed 
from RNA extracted from 
CHO cell binding 3D7A 
parasites 8 generations after 
selection, 3. 2.4 kb PCR 
product amplified from DNA 
(control), 4. RNA (not reverse 
transcribed), 5. H20 control.
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Figure 6.6 A. Dot blot of PCR amplified cDNA from selected 3D7A, 8 










Figure 6.6 A. RT-PCR of 3D7A, 8 generations after selection 
for CHO cell adhesion. The RT-PCR product hybridises to CHO 
sequence on dot blot membrane ,Top left hand corner,(lA). 
Figure 6.6 B. Schematic of var gene dot blot with positions of 
var sequences indicated. Position of RT-PCR hybridisation 
shown in red.
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To continue monitoring var gene switching over an extended period of time, an aliquot 
from this parasite culture was grown for a further 4 generations, before the ring stage 
RNA was again extracted and RT-PCR amplification performed (Fig. 6.5). Again a 
small PCR product, 1.0 kb was amplified, consistent with the transcription of var-CHO. 
No PCR band was detected at 2.4 kb. This suggests that 8 generations after selection it 
was still not possible to detect any change in the transcription of var genes in 3D7A. The 
RT-PCR product to total extracted RNA was again labelled with 32P and used to probe 
the var gene membrane. The only sequence to be highlighted by the product of this PCR 
was the var-CHO sequence providing further evidence that the predominant expressed 
sequence being detected by this experiment was the var-CHO sequence (Fig. 6.6). To 
continue the analysis an aliquot of parasites were cultured for a further 4 generations and 
again total RNA was extracted, used in an RT-PCR reaction and the products used to 
probe the var gene membrane. No change in the pattern of RT-PCR or dot blot 
hybridisation was observed. 7 further RNA extractions, RT-PCR amplifications and 
hybridisations were performed every fourth generation until the parasites had gone 
through 40 generations in total. After 40 generations, based on a switch rate of 2% per 
generation it is predicted that 55% of the parasite population would have switched to the 
expression of another var gene. After 40 generations the PCR product (Fig. 6.7) and the 
dot blot (Fig. 6.8) remained unchanged in their pattern of expression It was thus not 
possible to detect any change in var gene transcription once the CHO cell adhesion 
phenotype had been established. The experiment was subsequently terminated and the 
parasites preserved in liquid nitrogen.
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Figure 6.7 RT- PCR amplification ofRNA extracted from selected 3D7A 
parasites 40 generations after selection
1234567
4899bp
Figure 6.7 RT PCR of 3D7 A
parasites selected for adhesion 
to CHO.,1 molecular weight 
marker VII, 2. 1.0kb PCR 
product amplified from cDNA 
extracted from parasites 36 
generations after selection for 
adhesion to CHO cells, 3. 1.0 kb 
PCR product amplified from 
cDNA extracted from parasites 
40 generations after selection 
for adhesion to CHO cells, 4. 
RNA (not reverse transcribed),
5. RNA not reverse transcribed),
6. H20 and 7. 2.4 kb PCR 
product amplified from DNA 
(control).
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Figure 6.8 A. Dot blot of RT-PCR products amplified from 3D7A 













Figure 6.8 A. RT-PCR of 3D7A 40 generations after selection 
for CHO cell adhesion RT-PCR product hybridises to CHO 
sequence on dot blot membrane ,Top left hand corner,(lA). 
Figure 6.8 B. Schematic of var gene dot blot with positions of 
var sequences indicated. Position of RT-PCR hybridisation 
shown in red.
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6.2.4 Loss of cytoadhesion of selected 3D7A to CHO cells over 40 
generations
Antigenic variation in P. falciparum occurs at approximately 2% per generation, 
however it was not possible to detect any antigenic variation using the dot blot assay, 
therefore, another approach was used to detect var gene switching. It was predicted that 
every generation approximately 2% of the CHO cell, selected 3D7A parasite culture 
would which away from the expression of the var-CHO gene mediating adhesion to 
CHO cells in 3D7A. Over time an accumulation of these switches should result in a 
reduction in the adhesion of the parasite culture. To test this hypothesis an experiment 
was conducted to test the adhesive ability of CHO cell selected 3D7A, cultured for 
several generations in the absence of selection. The binding of selected 3D7A parasites 
that had been in culture for 40 generations without selection (G40) was compared to the 
adhesion of selected 3D7A parasites that had been recently selected for cytoadhesion 
(GO). These two parasite lines were synchronised by pre-treatment with 5% sorbitol (see 
methods) and cultured to 10% parasitaemia at early trophozoite stage. CHO cells were 
prepared as described in chapter 5. The GO and G40 3D7A parasites were incubated with 
semi-confluent CHO cells for 1 hour with gentle agitation every 15 minutes. Parasites 
not bound to CHO cells were subsequently washed off and the petri dishes were fixed 
and stained as previously described. The binding assay was conducted in duplicate and 
was repeated 3 times. The results of these experiments are displayed in Table 6.2. After 
forty generations of growth the 3D7A population still bound to the CHO cells to a 
greater extent than the control unselected 3D7A culture (Table 6.1, P = 0.0043). This 
binding was some what less that the binding of the GO parasite culture (Fig. 6.9/Table
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6.1, T Test P = 0.0014). These experiments thus suggest that a considerable proportion 
of the selected 3D7A parasites had lost their ability to bind over the 40 generations they 
had been in culture. Presumably due to the switching in the expression of var genes in 
culture.
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Figure 6.9 Bar graph of adhesion of 3D7A parasites 0 generations 
versus 40 generations after selection
Var gene switching and cytoadherence























471. 5 ± 119.3
2.5 ± 1
Table 6.1 3D7A parasites selected for adhesion to -CHO cells. Generation 0 (GO) 
parasites recently selected for adhesion to CHO cells. Generation 40 (G40) parasites
selected for adhesion of CHO cells and allowed to grow without selection for 40 
generations, experiments were conducted in duplicate N = 6; ± = Standard Deviation.
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6.3 Conclusions
Selection of 3D7A for adhesion to the CHO cell surface results in the expression of a 
specific var gene, var CHO. RT-PCR amplification of the transcribed RNA resulted in 
the amplification of a PCR band 1.0 kb in size, consistent with the amplification of the 
var-CHO gene product (Chapter 5). Hybridisation of this product to the var gene dot 
blot membrane revealed that the PCR product hybridised to the var-CHO sequence on 
the var gene dot blot membrane, providing further evidence that the var-CHO transcript 
was the predominant sequence being transcribed. The 3D7A selected parasite was 
cultured without selection for a further 4 generations, however no change in the 
transcript being expressed was detected either by RT-PCR or by hybridisation. The 
selected 3D7A parasite remained in culture for 40 generations without selection with no 
detection of var gene switching by the assay developed.
One possible interpretation of these results is that the parasites were not switching the 
var gene being expressed. An another explanation for the failure of the RT-PCR/dot blot 
assay to detect var gene switching could be that the dot blot membrane was not able to 
detect the var genes to which these parasites were switching. The var gene dot blot 
membrane only contains 28 of a possible 50 3D7A var genes. It is possible that the 
parasites had switched to the transcription of one of the 22 possible var genes not 
represented by the dot blot membrane. To account for the inability of this assay to detect 
2/5ths of the possible 50 var genes, the equation used to calculate the proposed switch 
rate of 2% per generation was modified.
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The equation used to calculate the switch rate in P. falciparum antigenic variation was 
(l-r)n = P (Roberts et al ., 1992)
r = rate of switching (2%)
n = Number of generations
P = Number of parasites expressing the original gene expressed
This equation was modified and the detectable switch rate over n generations was 
calculated using the equation.
l-3/5*r)n= P).
Using this equation the detectable switch rate of this RT-PCR dot blot assay becomes 
1 .2% per generation. After 40 generations the dot blot assay developed should detect 
that 38% of the parasite population had switched to the expression one or more of the 
other 27 var genes cloned. No switch was detected, thus a second explanation may be 
more plausible. The var-CHO clone contains a DBL-p sequence, which is always 3' of 
the DBL-oc sequence and thus RT-PCR amplification of the var-CHO sequence 
produces a PCR product half the size of the other 27 clones generated. The region 
amplified in the var-CHO gene (DBL-p -DBL-8 ) is shorter and thus more efficient to 
amplify than the longer DBL-a- DBL-8 region amplified in the 27 other var gene 
sequences cloned. Var-CHO transcripts present amongst the 27 DBL-a - DBL-8 
transcripts will be therefore preferentially amplified. As the parasites remain in culture 
for a number of generations without selection they may have switched the var gene 
being expressed, however the system developed may not have detected any switch 
because the var-CHO sequence was amplified in preference to the other 27 sequences,
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even when it represented a minority of total cDNA transcripts present. A better 
experimental design would possibly be to directly label cDNA and use this to hybridise 
the var gene dot blot membrane. This may avoid the possible problems involved in 
preferential PCR amplification of specific transcripts.
The analysis of the cytoadherence characteristics of the freshly selected generation zero 
parasites and the generation 40 parasites, which had been in culture for 40 generations 
without selection differed. Over a period of time the number of parasites binding per 
1000 CHO cells was reduced in the generation 40 parasites when compared to the 
generation zero parasites. This observation is consistent with the hypothesis that some of 
the parasite population have switched away from the expression of var CHO to the 





The cloning of the var gene family in 1995 was arguably the most significant achievement 
in the recent history of malaria research, not only due to technical difficulties involved in 
cloning these genes, but also because of the biological importance of the proteins the genes 
encode. The weight of current evidence supports the view that PfEMP-l proteins represent 
an important immune evasion strategy evolved by the parasite to avoid elimination by the 
host. If one defines antigenic variation to be the capacity of a single cell or organism to 
spontaneously change it's antigenic composition without any accompanying change at the 
genetic level, then these proteins mediate antigenic variation (Roberts et al., 1992). This 
may be the main mechanism used by P. falciparum to maintain chronic infection within 
the host, thus facilitating transmission to the mosquito vector.
The immune response against the infected erythrocyte surface which is currently assumed 
to be largely against PfEMP-1 protects against clinical malaria, thus understanding the 
immune response against these proteins is important (Marsh et al, 1989; Bull et al, 1998 
Giha et al, 2000). PfEMP-1 also mediates infected erythrocyte adherence to uninfected 
erythrocytes (resetting) and infected erythrocytes (auto-agglutination). The selective 
advantage that these adhesive phenotypes confer on to the parasite is not known, but both 
adhesive phenotypes have been associated with severe disease, (Carlson et al, 1990, 
Roberts et al, 2000). Disregulation of normal dendritic cell function by adhesion of 
infected erythrocytes to the dendritic cell surface is also thought to be a PfEMP-1 mediated
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phenotype (Urban et al., 2000), a phenotype which may also be important in the 
pathogenesis of severe disease. In addition PfEMP-1 mediates endothelial cytoadherence, 
which may result in the sequestration of mature infected erythrocytes in the post-capillary 
vascular beds of vital organs such as the brain, precipitating cerebral complications, and 
the placenta, increasing susceptibility to malaria infection during pregnancy.
Thus the study of PfEMP-l and the regulation of expression of the gene family that 
encodes these proteins is necessary to increase understanding of the basic biology of the 
parasite, which it is hoped, will facilitate the development of vaccines and anti-adhesive 
therapies. The aim of this study has been to study PfEMP-1 mediated cytoadherence and 
antigenic variation in P. falciparum. What follows is a discussion of the results obtained 
during these investigations.
7.1 Cytoadherence in 3D7A
In 1995 Rogerson and his colleagues developed an adhesion assay for the investigation of 
chondroitin sulphate A-mediated adhesion of infected erythrocytes to CHO cells 
(Rogerson et al, 1995). It was possible to use their assay to select 3D7A parasites capable 
of binding to the surface of CHO cells. Unselected 3D7A binds to CHO cells at very low 
levels, but this can be substantially increased by several rounds of selection.
To assay for the specificity of binding of selected 3D7A to CHO cells, free CSA in 
solution was used to inhibit cytoadhesion, essentially the experiment which was originally 
used to define CSA as a cytoadherence receptor (Rogerson et al., 1995). CSA in solution
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failed to inhibit binding of 3D7A infected erythrocytes to the surface of CHO cells. This 
result was supported by experiments employing the commercially available enzymic 
mixture, chondroitinase ABC to hydrolyse CSA from the CHO cell surface This also failed 
to inhibit binding. A third assay using a CHO cell line defective in glycolysation (CHO- 
745) was conducted. CHO-745 dose not express GAGs due to a deficiency in the 
production of xylosyltansferase (Esko et al .,1985). These cells cannot support chondroitin 
sulphate A mediated adhesion. The 3D7A parasites selected for normal CHO cell binding 
were able to bind to these mutant cells. These results constitute evidence that 3D7A 
infected erythrocytes adhere to CHO cells in a chondroitin sulphate A independent manner. 
This is consistent with the observation from the Gysin laboratory that 3D7A does not 
adhere to CSA expressed at the surface of Saimiri brain endothelial cells (SEBC) (Pouvelle 
et al 1998). The data presented in this thesis suggest that that there is another cytoadhesion 
receptor, in addition to CSA expressed at the surface of CHO cells. The question is what is 
this cytoadherence receptor?
To answer this question the combination of enzymatic digestion of CHO cells, inhibition 
of adhesion by free carbohydrate in solution and adhesion to the CHO-745 mutant cell line 
were also used to investigate the possibility that other GAGs expressed at the surface of 
CHO cells were mediating the observed adhesive phenotype. GAGs investigated include 
another chondroitin sulphate of similar structure, chondroitin sulphate C, the rosetting 
receptor heparan sulphate, and the placental adhesive receptor hyaluronic acid. None of 
these potential candidates were found to mediate the observed adhesive phenotype.
Sialic acid was also investigated as a candidate cytoadherence receptor. Sialic acid has not
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been identified as a cytoadherence receptor, however it is used by the merozoite stage of 
the parasite during erythrocyte invasion (Adams et al., 1992). It is also used by the 
protozoan parasite Typanosoma cruzi to invade mammalian cells (Ming et al, 1993). 
Enteropathogenic E. coli and Adenovirus type 37 also use this carbohydrate as an adhesion 
receptor (Vanmaele et al, 1994; Arnberg et al., 2000). Binding inhibition experiments 
conducted excluded sialic acid as the cytoadherence receptor mediating the observed 
cytoadherence phenotype.
In addition to these carbohydrates there are a number of proteins expressed at the 
endothelial surface which have been identified as host receptors mediating cytoadherence. 
They represent possible candidates for the adhesive receptor mediating CHO cell adhesion 
in this model. The leukocyte differentiation antigen CD36 has been demonstrated to be 
quantitatively the most important infected erythrocyte cytoadherence receptor (Newbold et 
al, 1997). Many members of the immunoglobulin superfamily, involved in the 
transmigration of leukocytes, are also infected erythrocyte cytoadherance receptors. 
ICAM-1, VCAM-1 and ECAM-1 have been identified as infected erythrocyte 
cytoadherence receptors (Berendt et al, 1989; Ockenhouse et al, 1991). Other endothelial 
proteins identified as cytoadherence receptors include thrombospondin, PECAM-1, 
complement receptor-1 and P-selectin. (Roberts et al, 1985; Treutiger et al, 1997; Rowe 
et al, 1991 \ Ho et al, 1998). None of these cytoadherence receptors however are known to 
be expressed at the surface of CHO cells (Makrides et al, 200; Hasler et al, 1993; 
Johnston et al, 2000; Cruthfield et al, 2000; Raingner et al, 2000;Pouvelle et al, 2000) 
and are unlikely candidate receptors for this adhesive phenotype. The authors referred to 
above attempted to detect the presence of these cytoadherence receptors at the surface of
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CHO cells using antibody to human endothelial proteins. It can not be excluded that CHO 
cells constitutively express hamster homologs of these human endothelial receptors which 
are not recognised by antibodies to human endothelial receptors. Thus to completely 
exclude these receptors as possible candidates, it may be necessary to test cytoadhesion to 
each of these receptors individually either by adhesion to these receptors attached to plastic 
petri-dishes or recombinant protein expression at the surface of cell lines such as CHO or 
cos-7 cells. Given more time these experiments would constitute part of a plan of further 
investigation. The experiments detailed however strongly suggest that cytoadhesion to 
CHO cells in 3D7A in mediated by a undefined cytoadherence receptor, a finding which 
has great implications for scientists in this field using CHO cells as an adhesion model for 
CSA binding (Sherf et al .,1995). Selection for adhesion to this cell type may be selecting 
not for one, but multiple adhesive phenotypes. Thus the use of a reliable purified protein 
based adhesion assay to validate the such obervations based on cellular assays is essential.
7.2 Var genes transcribed by 3D7A
Using RT-PCR it was possible to amplify at least 27 var genes from ring stage unselected 
3D7A. These sequences all contain 2 DBL domains, DBL-oc and DBL-8. Given that the 
expression of PfEMPl at the erythrocytes surface is perceived to be an immune evasion 
strategy employed by the parasite why are so many var genes being expressed within a 
single culture? Is this a true reflection of the var gene expression in vivo?
It is possible that in vivo antigenic variation occurs as it has been described in vitro 
(Roberts et al ., 1992), However in vivo the rate of switching or rather the exposure of a
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particular antigenic type to immune system may be modulated by the hosts immune 
system. Within an antigenically mixed population only parasites to which the host is 
immunologically naive can proliferate. These parasites proliferate whilst the host's 
immune response against its antigenic determinants is developing. When the immune 
responses against the PfEMPl type being expressed is fully developed these parasites are 
destroyed by the host immune response. Parasites that have switched their var gene 
expression escape this immune response. If the switching process is random, parasites 
which switch to an antigenic determinant which is recognised by the host are immediately 
destroyed. However those who switch to a novel antigenic determinant (with respect to the 
hosts immunity) survive, perpetuating another "cycle" of infection. This may explain the 
oscillating infection observed in a number of animal experiments (Brown & Brown 1965, 
Hommel et al, 1983 Barnwell et al, 1983), whilst in keeping with the observation of a 
large number of var gene transcripts being expressed in vitro. Another possible explanation 
for this "random" expression of a number of var genes is that var gene switching is not 
random. The mosquito stage in the parasites life cycle may"reset" the var gene expression 
cycle such that on entry in to the vertebrate host (or culture) the var gene expression is set 
to the expression of a single var gene. However over a period of time it is possible that the 
parasite culture becomes asynchronous giving the impression of "random" var gene 
expression. Thus the "random" expression of var genes in culture may simply represent the 
asynchronisity of the parasite culture. Greater knowledge of var gene expression and the 
nature of var gene switching will hopefully provide answers to these questions .
Analysis of the var gene sequences transcribed by 3D7A revealed that the sequences are 
diverse. Nucleotide homology < 20% between sequences was observed. Such high
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sequence diversity may function to maximise the antigenic diversity between PfEMP-1 
proteins. Studies have shown that the immune response against the infected erythrocytes 
surface and presumably PfEMP-l are important in the development of clinical immunity 
(Marsh et al, 1989, Bull et al, 1998; Giha et al., 2000). Antigenic diversity may promote 
parasite survival by confounding the effects of this host immune response. The sequence 
diversity and sequence length polymorphisms probably also result in changes in adhesive 
phenotypes permitting a single parasite to exhibit a number of different adhesive 
specificities. Alternatively it may be that not all PfEMP-1 variants are involved in adhesion 
and that disparate sequences only function to create antigenic diversity at the infected 
erythrocyte surface. Small regions of conserved sequence appear in sequence blocks of 
between 10-20 amino acids throughout the molecule. This conserved sequences may 
represent the structural framework of the PfEMP-1 protein. Such conserved sequence 
blocks have been observed in other malaria antigens (Cooper et al., 1993).
The transcribed var gene sequences were analysed alongside var gene sequences cloned 
from a panel of Sudanese clones and a "global" pool of var genes from the NCBI 
genebank database. (Ward et al., 1999). This analysis revealed that although most of the 
var genes sequenced exhibited little homology with var genes from other clones, some var 
gene sequences expressed from the 3D7A clone exhibited a high degree of sequence 
homology with some var genes cloned from one of the Sudanese clones 105. The 
3D7Avar clone 149 is identical to the 105 var gene SD105J, and IDlAVar 59 and var 
gene SD105M differ by 3 of 335 nucleotides sequenced. At the amino acid level there 
remains a great deal of sequence identity between some 3D7A var genes and some 105 var 
genes. For example the 3D7A var clone 37 and 105 clone SD105L are identical at 124 of
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125 amino acids and 3D7A clone var 43 and SD105R share 128 of 131 amino acids 
sequenced. The sequence similarity was also observed between 3D7A var gene sequences 
and some of the Brazilian sequences obtained from the genebank database, however the 
sequence similarities were less marked (<70%)(Ward et al 1999).
The similarity of var gene sequences from SD 105 and 3D7A may be due to contamination 
of the 3D7A cultures with SD105 parasites during culture. However during the course of 
this project 3D7A and the Sudanese parasite SD 105 were never in culture at the same 
time. No SD105 parasites were cultured during the period of this project, thus eliminating 
this as a possibility. Another possibility is that 3D7A Stocks have been contaminated with 
SD 105 parasites. Given the strict control of the WHO Malaria Registry this is also 
improbable. However this possibility could be completely eliminated by genotyping the 
cultured parasites using standard methods (Waliker et al, 1987).
One biological explanation for the sequence similarity between parasites from disparate 
geographies is that there is an exchange of gene sequence during recombination between 
randomly mating populations. In support of this hypothesis studies have shown that 
parasites in freely mixing parasite populations undergo recombination in the field (Conway 
et al., 1999). High rates of homologous recombination have also been observed in 
laboratory crosses of the parasite (Walliker et al, 1987). Recent data suggests that the 
diversity observed in var genes is greater than what would be expected by homologous 
recombination alone and that in addition to homologous recombination, gene conversion 
events between heterologous chromosomes may also be responsible for generating 
diversity (Freitas-Junior et al, 2000).
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These data illustrate that 3D7A transcribes at least 27 var genes containing 2 DEL 
domains DBL-oc and DBL-8. These genes are diverse at the nucleotide level which 
contributes to the antigenic complexity of the infected erythrocytes surface. These 
sequences are not clone specific and genes with similar sequence homology have been 
observed in other parasite clones. These data do not support the contention that the var 
genes expressed by a parasite clone segregate in to distinct non-overlapping repertoires has 
been suggested previously (Gupta et al, 1994). Rather this indicates that recombination 
permits exchange of var gene sequences between freely mixing genetically distinct 
parasites.
7.3 PfEMP-1 and cytoadherence
Chapter 3 describes the selection of parasites for adhesion to the surface of CHO cells. The 
adhesive receptor mediating this phenotype is yet to be described. However this thesis was 
also concerned with identifying the parasite derived molecule mediating the adhesion of 
selected 3D7A to the surface of CHO cells.
Binding of infected erythrocytes to the surface of CHO cells was abolished by the 
treatment of parasites with trypsin. Several laboratories have shown that PfEMP-1 is 
sensitive to trypsin digestion and that cytoadhesion mediated by PfEMP-1 can be abolished 
by treatment of parasites with trypsin (Baruch et al., 1996; Gardner et al., 1996). The 
trypsin sensitivity of this CHO cell adhesive phenotype is consistent with PfEMP-1 being 
the parasite-derived ligand supporting this adhesive phenotype.
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To further analyse the identity of the parasite derived cytoadherence receptor ring stage 
3D7A parasites selected for adhesion to CHO cells were subjected to RT-PCR 
amplification of total RNA using degenerate primers based on var genes sequences. The 
PCR product was cloned and sequenced and found to contain a single var gene sequence. 
Studies have previously shown that selection for a specific adhesive phenotype selects for 
the transcription of a specific var gene, the var gene mediating the adhesive phenotype 
(Rowe et al, 1997; Chen et al, 1998, Reeder et al, 1999, Buffet et al, 1999). It was 
shown in Chapter 4 that the primers used in the amplification of this gene were capable of 
amplifying at least 27 var genes. Therefore the amplification of a single transcript from the 
selected 3D7A culture is consistent with the transcription of this gene being selected for 
during the selection for adhesion and not simply due to bias of the primers used. The 
trypsin sensitivity of the adhesive phenotype supported by the cloning of a single var 
transcript from the selected parasite culture suggest that this adhesive phenotype is 
mediated by PfEMP-1. These data support the view that that the var gene cloned after 
selection, var-CHO is the gene encoding for the PfEMP-1 protein mediating this adhesion.
It was possible to extend the var-CHO sequence using genomics. Sequence reads from the 
Plasmodium falciparum Genome project were used to produce a contiguous sequence from 
the 5' end of the clone (DBL-p) to the 5' start codon of the gene. The 3' end of the exon 1 
of this var gene was however obtained by conventional methods (i.e. cloning and 
sequencing) because it was not possible to extend the var-CHO clone sequence into the var 
gene exon 2 sequence using sequence data from the P. falciparum genome project. The 
first exon of the var-CHO gene was sequenced and annotated. The var-CHO gene
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sequence contains 3DBL domains a DBL-a, DBL-(3 and a DBL-6, these domains were 
defined by sequence motifs specific to each of the DBL domains. The sequence also 
contains two CIDR domains, CIDR-a and CTDR-(3, 3' of DBL-a and DBL-8 respectively. 
3' of the DBL-(3 domain is a small C2 domain which is consistently found in tandem with 
the DBL-P domain (Smith et al, 2000 b).
PfEMP-1 mediated adhesion is mediated by discrete binding epitopes within specific DBL 
domains. For example the DBL-a domain is yet to be associated with cytoadherence but 
has been identified as the domain mediating the rosetting phenotype by two laboratories 
using different clones which rosette via different host receptors (Rowe et al, 1997; Chen et 
al, 1998). The CIDR-a domain has been defined as the domain mediating cytoadherence 
via the membrane glycoprotein CD36 (Baruch et al, 1997) Recently, the tandem PfEMP-1 
domain DBL-p -C2 has been identified as the binding domain responsible for adhesion to 
ICAM-1 (Smith et al, 2000 a). The DBL-y domain contains the binding epitope mediating 
cytoadherence to CSA. The presence of the binding domain within the DBL-y sequence 
has been confirmed by two laboratories independently using two different parasite clones 
(Buffet et al, 1999; Reeder et al, 1999). It has been suggested that PffiMP-1 variants that 
bind to a specific receptor will bind via the same DBL domain. For example it is predicted 
that all PffiMP-1 variants that bind to CSA will bind via a DBL-y domain (Smith et al, 
2000 b). In keeping with this hypothesis the var-CHO sequence does not contain a DBL-y 
sequence. This provides further support for the view that the 3D7A adherence to CHO 
cells is not a CSA mediated adhesive phenotype.
To provide conclusive evidence that this adhesive phenotype is PFEMP-1 mediated it
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would be necessary to clone fragments or domains of the var-CHO gene. Domains of the 
PfEMP-1 protein can be expressed in bacterial expression vectors as Glutathione-S- 
transferase (GST) fusion proteins (Baruch et al, 1995, 1997). These fusion proteins can be 
used directly to inhibit adhesion to the CHO cell surface. This type of experiment has been 
used in the identification of the CIDR-a as the PfEMP-1 domain of the Malayan camp 
parasite clone mediating adherence to CD36, and in the identification of the DBL-cc 
domain of the PfEMP-1 from the FCR3 SI.2 clone as the domain mediating rosetting via 
heparan sulphate (Baruch et al 1997; Chen et al., 1998 a). Another possibility is to raise 
antibody to specific PfEMP-1 recombinant proteins by the immunisation of mice. The use 
of these antibodies to inhibit adhesion of cytoadherence provides indirect evidence of the 
involvement of particular PfEMP-1 domains in adhesion (Reeder et al., 1999). A 
frequently used method for the identification of adhesive domains within the PfEMP-1 
protein has been the cloning of var gene sequence into mammalian transfection vectors 
such as CHO or COS-7 cells. Transfection of var sequence into these vectors allows these 
mammalian cells to support cytoadhesion. This methodology has been used in the 
identification of the PfEMP-1 domain mediating rosetting via CRI (Rowe et al, 1997) and 
the PfEMP-1 domains involved in cytoadhernece via CD36, CSA and ICAM-1 (Smith et 
al, 1998; Buffet et al, 1998; Smith et al, 2000). Identification of the PfEMP-1 domain 
mediating this adhesive phenotype would permit further investigation on to the molecular 
basis of this interaction.
7.4 Var gene switching
Using RT-PCR dot blot assay it was not possible to detect var gene switching in the
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parasite clone 3D7A. The possible technical reasons for this have been detailed in chapter 
6. One biological explanation for this could be that the parasites, once selected for 
adhesion to the surface of CHO cells stop switching. However this is inconsistent with the 
adhesion data which shows that selected 3D7A parasites cultured without selection over a 
period of 40 generations lose their binding phenotype, presumably due to switching to 
another PfEMPl variant. The binding data is consistent with the observations of Roberts et 
«/.,(! 992), that 3D7A also undergoes antigenic variation, possibly at a rate similar to the 
A4 parasite clone.
Var genes are located at the subtelomers of each of the 14 Plasmodium chromosomes, 
although the are some chromosome internal var gene clusters. The genes are expressed in 
situ, they are not transported to specific transcription sites to be transcribed (Fischer et al., 
1997; Scherf et al., 1998). Recently it has been shown that parasites selected for an 
specific adhesive phenotype, resetting, transcribe a number of different var genes from 
different chromosomes simultaneously during early ring stage infection. This transcription, 
by the early trophozoite stage becomes restricted to the single var gene that is translated 
into protein and expressed at the infected erythrocytes surface (Chen et al., 1998 b). Others 
have observed a similar pattern of transcription in ring stage parasites when selected for 
adhesion to CSA. The authors suggest that the multiple transcripts found in the early ring 
stage disappear as the parasite matures to the trophozoite stage leaving a single transcript. 
This process has been by described as allelic exclusion (Scherf et al., 1998). The results 
obtained during the development of this thesis do not support the theory of allelic 
exclusion. All PCR reactions were conducted on the early, 6-9 hour ring stage, of selected 
parasites. However only a single transcript was amplified. Plasmodium genes are prone to
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relaxed gene transcription. It is possible that genes not being transcribed can synthesise 
short incomplete 5' transcripts at the ring stage of the parasite infection and that multiple 
transcripts amplified by these authors represent incomplete 5' transcripts, not full length 
var gene transcripts. This idea is supported by Taylor et al (1999) who demonstrated by 
RT-PCR of DBL-a that it is possible to amplify a number of var gene transcripts from 
selected ring stage parasites which when analysed by northern hybridisation, are not 
complete PfEMP-1 transcripts. Only one full length transcript is present. The RT-PCR data 
generated in this thesis tend to support this hypothesis however, more experiments on the 
transcriptional regulation of these genes may help to clarify this issue.
Summary
The work in this thesis has demonstrated that the parasite clone 3D7A adheres to CHO 
cells by an undefined cytoadherence receptor. This receptor must be identified as it may 
represent an adhesion molecule involved in the pathogenesis of cerebral and/or placental 
malaria. We have also demonstrated that consistent with the findings of others, the 
adhesive phenotype exhibited by 3D7A is mediated by the parasite derived protein 
PfEMP-1.Conformation of this requires recombinant protein expression studies, which will 
facilitate the identification of which epitope from the var-CHO sequence is involved in 
adhesion. This will also permit immunological studies investigating the clinical relevance 
of the immune response against this adhesive epitope by determining whether the immune 
response against this epitope is protective against disease or infection. Further studies will 
also determine whether this epitope can be used to prevent adhesion of parasites to the 
adhesion molecule expressed at the surface of CHO cell, experiments which may have 
implications for anti adhesive therapy. These studies should form the basis for further 
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Abstract
The var genes of Plasmodium falciparum encode a family of parasite erythrocyte surface antigens, the PfEMP-1 
proteins, which function as adhesion ligands for host endothelial and erythrocyte receptors. PfEMP-l is extremely 
polymorphic although the extent of this variation in naturally transmitted parasite populations is unclear. We have 
identified 56 different sequences from the Duffy binding-like (DBL-1) domain of var genes amplified from six different 
P. falciparum clones isolated from patient infections in a Sudanese village in October-November 1989. These clones 
have been compared with 25 PfEMP-1 sequences expressed from different var gene loci by the 3D7A clone and 48 
PfEMP-1 sequences from different isolates in endemic areas such as Kenya, Brazil, Gambia, Vietnam and Vanuatu 
to analyse diversity in clonal, local and 'global' P. falciparum populations. Evidence that certain conserved sequences 
recur in clones from one Sudanese village and in isolates from all over the world suggests that var gene diversity is 
the result of recombinational reshuffling of a subset of conserved, presumably ancestral sequences. Recurrence of 
particular var sequence blocks thus leads to 'overlaps' in the PfEMP-1 sequence repertoire of different P. falciparum 
clones. © 1999 Elsevier Science B.V. All rights reserved.
Keywords: Plasmodium falciparum; Antigenic variation; var gene recombination; Global diversity
1. Introduction
Abbreviations: CIDR, cysteine-rich interdomain region; Plasmodium falciparum parasites are genetically
DEL, Duffy antigen binding-like region. diverse [1-4] and patient infections are frequently* Note: Nucleotide sequence data reported in this paper are mixtures of several haploid parasite clones [5,61.available in the EMBL, Genebank™ and DDJB data bases .. . D /• / • t -. . AC mm Acm«n A Many immunogenic P. falciparum antigens areunder the accession numbers AF127272-AF127330 and J - J . . . , ...AF15'1 57'>-AF152582 polymorphic and most parasite isolates have dif-
* Corresponding author. ferent combinations of variants of these antigens.
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This between-done antigenic diversity in the para­ 
site population is generally considered to benefit 
the parasite in that it renders host immunity 
relatively clone-specific.
The discovery of the var multi-gene family es­ 
tablished that P. faldparum also has within-clone 
antigenic diversity generating mechanisms [7,8]. 
Each of several dozen genomic var genes encodes 
a PfEMP-1 which acts as an endothelial and 
erythrocytic adhesion molecule on the surface of 
parasite infected red blood cells. Although 
PfEMP-1 sequences are highly polymorphic, all 
var genes encode proteins containing 1-5 Duffy 
binding-like (DEL) domains with a cysteine rich 
interdomain region (CIDR) adjacent to the 
N-terminal DBL-1 domain. Switches in PfEMP-1 
expression occur within clones[9] and correlate 
with changes in the cytoadherent and antigenic 
properties of the infected red blood cell [10]. This 
allows clonal infections to evade immune re­ 
sponses against essential, but vulnerable, ery- 
throcte membrane proteins by switching between 
antigenically distinct but functionally similar 
proteins.
Two studies have shown a positive correlation 
between the capacity of individuals' serum to 
agglutinate a larger number of parasite isolates 
and protection from clinical malaria attacks 
[11,12]. The possible relationship between anti- 
PfEMP-1 antibody responses and clinical protec­ 
tion has led to the prediction that immune 
selection will shape the genetic structure of P. 
falcipanim populations in order to minimise over­ 
lap in var gene repertoires. This would generate a 
population 'strain structure' in which each 'strain' 
has a distinct, non-overlapping repertoire of 
PfEMP-1 variants [13]. We have analysed the first 
'Duffy binding-like' domain (DBL-1) of PfEMP-1 
genes in P. falcipanim clones isolated from 
malaria patients in a Sudanese village during the 
malaria transmission season of 1989. These were 
compared to the expressed var sequences of the 
3D7A clone and the existing databank of PfEMP- 
1 sequences to analyse the var repertoires of 
'global' and 'local' populations of P. falcipanim. 
Phylogenetic analysis has been used to determine 
the most statistically likely relationships between 
these sequences.
2. Materials and methods
2.1. Parasite clones
The parasite clones SD101. SD102, SD105, 
SD106, SD126 and SD128 were made from six 
unrelated Sudanese patient samples isolated dur­ 
ing October and November 1989 [14]. Each of 
these parasites has a distinct phenotype, genotype 
and molecular karyotype [2,14,15]. The 3D7A 
clone [16] derives from the Nijmegan NF54 isolate 
originally isolated from a young Dutch girl who 
spent one night on a boat several miles from 
Amsterdam Airport in July 1979. This isolate is 
thus of mysterious provenance although its sensi­ 
tivity to all anti-malarial drugs makes an African 
origin seem most likely.
2.2. Preparation of parasite DNA and RNA
Parasites were grown to a 5% parasitaemia in 
culture and parasite pellets obtained by saponin 
lysis. Parasite pellets were digested with 
proteinase K in the presence of 10% sodium dode- 
cyl sulphate, and DNA isolated by phenol chloro­ 
form extraction and subsequent ethanol 
precipitation [17]. RNA was extracted using the 
Genosys RNA Isolator kit.
2.3. PCR and RT PCR amplification of var 
DBLl sequences
PCR amplification of var DBLl sequences was 
obtained using the 5' oligonucleotides Forward 1 
(CGAGGATCCGGWGCWTGYGCWCCWTVV- 
YMG) and Forward 2 (CGAGGATCCCCA- 
TATAGACGATTACATSTATG) and the 3' 
oligonucleotides Reverse 1 (GCACTCGAGTT- 
AWATRTCYGCAAAACTKCGTG), Reverse 2 
(GCACTCGAGTTANARRTAYTGWGGWAC- 
RTARTC) and Reverse 3 (GCACTCGAGT- 
TATTCTTYTYTTTGGTTATCTATCCA). For 
ward 2, Reverse 1 and Reverse 3 are based on 
primer sequences kindly provided by Dr Sue 
Kyes, Oxford University [18]. Forward 1 and 
Reverse 2 are based on published primer se­ 
quences [8]. Reverse transcription PCR used the
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Boetortnger Expand Kit and cDNA primer
(CCWGGWACATAWATATCATTWATRTC) 
followed by PCR forward primer RT1 (GCACG-
MAGTTTTGCRGAYATWGG) and PCR re­ 
verse primer RT2 (GTATARTCGTCGYC- 
TCCTGGGTGGSAYAC). (Redundancies, M = 
A/C; R = A/G; W = A/T; S = C/G; Y = C/T; 
K = G/T; V = A/C/T; H = A/C/T; D = A/G/T; 
B = C/G/T; N = A/C/G/T).
2.4. Cloning of var DEL I sequences into the 
vectors pCRII and pGEM
PCR amplified var gene fragments were cloned 
into the plasmid vectors pCRII and pGEM using 
the Invitrogen TA cloning kit and the Promega 
pGEM-T Vector System I cloning kit respectively. 
E. coli XL-1 blue was used as the host cell line for 
the recombinant plasmids.
2.5. Sequencing of cloned var gene fragments
The Qiagen Spin Plasmid kit was used to pre­ 
pare recombinant plasmid for use as the template 
in sequencing reactions. Sequencing was carried 
out using the ABI PRISM automated sequencing 
system with the ABI Dye Terminator sequencing 
kit.
2.6. Analysis of var gene sequences
For the purposes of this analysis the first Duffy 
Binding-like domain (DBL-1) is defined as the 
ammo-terminal 400 amino acids of the var-I type- 
sequence [8]. The defining features of the domain 
are the 16-18 conserved cysteine residues (Fig. 1). 
The figure shows the positions of the forward and 
reverse primer sequences that have been used to 
amplify and sub-clone DBL-1 var sequences for 
this study and the sequence blocks used to analyse 
phylogenetic relationships. Sequences obtained 
were confirmed as var fragments by BLAST anal­ 
ysis, var sequences from parasite isolates from the 
Gambia, Brazil, Indochina, Kenya, Papua New 
Guinea, Vanuatu, Vietnam and from 3D7A were 
obtained from the Genebank database. Deduced 
amino acid alignments of these Genebank se­ 
quences with the Sudanese and 3D7A DNA se­ 
quences were made using the GCG pileup and 
MacVector clustal functions. Alignments were 
created using program default parameters with 
gap weight of 3.0 and gap length weight of 0.1 
and edited by hand. Phylogenetic analysis of se­ 
quence alignments from two regions of DBL-1 
was carried out using the computer program 
PAUP 3.1.1 [19]. Further cladograms and align­ 
ments containing all of the Sudanese and 'global'
RT1
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Fig. 1. A schematic model of DBL-1. The relative positions of the conserved cysteines 1-18 are indicated by asterisk. The anealing 
sites of primers Fl. F2. Rl, R2, R3 and RT1 are shown, the RTPCR reverse primer RT2 anneals to a region 3' of DBL-1 and is 
not shown. The hatched area corresponds to the region of sequence aligned in Fig. 2 and used to generate the phlyogenetic model 
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iar gene sequences amplified by different primer combinations
Primer 
combination"-1"















SD102A, SD102B, SD102C, SD102D, SD102E, SD102F, SD102F2, SD102G,
SD102H, SD102J, SD105G, SD105L2, SD105N, SD105P, SD126E, SD126F.
SD126G, SD126H, SD126J, SD126K, SD126N, SD128J
SD105A, SD105B, SD105D, SD105E, SD105F, SD105K
SD105C, SD105J, SD105L, SD105M, SD126M
SD105T, SD106B, SD106D. SD106E, SD106F, SD106G, SD126D, SD128A,
SD128C, SD128D, SD128E, SD128G, SD128H, SD128K, SD128L
SD101A, SD101B
SD105Q, SD105R, SD105S. SD105U, SD106A, SD106C, SD126A, SD126B,
SD126C
a Primer anealing sites are indicated in Fig. 1.
b The sequences obtained by each primer combination are in Fig. 2. Only those sequences amplified by the primer combinations 
F1/R2, F1/R3. F2/R2 and F2/R3 are aligned in Fig. 3.
c The name of each variant indicates the parasite clone from which it originated e.g. the variant SD102A was isolated from the 
parasite clone SD102.
sequences analysed can be obtained from the 
authors.
3. Results
3.1. var gene sequences from clones isolated in a 
Sudanese village in October and November 1989
DNA isolated from parasite clones SD101, 
SD102, SD105, SD106, SD126 and SDI28 was 
used to amplify the DBL-1 domains of their var 
genes. All of the sequences analysed encode at 
least the 50-60 amino acids between the F2 and 
Rl primer sequences (Fig. 1). Excluding the 
primer sequences, an alignment over this region of 
55 different sequences from the Sudanese clones is 
presented in Fig. 2. Each sequence was isolated 
from a subclone library at least twice. Different 
subsets of var genes were obtained from each 
parasite clone when different primer pairs were 
employed. Frequently, var types amplified using 
either Fl or F2 with either R2 or R3 were also 
isolated when using these forward primers and Rl 
(Rl encodes part" of the LARSFADIGI motif 
found in all PfEMP-1 sequences). Table 1 lists the 
var types obtained using each primer combination 
and the length of fragment amplified. In three
cases, identical sequences were identified from 
different parasite clones from different patients 
(SD101A (F2/R2) and SD102C (F1/R1); SD102E 
(F1/R1) and SD126F (F1/R1); and SD126B (Fl/ 
Rl) and SD128H (F1/R1)).
Fig. 3 shows alignments of 22 sequences gener­ 
ated using the R2 and R3 reverse primers. Figs. 2 
and 3 together show Pileups aligned around 13 
conserved cysteine residues (positions 6-18 in 
Fig. 1). Cysteine 6 is missing in 7/58 of these var 
variants (SD105A, SD106D, SD106E, SD126C, 
SD126D. SD126M, SD126N and SD128C). 
SD126D is missing cysteine 6 but has a cysteine at 
an unusual position (position 15, Fig. 2). Cysteine 
7 is not found in 1/58 sequences (SD106E) and 
cysteine 9 and 11 are absent from SD105L and 
SD105D respectively. SD101A has an 'extra' cys­ 
teine adjacent to cysteine 8 (position 102 in Fig. 
3). Cysteines 8, 10 and 12-18 are conserved in all 
Sudanese var genes examined. The large aromatic 
amino acids phenlylalanine, tryptophan, and ty- 
rosine are highly conserved in the P. falciparum 
PfEMP-1 DBL-1 domain, a feature also observed 
in the Duffy-binding antigens of P. knowlesi and 
P. vivax [20].
The region from cysteine 7-18 (Fig. 3) contains 
between 182 and 204 amino acids. In three pairs 
of these sequences this sub-domain contains iden-
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tical numbers of amino acids. Several almost iden­ 
tical large sequence blocks occur in more than one 
PfEMP-1 protein in this region. SD105Q and 
SD105S are identical at nucleotide level over a 
region encoding 155 amino acids but diverge after
cysteine 15. SD105L and SD105L2 are practically 
identical (53/55) residues over the region covered 
by the F2 and Rl primers and similarly SD102F 
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Fig. 3. Alignment of 22 Sudanese DBL-1 sequences from four parasite clones over the region between Rl and R2 (see Fig. 1). The 
first two residues of this alignment overlap with Fig. 2. Conserved residues are boxed and shaded dark grey; conservatively 
substituted residues are boxed and shaded light grey. Consensus residues are shown below the alignment.. The conserved cysteines 
at positions !. 101. 118, 132. 134. 176, 190. 202, 209, 225, 228 and 232 correspond to cysteines 7-18, respectively. The aromatic 
residues phenylalanine, tyrosine and tryptophan are highly conserved at positions 8, 21, 45, 69, 80, 81. 87, 88. 96, 112, 113, 157, 158, 
160 164 16".' 168. 171. 176, 201. 207 and 235. The sequences SD105Q and SD105S are identical until position 209 after which they 
diverse.
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3.2. DEL-1 domain variation between different mr 
gene loci in the 3D7A clone
To analyse PfEMP-1 variation in a single 
clone, reverse transcription of clone 3D7A 
mRNA followed by PCR amplification and sub- 
cloning was used to obtain expressed PfEMP-1 
sequences from a laboratory isolate, 3D7A, cur­ 
rently being sequenced by the P. falciparum 
Genome Project [21]. The sequence of 3D7A 
Chromosome 2 has recently been reported [22] 
and it contains two sub-telomerically located full- 
length var genes in addition to five small ORFs 
with sequences resembling the var exon II-related 
Pf60.1 genes which lack DBL-1 domains [23]. 
Asynchronous in vitro cultures of this clone ex­ 
press numerous different var genes. To date 25 
different expressed PfEMP-1 cDNA sequences 
have been identified. Alignments have been made 
of these 25 sequences with 20 DBL-1 sequences 
from Genebank and the 22 Sudanese sequences 
over the region corresponding to positions 14- 
102 in Fig. 3 (data not shown). The patterns of 
variation in these sequences are essentially identi­ 
cal to that found in the Sudanese sequences 
analysed above and in an earlier comparative 
analysis of a smaller number of sequences [18]. 
Several large sequence blocks are shared with 
other sequences in the global data bank. The 
sequence 3D7-93 is identical to the Sudanese se­ 
quence SD105J. 3D7-16 and SD105M have a 
single synonymous substitution. Other 3D7A se­ 
quences are very similar to some Sudanese se­ 
quences. For example, 3D7-111 and SD105L 
(73/74 identical amino acids); 3D7-11 and 
SD105R (69/71); 3D7-3 and SD105F (54/63, with 
the 9 differences occurring in consecutive 
residues); and 3D7-44 with SD105E (66/78, all 
differences within a 32 residue block).
3.3. Phylogenetic analysis
Phylogenetic analysis was performed to investi­ 
gate the relationship between the 56 Sudanese 
sequences and their relationship to 47 'global' 
DBL-1 sequences. Trees were generated using the 
same region of the molecule as was used to align 
the Sudanese sequences presented in Fig. 2. Nei­
ther the Sudanese nor any other set of sequences 
form an isolated sub-group of distinct DBL-1 
domains. A total of 34 of the Sudanese sequences 
and 17 'global' sequences formed clusters statisti­ 
cally supported by the bootstrap re-sampling 
method (100 re-samples). A cladogram illustrat­ 
ing the relationships between these sequences is 
presented in Fig. 4.
Sudanese sequences cluster with sequences 
from Vietnam (bootstrap values of 70-96%); 
Brazil (bootstrap values of 96-98%); Gambia 
(bootstrap values of 74-89%); Kenya (bootstrap 
value of 70%) and 3D7A (bootstrap values of 
83-100%). Three Sudanese sequences are identi­ 
cal to 3D7A sequences in this region (SD105D 
and 3D7A-4; SD105Q/SD105S and 3D7A-2; 
SD105R and 3D7A-1). SD106D is identical to 
the Brazil-1 sequence. SD106A shares 53/54 
amino acid residues with the Kenya-1 sequence 
and SD106G shares 51/57 amino acid residues 
with the Vietnam-4 sequence.
Certain sequences from different Sudanese par­ 
asite clones appear closely related and cluster 
together. Cluster I (bootstrap support of 96%) 
contains five different sequences from 5/6 of the 
Sudanese clones analysed (SD101A/SD102C, 
SD105N, SDI06G, SD126G and SD126J) and 
the Vietnam-4 sequence. These sequences share 
around 80% of residues over this ~ 60 amino 
acid sub-region. Cluster II (bootstrap support of 
86%) contains the closely related sequences 
SD105D, SD106B, Gambia-1 and 3D7A-4.
A further phylogenetic analysis was performed 
on the region corrsponding to positions 14-102 
in Fig. 3 (data not shown). Included in this anal­ 
ysis were 25 expressed 3D7A sequences, 22 Su­ 
danese sequences and 20 'global' database 
sequences. Sudanese and 3D7A sequences 
grouped together in six clusters in this analysis 
(bootstrap values of 83-100%). Two of the ex­ 
pressed 3D7A sequences grouped with a Brazil­ 
ian sequence (66% bootstrap support). Around 
half of all the sequences used in these compari­ 
sons (22 Sudanese and 29 'global' sequences) did 
not resolve into any statistically supported cluster 
because they are no more closely related to any 
one sequence than they are to any other in the 
data set.
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Fig. 4. A phylogenetic model of the relationship between 34 
Sudanese and 17 Genebank sequences from diverse geographi­ 
cal locations. The model was generated by performing a 
Maximum Parsimony analysis using the PAUP program on a 
sequence alignment of the same region of DBL-l as presented 
in Fig. 2. The alignment was made using the GCG and 
MacVector programmes and edited manually. Statistical sup­ 
port is provided by the booststrap resampling method (100 
resamplings). Bootstrap values are shown above branch lines. 
Branches with a bootstrap value of less than 50% are col­ 
lapsed. The non-Sudanese sequences have the following acces­ 
sion numbers 3D7A-1 (z94746); 3D7A-2 (z94751); 3D7A-3 
(Z94750): 3D7A-4 (z94749); Vietnam-1 (z94744); Vietnam-2 
(Z94737): Vietnam-3 (z94745); Vietnam-4 (z94741); Kenya-1 
(z94730); Gambia-1 (u67960): Gambia-2 (af003473); Gambia-3 
(U67959): Brazil-1 (142245); Brazil-2 (y 13408); Brazil-3 
(y 13402): Brazil-4 (142247); and Brazil-5 (u3I083). 22 Sudanese 
sequences and 31 sequences from the 'global' databases did 
not form statistically significant clusters with any of the other 
sequences analysed and are not included in this cladogram.
4. Discussion
The original sequence comparisons of PfEMP-1 
variants showed that each protein had one to four 
domains with a sequence motif which had been 
noted in the Duffy positive erythrocyte binding 
domains of a merozoite surface protein of P. 
vivax and P. knowlesi [20]. This Duffy binding- 
like (DBL) motif has also been found in a P. 
falciparum erythrocyte-binding antigen (EBA 175) 
that binds erythrocyte surface sialic acid [24]. 
Even in the most conserved region of PfEMP-l, 
the DBL-l domain, no more than 15-20% of 
amino acids are conserved in all variants and 
many thousands of different DBL-l sequences 
must circulate in the parasite population's var 
genes. This study has analysed variation in this 
domain in sequences expressed by a single labora­ 
tory clone, in a set of clones derived from patients 
during the autumn 1989 malaria season in a Su­ 
danese village and in the database of P. falci­ 
parum sequences.
Comparisons between these sequences show 
that there is marked conservation of the positions 
of certain residues in the DBL-l domain. In par­ 
ticular, the positions of eight to nine pairs of 
cysteine residues are essentially invariant. The ma­ 
jority of DBL-l sequences contain nine cysteine 
pairs although some variants lack one or two of 
these residues, or contain an additional cysteine. 
Positions of bulky aromatic residues such as tryp- 
tophan, tyrosine and phenylalanine are also con­ 
served (as previously noted in related Plasmodium 
adhesion receptors [20,25]). The length of the 
hyper-variable regions between conserved motifs 
shows very little variation between different se­ 
quences. Large numbers of DBL-l sequences 
share short (10-20 amino acid) regions of se­ 
quence including the one universally conserved 
sequence, the 11 amino acid LARSFADIGDI 
motif. Longer (20-80 amino acid) regions of ho- 
mology can be identified in parasite clones iso­ 
lated from patients in a Sudanese village, in 
isolates taken from infections in other areas of the 
globe and in the laboratory clone 3D7A.
These observations support a hypothesis that 
the structural framework of the DBL-l domain in 
most, if not all, of these molecules is highly con-
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served. Variants with unusual numbers of cys- 
teines however, may form a subset with altered 
antigenic and adhesive properties. Possible selec­ 
tive constraints may be the requirement for bind­ 
ing to relatively invariant host receptors during 
erythrocyte invasion [20,24], or adhesion to unin"- 
fected red blood cells in the resetting reaction 
[26,27]. Some mutations may be selected because 
they give rise to antigenic differences between 
functionally similar molecules. Structural diversity 
in PffiMP-1 DBL-1 domains seems less like that 
observed in the non-adherent variable trv- 
panosome surface antigens and more analogous 
to the situation found in adhesion receptor-bind­ 
ing viruses such as Foot and Mouth Disease Virus 
(FMDV). In FMDV virions three diverse capsid 
proteins mask an essential ROD adhesin motif in 
the first virion protein which is essential for recep­ 
tor binding and host cell invasion [28]. The 
LARSFADIGDI motif could have an analogous 
role in PfEMP-I function.
Long stretches of amino acid identity occur 
between DBL-1 domains in the PfEMP-1 
molecules of parasites from different locations 
and universally conserved motifs exist. Thus al­ 
though the var genes potentially encode a vast 
amount of antigenic diversity, PfEMP-1 proteins 
appear to be composites of a set of more con­ 
strained sequences, presumably evolved from a 
common ancestral protein. Previous reports have 
differed on the extent to which the human aggluti­ 
nating antibody responses to infected erythrocytes 
(considered to be mainly directed against PfEMP- 
l) are isolate specific [29,30]. In a recent study of 
agglutinating antibody specificity, isolates from 
infections in a Sudanese village were genetically 
characterised and their capacity to be recognised 
by sera samples from individuals from the same 
village was analysed [31]. Each of the isolates 
induced agglutinating antibodies capable of recog­ 
nising at least some of the serotypes expressed by 
the other parasite isolates. Our data on PfEMP-1 
diversity demonstrates that different parasite iso­ 
lates can encode stretches of similar or identical 
PfEMP-1 sequence. It can therefore explain 
observations that agglutinating antibodies some­ 
times cross-react with geographically diverse iso­ 
lates.
Generation of diversity by recombination has 
been suggested as the reason for the sub-telomeric 
chromosomal location of many var genes and 
their association with repetitive sequences [32]. 
Frequent recombination has been demonstrated 
in laboratory crosses of the parasite [16,33], and 
high rates of recombination have been observed in 
natural populations of P. falciparum [34]. A P. 
falciparum population model has proposed that 
individual PfEMP-1 variants can confer enhanced 
and long lasting immunity relative to sporozoite 
and merozoite antigens and will thus structure the 
parasite population into distinct and rarely re- 
combining strains that have little overlap between 
their PfEMP-1 repertoires [13]. The phylogenetic 
analysis presented here, places var sequences from 
genetically different co-circulating parasite clones 
in clusters with a high bootstrap support. It also 
places some var genes from parasite isolates of 
diverse origin in well-supported clusters. Finally, 
it illustrates that many DEL-1 sequences are not 
more closely related to any particular sequence 
than they are to any other. Recombination be­ 
tween rapidly evolving sequences is the most plau­ 
sible mechanism to explain these patterns of 
DBL-1 diversity. The phylogenetic analysis sup­ 
ports neither a 'distinct strains' model for P. 
falciparum, nor distinctly segregating repertoires 
of var genes. Rather, it adds to the accumulated 
evidence for frequent recombination in randomly 
mating populations of P. falciparum. [35,36]. Ex­ 
tra-cellular portions of PflEMP-1 other than DBL- 
1 are known to be immunogenic [37] and it 
remains possible to hypothesise that such epitopes 
could be sufficiently immuno-dominant to 'strain- 
structure' the parasite population. However these 
regions of the protein are even more polymorphic 
than the DBL-1 domain, and it is unlikely that 
they are exempt from the exchanges that appear 
to be shuffling and reshuffling DBL-1.
DBL-1 is only one of several distinct domains 
of the complex PfEMP-1 molecule and the other 
part of the conserved 'head structure', the CIDR 
domain, can bind CD36 without help from any 
other PfEMP-1 sequences [37,38]. Binding to 
thrombospondin, to CD36 and the resetting of 
uninfected erythrocytes are the most common ad­ 
hesive phenotypes of parasitised erythrocytes [39-
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41]. Parasitised cells are known to express the 
cytoadherance phenotype prior to resetting and 
immunoglobulin binding [42]. Whether CIDR- 
mediated endothelial adhesion precedes DBL-1- 
mediated red blood cell capture within capillary 
beds or whether sequestrin [39], other regions of 
PfEMP-1, or other variable parasite encoded 
erythrocyte membrane proteins [43,44] are in­ 
volved in these processes is not known.
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